
<html lang="en"     class="pb-page"  data-request-id="b62678a0-7185-43f2-938e-3db34a05347b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2012.55.issue-18;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm301040s;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Anti-AIDS Agents 90. Novel C-28 Modified Bevirimat Analogues as Potent HIV Maturation Inhibitors" /></meta><meta name="dc.Creator" content="Keduo  Qian" /></meta><meta name="dc.Creator" content="Ibrahim D.  Bori" /></meta><meta name="dc.Creator" content="Chin-Ho  Chen" /></meta><meta name="dc.Creator" content="Li  Huang" /></meta><meta name="dc.Creator" content="Kuo-Hsiung  Lee" /></meta><meta name="dc.Description" content="In a continuing study of bevirimat (2), the anti-HIV-maturation clinical trials agent, 28 new betulinic acid (BA, 1) derivatives were designed and synthesized. Among these compounds, 17, with a C-2..." /></meta><meta name="Description" content="In a continuing study of bevirimat (2), the anti-HIV-maturation clinical trials agent, 28 new betulinic acid (BA, 1) derivatives were designed and synthesized. Among these compounds, 17, with a C-2..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 14, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301040s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301040s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301040s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301040s" /></link>
        
    
    

<title>Anti-AIDS Agents 90. Novel C-28 Modified Bevirimat Analogues as Potent HIV Maturation Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301040s" /></meta><meta property="og:title" content="Anti-AIDS Agents 90. Novel C-28 Modified Bevirimat Analogues as Potent HIV Maturation Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0008.jpeg" /></meta><meta property="og:description" content="In a continuing study of bevirimat (2), the anti-HIV-maturation clinical trials agent, 28 new betulinic acid (BA, 1) derivatives were designed and synthesized. Among these compounds, 17, with a C-28 MEM ester moiety, and 22, with a C-28 ethyl hexanoate, increased the anti-HIV replication activity compared with 2 by 2-fold while compounds 40, 41, 48, and 49, with C-28 piperazine or piperidine amide substitutions, increased the activity by 3- to 15-fold. The best new compound, 41, exhibited an anti-HIV IC50 of 0.0059 μM compared with 0.087 μM for 2. All of the active compounds showed only antimaturation effects, as confirmed by TZM-bl assay, in blocking the HIV replication. The results suggest that proper C-28 substitutions can further enhance the antimaturation activity of 2 without any antientry effects. Thus, 41 may serve as a promising new lead for development of anti-AIDS clinical trial candidates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301040s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301040s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301040s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301040s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301040s&amp;href=/doi/10.1021/jm301040s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8128-8136</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301024w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301066h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Anti-AIDS Agents 90. Novel C-28 Modified Bevirimat Analogues as Potent HIV Maturation Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keduo++Qian">Keduo Qian</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ibrahim+D.++Bori">Ibrahim D. Bori</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chin-Ho++Chen">Chin-Ho Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Huang">Li Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuo-Hsiung++Lee">Kuo-Hsiung Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung 401, Taiwan</span></div><div class="corresp-info"><strong>*</strong>For K.Q.: phone, 919-883-5306; fax, 919-966-3893; e-mail, <a href="/cdn-cgi/l/email-protection#7e151a0f171f103e0b101d501b1a0b"><span class="__cf_email__" data-cfemail="82e9e6f3ebe3ecc2f7ece1ace7e6f7">[email protected]</span></a>. For K.-H.L.: phone, 919-962-0066; fax, 919-966-3893; e-mail, <a href="/cdn-cgi/l/email-protection#a3c8cbcfc6c6e3d6cdc08dc6c7d6"><span class="__cf_email__" data-cfemail="92f9fafef7f7d2e7fcf1bcf7f6e7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301040s&amp;href=/doi/10.1021%2Fjm301040s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8128–8136</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 14, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 July 2012</li><li><span class="item_label"><b>Published</b> online</span>14 September 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 September 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301040s" title="DOI URL">https://doi.org/10.1021/jm301040s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8128%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKeduo%2BQian%252C%2BIbrahim%2BD.%2BBori%252C%2BChin-Ho%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D18%26contentID%3Djm301040s%26title%3DAnti-AIDS%2BAgents%2B90.%2BNovel%2BC-28%2BModified%2BBevirimat%2BAnalogues%2Bas%2BPotent%2BHIV%2BMaturation%2BInhibitors%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8136%26publicationDate%3DSeptember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301040s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1771</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301040s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Anti-AIDS Agents 90. Novel C-28 Modified Bevirimat Analogues as Potent HIV Maturation Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Keduo&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Ibrahim&quot;,&quot;last_name&quot;:&quot;D. Bori&quot;},{&quot;first_name&quot;:&quot;Chin-Ho&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Kuo-Hsiung&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;8128-8136&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301040s&quot;},&quot;abstract&quot;:&quot;In a continuing study of bevirimat (2), the anti-HIV-maturation clinical trials agent, 28 new betulinic acid (BA, 1) derivatives were designed and synthesized. Among these compounds, 17, with a C-28 MEM ester moiety, and 22, with a C-28 ethyl hexanoate, increased the anti-HIV replication activity compared with 2 by 2-fold while compounds 40, 41, 48, and 49, with C-28 piperazine or piperidine amide substitutions, increased the activity by 3- to 15-fold. The best new compound, 41, exhibited an anti-HIV IC50 of 0.0059 μM compared with 0.087 μM for 2. All of the active compounds showed only antimaturation effects, as confirmed by TZM-bl assay, in blocking the HIV replication. The results suggest that proper C-28 substitutions can further enhance the antimaturation activity of 2 without any antientry effects. Thus, 41 may serve as a promising new lead for development of anti-AIDS clinical trial candidates.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301040s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301040s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301040s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301040s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301040s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301040s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301040s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301040s&amp;href=/doi/10.1021/jm301040s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301040s" /></input><a href="/doi/pdf/10.1021/jm301040s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (483 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301040s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301040s%26sid%3Dliteratum%253Aachs%26pmid%3D22978745%26genre%3Darticle%26aulast%3DQian%26date%3D2012%26atitle%3DAnti-AIDS%2BAgents%2B90.%2BNovel%2BC-28%2BModified%2BBevirimat%2BAnalogues%2Bas%2BPotent%2BHIV%2BMaturation%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D18%26spage%3D8128%26epage%3D8136%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290659" title="DNA replication">DNA replication</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jmcmar.2012.55.issue-18/production/jmcmar.2012.55.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In a continuing study of bevirimat (<b>2</b>), the anti-HIV-maturation clinical trials agent, 28 new betulinic acid (BA, <b>1</b>) derivatives were designed and synthesized. Among these compounds, <b>17</b>, with a C-28 MEM ester moiety, and <b>22</b>, with a C-28 ethyl hexanoate, increased the anti-HIV replication activity compared with <b>2</b> by 2-fold while compounds <b>40</b>, <b>41</b>, <b>48</b>, and <b>49</b>, with C-28 piperazine or piperidine amide substitutions, increased the activity by 3- to 15-fold. The best new compound, <b>41</b>, exhibited an anti-HIV IC<sub>50</sub> of 0.0059 μM compared with 0.087 μM for <b>2</b>. All of the active compounds showed only antimaturation effects, as confirmed by TZM-bl assay, in blocking the HIV replication. The results suggest that proper C-28 substitutions can further enhance the antimaturation activity of <b>2</b> without any antientry effects. Thus, <b>41</b> may serve as a promising new lead for development of anti-AIDS clinical trial candidates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>∥</span> Author Contributions</h4><p class="last">These authors contributed equally to the paper.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although introduction of highly active antiretroviral therapy (HAART) has significantly improved the treatment of HIV/AIDS,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> HIV incidence is still increasing in many countries and regions. Over 2.6 million new infections occurred in 2009 alone, contributing to the current global incidence of 33.3 million.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> New infections continue to outpace the number of people placed on treatments, and the virus is suppressed rather than eradicated.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> In addition, the efficacy of the treatments is hampered by the emergence of drug-resistant viral strains and severe drug–drug interactions.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Therefore, novel potent antiretroviral agents with different targets are still urgently needed.</div><div class="NLM_p">Triterpenes, such as betulinic acid (BA, <b>1</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> represent a promising class of anti-HIV agents with novel mechanisms. In our prior research on modified triterpenes, bevirimat [3-<i>O</i>-(3′,3′-dimethylsuccinyl)betulinic acid, <b>2</b>] was found to exhibit remarkable anti-HIV-1 activity against primary and drug-resistant HIV-1 isolates (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Mechanism of action study revealed that <b>2</b> blocks the last step of viral gag precursor polyprotein processing from p25 (CA-SP1) to functional p24 (CA), resulting in the production of noninfectious immature HIV-1 particles.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Therefore, <b>2</b> represents a unique first in a class of anti-HIV compounds termed maturation inhibitors (MIs), and it succeeded in phase I and IIa clinical trials against sensitive viruses during 2007–2009.<a onclick="showRef(event, 'ref14 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17 ref18 ref19 ref20">(14, 16-20)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Introduction of a C-28 side chain into a C-3 modified BA-analog (e.g., <b>2</b>) can generate a bifunctional HIV inhibitor with both antimaturation and antientry activities.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Consequently, in the current study, additional C-28 side chains were investigated. Interestingly, it was discovered that certain C-28 side chains could significantly enhance the anti-HIV maturation activity of <b>2</b> without introducing the second mechanism of antientry effects. Their syntheses, anti-HIV evaluation, and structure–activity relationship (SAR) correlations are reported in this paper.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design</h3><div class="NLM_p">Prior C-28 modification of <b>1</b> focused only on the promotion of anti-HIV entry activity. It was found that C-28 amide functionality, a second aminoalkanoic acid group near the end of the C-28 side chain, and a 7–10 carbon alkane chain between these two amide moieties are important to the enhanced antientry potency.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In order to design antimaturation promoting C-28 side chains without an antientry effect, we first synthesized a group of BA derivatives (<b>3</b>, <b>4</b>, <b>7</b>–<b>15</b>, and <b>29</b>) with a C-28 ester moiety rather than the prior amide functionality. Methoxymethyl (MOM), methoxyethoxymethyl (MEM), and tetraethylene glycol chains were incorporated to improve the hydrophilicity of the compounds (<b>7</b>, <b>8</b>, and <b>29</b>) and to investigate the influence of a polar heteroatom (e.g., oxygen) present within the C-28 side chain, which was originally a pure carbon alkane chain. Bulky substitutions (<b>9</b> and <b>12</b>) and an unsaturated C-28 chain (<b>11</b>) were also synthesized. Different lengths of the C-28 alkane chains with or without a second ester group near the terminus were also investigated (<b>14</b> vs <b>10</b>, <b>13</b>, and <b>15</b>). These 28-modified BA derivatives were evaluated for anti-HIV replication activity to determine if these compounds function as HIV-1 entry inhibitors before the C-3 antimaturation pharmacophore, a dimethylsuccinyl side chain, was incorporated to generate the corresponding 28-substituted derivatives (<b>16</b>–<b>24</b> and <b>30</b>) of <b>2</b>.</div><div class="NLM_p">In addition, a cyclic secondary amine from piperazinebutyric acid or piperazinepentanoic acid, rather than a primary amine, was used to form the amide bond with the C-28 carboxylic acid of <b>1</b> to yield compounds <b>38</b> and <b>39</b>. In this design, an additional polar heteroatom nitrogen was present within the side chain, and the substitution near the C-28 amide moiety was bulkier, in order to reduce the potential antientry activity and promote the antimaturation effect. The corresponding C-3 succinylated compounds <b>40</b> and <b>41</b> were then prepared and evaluated in comparison with <b>2</b>. Previously synthesized compounds <b>42</b>–<b>49</b>, with C-28 piperidine side chains (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> were also tested because of their structural similarity to <b>38</b>–<b>41</b>. The SAR of the antimaturation promoting activity of C-28 side chains was then established.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of BA derivatives <b>3</b>–<b>6</b> were carried out according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Four equivalents of MOMCl or MEMCl were reacted with <b>1</b> and DIEA in CH<sub>2</sub>Cl<sub>2</sub> at room temperature overnight or in THF at 65 °C for 6 h to generate compounds <b>3</b> and <b>4</b>, respectively, in 83% or 89% yield. Hydrolysis of <b>3</b> and <b>4</b> using 4 N NaOH provided <b>5</b> and <b>6</b> in over 90% yield.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> depicts the synthetic pathway to compounds <b>7</b>–<b>24</b>. Compounds <b>7</b> and <b>8</b> were obtained by reducing the amount of MOMCl or MEMCl to 1.1 equiv in the reaction mixture. <i>N</i>-Hydroxysuccinimide and <b>1</b> were reacted in the presence of EDCI and DMAP overnight to furnish <b>9</b> in 53% yield. Compounds <b>10</b>–<b>15</b> (67–98% yield) were obtained by treating <b>1</b> with Cs<sub>2</sub>CO<sub>3</sub>, followed by adding different halogenated alkanes or alkynes. Esterification of <b>7</b>–<b>11</b> and <b>13</b>–<b>15</b> with 2,2-dimethylsuccinic anhydride was conducted using microwave conditions rather than conventional oil-bath heating to yield compounds <b>16</b>–<b>23</b>. A catalytic amount of PTSA and THF as solvent was used instead of pyridine, resulting in yields of 40–55%. Compound <b>24</b> was synthesized in 75% yield by click reaction of <b>20</b> with AZT in the presence of CuI and <i>N</i>,<i>N</i>-diisopropylethylamine in DMF using a microwave synthesizer at 120 °C for 30 min.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A tetraethyleneglycol chain was also introduced at the C-28 position of <b>2</b>, and compounds <b>29</b> and <b>30</b> were prepared as described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Overall, <b>25</b> was first protected with TBSCl to yield <b>26</b>, which was then converted to bromo-substituted <b>27</b> in 85% yield by reaction with CBr<sub>4</sub> using PPh<sub>3</sub> and pyridine. Reaction of <b>27</b> with <b>1</b> provided <b>28</b> in a yield of 72%, and deprotection of <b>28</b> using TBAF provided <b>29</b>. Compound <b>30</b> was prepared by a microwave reaction as described above.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The syntheses of piperazine incorporated BA derivatives <b>38</b>–<b>41</b> were achieved according to Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. The C-28 piperazine side chains of <b>34</b> and <b>35</b> were prepared in toluene at 80 °C. C-3 acetyl protected BA (3-OAc-BA) was prepared previously<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and was activated by oxalyl chloride before reacting with <b>34</b> and <b>35</b> to furnish <b>36</b> and <b>37</b> in 89% and 100% yields, respectively. After hydrolysis, the resulting compounds <b>38</b> and <b>39</b> were reacted with 2,2-dimethylsuccinic anhydride in a microwave synthesizer to provide compounds <b>40</b> and <b>41</b> in approximately 40% yield.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The anti-HIV-1 replication activity of BA derivatives <b>3</b>–<b>24</b>, <b>29</b>, <b>30</b>, and <b>38</b>–<b>49</b> was assessed in HIV-1<sub>NL4-3</sub> infected MT-4 cell lines in parallel with AZT and <b>2</b>, and the results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The results indicated that compounds with MOM or MEM substitution at C-3 (<b>5</b> and <b>6</b>), C-28 (<b>7</b> and <b>8</b>), or both positions (<b>3</b> and <b>4</b>) of <b>1</b> did not show anti-HIV activity. Similarly, compounds <b>9</b>–<b>15</b> and <b>29</b> with a C-3 hydroxy group and C-28 ester substitutions of different length or size, or with heteroatoms within the side chains, did not show antiviral activity, suggesting that <b>1</b> derivatives bearing ester modifications at the C-28 position do not exhibit anti-HIV-1 activity and are not entry inhibitors. The results confirmed that C-3 dimethylsuccinyl substitution is essential to the antimaturation activity of <b>2</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Anti-HIV-1 Replication Activities in HIV-1<sub>NL4-3</sub> Infected MT-4 Cell Lines<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">TI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AZT</td><td class="colsep0 rowsep0" align="left">0.030</td><td class="colsep0 rowsep0" align="left">>37</td><td class="colsep0 rowsep0" align="left">1248</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bevirimat (<b>2</b>)</td><td class="colsep0 rowsep0" align="left">0.087</td><td class="colsep0 rowsep0" align="left">14.2</td><td class="colsep0 rowsep0" align="left">171</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">12.4</td><td class="colsep0 rowsep0" align="left">70.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">0.046</td><td class="colsep0 rowsep0" align="left">12.1</td><td class="colsep0 rowsep0" align="left">261.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">11.0</td><td class="colsep0 rowsep0" align="left">86.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.088</td><td class="colsep0 rowsep0" align="left">10.4</td><td class="colsep0 rowsep0" align="left">118.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">0.067</td><td class="colsep0 rowsep0" align="left">15.3</td><td class="colsep0 rowsep0" align="left">226.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">14.8</td><td class="colsep0 rowsep0" align="left">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.056</td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="left">153.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">11.0</td><td class="colsep0 rowsep0" align="left">101.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">0.079</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">111.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">0.011</td><td class="colsep0 rowsep0" align="left">13.0</td><td class="colsep0 rowsep0" align="left">1181</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">0.0059</td><td class="colsep0 rowsep0" align="left">13.2</td><td class="colsep0 rowsep0" align="left">2237</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">NS<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">>13.3</td><td class="colsep0 rowsep0" align="left">>55.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">0.07</td><td class="colsep0 rowsep0" align="left">10.9</td><td class="colsep0 rowsep0" align="left">155.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">0.035</td><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">286.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">0.031</td><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">321.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">All data presented are averages of at least three separate experiments. IC<sub>50</sub>: concentration that inhibits HIV-1<sub>NL4-3</sub> replication by 50%. CC<sub>50</sub>: concentration that inhibits mock-infected MT-4 cell growth by 50%. TI = CC<sub>50</sub>/IC<sub>50</sub>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">NS: no suppression at the testing concentration (10 μM).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">NT: not tested.</p></div></div></div><div class="NLM_p">Diverse C-28 ester substituted <b>2</b> derivatives (<b>16</b>–<b>24</b> and <b>30</b>) were then investigated to establish the SAR of the C-28 side chain toward <b>2</b>’s antimaturation potency. Compounds <b>19</b>, <b>21</b>, and <b>23</b>, with the C-28 alkane chain length increasing from propyl to hexyl to octyl, respectively, showed a decreasing activity trend. While <b>19</b> (IC<sub>50</sub> = 0.088 μM) and <b>2</b> (IC<sub>50</sub> = 0.087 μM) exhibited equivalent anti-HIV potency, compound <b>21</b> was approximately 20-fold less potent (IC<sub>50</sub> = 1.8 μM) and <b>23</b> showed no inhibition of HIV-1 replication. Compound <b>20</b>, with a C-28 prop-2-ynyl moiety, exhibited good antiviral activity (IC<sub>50</sub> = 0.067 μM), and <b>22</b>, with a second ester substitution at the terminus of a C-28 hexyl chain, showed increased antiviral potency (IC<sub>50</sub> = 0.056 μM). For those compounds with one or two polar oxygen atoms present within their C-28 side chain, <b>16</b> (MOM ester) had an anti-HIV IC<sub>50</sub> of 0.17 μM, while <b>17</b> (MEM ester) had an IC<sub>50</sub> of 0.046 μM and thus was 3.7-fold more potent than <b>16</b> and 2-fold more potent than <b>2</b>. Compound <b>30</b>, with a C-28 tetraethylene glycol side chain terminating in a dimethyl succinyl ester, in addition to the dimethyl succinyl ester at C-3, was equipotent (IC<sub>50</sub> = 0.079 μM) with <b>2</b>. Compounds with bulky C-28 substituents, such as an <i>N</i>-succinimide ester (<b>18</b>), or conjugated to AZT through a triazole linkage (<b>24</b>) displayed slightly reduced anti-HIV-1 activity (IC<sub>50</sub> of 0.13 and 0.10 μM, respectively) relative to <b>2</b>.</div><div class="NLM_p">To further investigate the effect of C-28 side chains, cyclic secondary amines from piperazinebutyric acid, piperazinepentanoic acid, and piperidinebutyric acid, rather than a primary amine, were used in amidation reactions with the C-28 carboxylic acid of 3-acetylated BA, resulting in <b>38</b>, <b>39</b>, and <b>42</b>–<b>45</b>. None of these <b>1</b> analogues exhibited anti-HIV replication activity in MT-4 lymphocytes, suggesting that bulkier C-28 amide moieties compromised the antientry effect of C-28 modified BAs.</div><div class="NLM_p">Subsequently, the C-3 hydroxy group of <b>38</b>, <b>39</b>, and <b>42</b>–<b>45</b> was esterified with a dimethylsuccinyl moiety. Among the resulting compounds, <b>40</b>, <b>41</b>, <b>48</b>, and <b>49</b> showed significantly increased antiviral activity (IC<sub>50</sub> values ranging from 0.0059 to 0.035 μM). These results indicate that incorporating a cyclic secondary amide group with an extended side chain at the C-28 position can remarkably enhance the activity of <b>2</b>. Specifically, a C-28 amide from piperidinebutyric acid with a second amide group formed from ethylmorpholine (<b>48</b>) or propylmorpholine (<b>49</b>) increased the antiviral activity of <b>2</b> by about 3-fold, with IC<sub>50</sub> values of 0.035 and 0.031 μM, respectively. The presence of additional polar nitrogen heteroatom within the C-28 amide side chain (from piperazinebutyric or piperazinepentanoic acid) significantly increased the potency by 8- to 15-fold, as shown by compound <b>40</b> (IC<sub>50</sub> = 0.011 μM) and <b>41</b> (IC<sub>50</sub> = 0.0059 μM), respectively.</div><div class="NLM_p">A TZM-bl assay was used to confirm the mechanism of action of active compounds. This assay measures neutralization in TZM-bl cells as a function of a reduction in Tat-induced luciferase (Luc) reporter gene expression after a single round of virus infection. The TZM-bl cell line is a HeLa cell clone that was engineered to express CD4 and CCR5 and contains integrated reporter gene for firefly luciferase and <i>E.coli</i> β-galactosidase under control of an HIV-1 LTR. Expression of the reporter genes is induced in trans by viral Tat protein soon after infection, and the TZM-bl assay can detect HIV-entry inhibitors sensitively. However, because maturation inhibitors block HIV-1 replication only at the last step of the viral life cycle and, thus, still permit the production of immature noninfectious viral particles, the single round TZM-bl assay cannot detect HIV-maturation inhibitors because the expression of reporter gene is not impaired in the first cycle. Therefore, all of the novel active 3,28-modified BAs were further screened in this assay system. As expected, none of the compounds were active in the single round TZM-bl assay, proving that they do not function as HIV entry inhibitors and, thus, their antiviral replication activity should result from an antimaturation mechanism of action.</div><div class="NLM_p">The following SAR conclusions summarize the effects of the C-28 substitutions to promote the antimaturation activity of <b>2</b>. C-28 ester side chains with a three- to six-carbon alkyl chain result in enhanced anti-HIV activity. The presence of a polar oxygen atom within the side chain and the introduction of a second ester functionality at the terminus of the C-28 ester chain can moderately enhance the antimaturation activity of <b>2</b>, as shown by <b>17</b> and <b>22</b>. Meanwhile, while <b>1</b> analogues with C-28 primary amide substitutions function as antientry agents, <b>1</b> analogues with C-28 secondary cyclic amide groups do not. Instead, the latter compounds exhibit significant antimaturation promoting activity. Thus far, compound <b>41</b>, which has an additional polar nitrogen heteroatom present in the C-28 amide (piperazinepentanoic acid), showed the best antiviral replication activity acting through an antimaturation mechanism of action.</div><div class="NLM_p">To evaluate its potential as a drug candidate, <b>41</b> was further assessed for its in vitro metabolic stability in pooled human liver microsomes (HLMs). The results revealed that 86.15% of <b>41</b> remained intact after 60 min of incubation in HLMs. Compound <b>41</b>’s long in vitro half-life (<i>t</i><sub>1/2</sub> of 327 min) and low clearance (CL<sub>int</sub> of 0.0021 mL min<sup>–1</sup> mg<sup>–1</sup>) proved that incorporation of C-28 cyclic secondary amide chains would not decrease the stability of <b>2</b>, which has a long elimination half-life (<i>t</i><sub>1/2</sub> of 56.3–69.5 h) in healthy volunteers.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p last">Overall, new BA derivatives were designed and synthesized in order to investigate the modulating effects of C-28 substitution toward <b>2</b>’s antimaturation activity. It was discovered that certain ester or cyclic secondary amide substitutions at C-28 will enhance the antiviral activity of <b>2</b>, acting only through an antimaturation effect. The best new compound <b>41</b> showed excellent anti-HIV activity with an IC<sub>50</sub> of 0.0059 μM, 15-fold better than that of <b>2</b>. Compound <b>41</b> also exhibited good in vitro metabolic stability in HLMs, and therefore, may serve as an attractive new lead for the development of a next generation of maturation inhibitors as anti-AIDS clinical trial candidates.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p last">The melting points were measured with a Fisher Johns melting apparatus without correction. <sup>1</sup>H NMR spectra were measured on an Inova 400 MHz spectrometer using Me<sub>4</sub>Si (TMS) as internal standard. The solvent used was CDCl<sub>3</sub>, unless otherwise indicated. High resolution mass spectra were measured on a Shimadzu LCMS-IT-TOF with ESI interface. HPLC for purity determinations was conducted using a Shimadzu LCMS with a Grace Alltima 2.1 mm ×150 mm HP C18 5 μm column and a Shimadzu SPD-M20A detector at 205 or 220 nm wavelength. The detailed solvent percentage conditions for each tested compound are listed in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>. All target compounds were at least 95% pure. Optical rotations were measured with a Jasco Dip-2000 digital polarimeter at 25 °C at the sodium D line. Thin-layer chromatography (TLC) was performed on Merck precoated silica gel 60 F-254 plates. For purification of all synthetic BA derivatives, a Grace Reveleris flash system equipped with RevealX detection allowing for multisignal (UV/ELSD) collection to low milligram quantities was used for medium pressure column chromatography. Reveleris Navigator method optimizer and Grace Reveleris flash silica cartridges were employed for high quality separations. Commercial chemicals were obtained from Sigma-Aldrich, Inc.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Syntheses of <b>3</b> and <b>7</b></h3><div class="NLM_p last">Compound <b>1</b> (1 equiv), DIEA (4 equiv), and MOMCl (4 equiv for <b>3</b> and 1.1 equiv for <b>7</b>) were dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at 0 °C. The mixture was stirred overnight under N<sub>2</sub>, allowing a gradual warming to room temperature. The solution was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and washed with brine. The organic layer was dried over anhydrous MgSO<sub>4</sub> and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield the pure target compounds <b>3</b> and <b>7</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Methoxymethyl 3β-Methoxymethoxylup-20(<b>29</b>)-en-28-oate (<b>3</b>)</h3><div class="NLM_p last">Yield, 149 mg (83% yield), starting from 179 mg of <b>1</b>; white amorphous powder. Mp 99–102 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 543.3991 (C<sub>34</sub>H<sub>56</sub>O<sub>5</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.28–5.22 (2H, app d, <i>J</i> = 5.6 Hz, -COOC<i>H</i><sub>2</sub>O-), 4.80, 4.67 (1H each, app d, <i>J</i> = 6.4 Hz, -OC<i>H</i><sub>2</sub>O-), 4.73, 4.61 (1H each, s, H-29), 3.48, 3.38 (3H each, s, -OC<i>H</i><sub>3</sub>), 3.08–2.99 (2H, m, H-3, H-19), 1.69 (3H, s, H-30), 0.97, 0.95, 0.93, 0.83, 0.78 (3H each, s, 5 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.9, 16.2, 16.4, 16.5, 18.5, 19.6, 21.1, 24.4, 25.8, 28.2, 29.8, 30.8, 32.2, 34.6, 37.1, 37.3, 38.5, 38.9, 38.9, 41.0, 42.6, 47.1, 49.6, 50.8, 55.7, 56.0, 57.0, 57.9, 85.4, 90.1, 96.2, 109.9, 150.7, 175.8.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Methoxymethyl 3β-Hydroxylup-20(<b>29</b>)-en-28-oate (<b>7</b>)</h3><div class="NLM_p last">Yield, 190 mg (86% yield), starting from 200 mg of <b>1</b>; white amorphous powder. Mp 114–115 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 499.3745 (C<sub>32</sub>H<sub>52</sub>O<sub>4</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.28–5.22 (2H, app q, <i>J</i> = 6.0, 5.6 Hz, -COOC<i>H</i><sub>2</sub>O-), 4.73, 4.61 (1H each, s, H-29), 3.48 (3H, s, -OC<i>H</i><sub>3</sub>), 3.18 (1H, dd, <i>J</i> = 11.2, 5.2 Hz, H-3), 3.05–2.98 (1H, m, H-19), 2.21–2.30 (2H, m, H-16), 1.69 (3H, s, H-30), 0.97, 0.96, 0.93, 0.82, 0.75 (3H each, s, 5 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.9, 15.6, 16.2, 16.3, 18.5, 19.6, 21.1, 25.7, 27.6, 28.2, 29.8, 29.9, 30.7, 32.2, 34.6, 37.1, 37.4, 38.4, 38.9, 39.0, 40.9, 42.6, 47.1, 49.6, 50.8, 55.6, 56.9, 57.9, 79.1, 90.1, 109.9, 150.6, 175.8.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Syntheses of <b>4</b> and <b>8</b></h3><div class="NLM_p last">Compound <b>1</b> (1 equiv), DIEA (4 equiv), and MEMCl (4 equiv for <b>4</b> and 1.1 equiv for <b>8</b>) were dissolved in THF (5 mL) at room temperature. For <b>4</b>, the mixture was stirred at 65 °C under N<sub>2</sub> for 6 h, and for <b>8</b>, the mixture was stirred at 60 °C for 3 h. The solution was then diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub>, and washed with brine. The organic layer was dried over anhydrous MgSO<sub>4</sub> and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield the pure target compounds <b>4</b> and <b>8</b>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Methoxyethoxymethyl 3β-Methoxyethoxymethoxylup-20(29)-en-28-oate (<b>4</b>)</h3><div class="NLM_p last">Yield, 311 mg (89% yield), starting from 252 mg of <b>1</b>; white amorphous powder. Mp 102–105 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 655.4579 (C<sub>38</sub>H<sub>64</sub>O<sub>7</sub> + Na). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.37–5.30 (2H, app dd, <i>J</i> = 6.0, 5.8 Hz, -COOC<i>H</i><sub>2</sub>O-), 4.81, 4.65 (1H each, app d, <i>J</i> = 6.8 Hz, -OC<i>H</i><sub>2</sub>O-), 4.71, 4.58 (1H each, s, H-29), 3.80, 3.71, 3.57, 3.50 (2H each, m, 2 × -OC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>O-), 3.38 (6H, s, 2 × -OC<i>H</i><sub>3</sub>), 3.09–3.05 (1H, dd, <i>J</i> = 11.4, 4.4, 4.0 Hz, H-3), 3.01–2.94 (1H, m, H-19), 1.68 (3H, s, H-30), 0.97, 0.93, 0.91, 0.83, 0.77 (3H each, s, 5 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.91, 16.25, 16.38, 16.49, 18.51, 19.59, 21.14, 24.30, 25.78, 28.27, 29.88, 30.76, 32.20, 34.60, 37.10, 37.27, 38.45, 38.86, 38.89, 41.98, 42.64, 47.11, 49.62, 50.79, 55.94, 56.93, 59.26, 59.31, 67.19, 69.70, 71.76, 72.07, 85.33, 89.08, 95.13, 109.88, 150.70, 175.79.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Methoxyethoxymethyl 3β-Hydroxylup-20(29)-en-28-oate (<b>8</b>)</h3><div class="NLM_p last">Yield, 219 mg (92% yield), starting from 200 mg of <b>1</b>; white amorphous powder. Mp 119–121 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 567.4043 (C<sub>34</sub>H<sub>56</sub>O<sub>5</sub> + Na). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.37–5.30 (2H, app dd, <i>J</i> = 6.4, 6.0 Hz, -COOC<i>H</i><sub>2</sub>O-), 4.73, 4.60 (1H each, s, H-29), 3.80, 3.56 (2H each, t, <i>J</i> = 5.2 Hz, -OC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>O-), 3.39 (3H, s, -OC<i>H</i><sub>3</sub>), 3.18 (1H, m, H-3), 3.04–2.98 (1H, m, H-19), 1.68 (3H, s, H-30), 1.00, 0.97, 0.92, 0.82, 0.75 (3H each, s, 5 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.9, 15.6, 16.2, 16.4, 18.5, 19.6, 21.1, 25.8, 27.6, 28.2, 29.9, 30.8, 32.2, 34.6, 37.1, 37.4, 38.4, 39.0, 39.1, 41.0, 42.7, 47.1, 49.6, 50.8, 55.6, 56.9, 59.3, 69.7, 71.8, 79.2, 89.1, 109.9, 150.7, 175.8.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Syntheses of <b>34</b> and <b>35</b></h3><div class="NLM_p last">Piperazine <b>31</b> (2 equiv) was dissolved in toluene, and the mixture was heated to 80 °C. Compound <b>32</b> or <b>33</b> (1 equiv) was added, and the reaction proceeded for 4 h. After the mixture was cooled and filtered, the organic layer was concentrated under reduced pressure. The residue was chromatographed using a silica gel column to yield 500 mg of <b>34</b> (50%) and 498 mg of <b>35</b> (42%).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Syntheses of <b>36</b> and <b>37</b></h3><div class="NLM_p last">Oxalyl chloride solution (2 M in CH<sub>2</sub>Cl<sub>2</sub>, 10 mL) was added to 3-OAc-BA (1 equiv)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), and the mixture was stirred for 2 h. After concentration under vacuum, the residual mixture was treated with <b>34</b> or <b>35</b> (1.6 equiv) and triethylamine (Et<sub>3</sub>N, 1.2 equiv) in CH<sub>2</sub>Cl<sub>2</sub>. The mixture was stirred at room temperature overnight. The solution was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and washed with brine. The organic layer was dried over anhydrous MgSO<sub>4</sub> and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield the pure target compounds <b>36</b> and <b>37</b>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Methyl <i>N</i>-[3β-Acetoxylup-20(29)-en-28-oyl]-4-piperazinebutanoate (<b>36</b>)</h3><div class="NLM_p last">Yield, 177.5 mg (89% yield), starting from 150 mg of 3-OAc-BA; white amorphous powder. Mp 203–205 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 667.5055 (C<sub>41</sub>H<sub>66</sub>N<sub>2</sub>O<sub>5</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.72, 4.60 (1H each, s, H-29), 4.47 (1H, dd, <i>J</i> = 12.4, 5.6 Hz, H-3), 3.68 (3H, s, -COOC<i>H</i><sub>3</sub>), 3.61–3.52 (4H, m, 28-CON(C<i>H</i><sub>2</sub>CH<sub>2</sub>)<sub>2</sub>N-), 3.01 (1H, m, H-19), 2.91–2.76 (4H, m, 28-CON(CH<sub>2</sub>C<i>H</i><sub>2</sub>)<sub>2</sub>N-), 2.46 (2H, m, -NC<i>H</i><sub>2</sub>-), 2.05 (3H, s, OCOC<i>H</i><sub>3</sub>), 1.68 (3H, s, H-30), 1.02, 0.99, 0.96, 0.85, 0.81 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methyl <i>N</i>-[3β-Acetoxylup-20(29)-en-28-oyl]-5-piperazinepentanoate (<b>37</b>)</h3><div class="NLM_p last">Yield, 847 mg (100% yield), starting from 622.8 mg of 3-OAc-BA; white amorphous powder. Mp 217–218 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 681.5219 (C<sub>42</sub>H<sub>68</sub>N<sub>2</sub>O<sub>5</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (1H each, s, H-29), 4.46 (1H, m, H-3), 3.67 (3H, s, -COOC<i>H</i><sub>3</sub>), 3.58–3.47 (4H, m, 28-CON(C<i>H</i><sub>2</sub>CH<sub>2</sub>)<sub>2</sub>N-), 3.00 (1H, m, H-19), 2.87–2.76 (4H, m, 28-CON(CH<sub>2</sub>C<i>H</i><sub>2</sub>)<sub>2</sub>N-), 2.46 (2H, m, -NC<i>H</i><sub>2</sub>-), 2.06 (3H, s, OCOC<i>H</i><sub>3</sub>), 1.69 (3H, s, H-30), 0.98, 0.97, 0.90, 0.86, 0.83 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Syntheses of <b>5</b>, <b>6</b>, <b>38</b>, and <b>39</b></h3><div class="NLM_p last">To a solution of the appropriate ester intermediates <b>3</b>–<b>4</b> and <b>36</b>–<b>37</b> (1 equiv) in MeOH (8 mL) and THF (4 mL) was added 4 N NaOH (4 mL). The mixture was stirred overnight and then neutralized with 20% HCl. The solution was dried under vacuum and reconstituted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with brine and dried over anhydrous MgSO<sub>4</sub> and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield the pure target compounds <b>5</b>–<b>6</b> and <b>38</b>–<b>39</b>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3β-Methoxymethoxybetulinic Acid (<b>5</b>)</h3><div class="NLM_p last">Yield, 85 mg (93% yield), starting from 100 mg of <b>3</b>; white amorphous powder. Mp 117–119 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 499.3730 (C<sub>32</sub>H<sub>52</sub>O<sub>4</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.75, 4.62 (1H each, app d, <i>J</i> = 6.4 Hz, -OC<i>H</i><sub>2</sub>O-), 4.71, 4.59 (1H each, s, H-29), 3.36 (3H, s, -OC<i>H</i><sub>3</sub>), 3.05–2.96 (2H, m, H-3, H-19), 1.71 (3H, s, H-30), 0.97, 0.95, 0.90, 0.83, 0.77 (3H each, s, 5 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.7, 16.1, 16.1, 16.3, 18.3, 19.4, 20.9, 24.2, 25.5, 28.0, 29.7, 30.6, 32.2, 34.3, 37.1, 38.4, 38.7, 40.7, 42.4, 47.0, 49.3, 50.5, 55.5, 55.7, 56.4, 77.3, 85.2, 96.0, 109.7, 150.4, 181.8.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3β-Methoxyethoxymethoxybetulinic Acid (<b>6</b>)</h3><div class="NLM_p last">Yield, 118 mg (92% yield), starting from 150 mg of <b>4</b>; white amorphous powder. Mp 121–124 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 567.4033 (C<sub>34</sub>H<sub>56</sub>O<sub>5</sub> + Na). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.80, 4.66 (1H each, app d, <i>J</i> = 6.8 Hz, -OC<i>H</i><sub>2</sub>O-), 4.70, 4.58 (1H each, s, H-29), 3.69, 3.52 (2H each, t, <i>J</i> = 4.4 Hz, -OC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>O-), 3.36 (3H, s, -OC<i>H</i><sub>3</sub>), 3.07 (1H, dd, <i>J</i> = 12.0, 4.4 Hz, H-3), 3.00 (1H, m, H-19), 1.67 (3H, s, H-30), 0.94, 0.91, 0.89, 0.80, 0.73 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-[3β-Hydroxylup-20(29)-en-28-oyl]-4-piperazinebutyric Acid (<b>38</b>)</h3><div class="NLM_p last">Yield, 91 mg (79% yield), starting from 125 mg of <b>36</b>; white amorphous powder. Mp 153–154 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 609.4646 (C<sub>38</sub>H<sub>62</sub>N<sub>2</sub>O<sub>4</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.71, 4.60 (1H each, s, H-29), 3.65–3.49 (4H, m, 28-CON(C<i>H</i><sub>2</sub>CH<sub>2</sub>)<sub>2</sub>N-), 3.17 (1H, m, H-3), 3.01 (1H, m, H-19), 2.82–2.68 (4H, m, 28-CON(CH<sub>2</sub>C<i>H</i><sub>2</sub>)<sub>2</sub>N-), 2.45 (2H, m, -NC<i>H</i><sub>2</sub>-), 1.69 (3H, s, H-30), 1.01, 0.98, 0.89, 0.84, 0.78 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-[3β-Hydroxylup-20(29)-en-28-oyl]-5-piperazinepentanoic Acid (<b>39</b>)</h3><div class="NLM_p last">Yield, 624 mg (85% yield), starting from 800 mg of <b>37</b>; white amorphous powder. Mp 159–161 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 623.4781 (C<sub>39</sub>H<sub>64</sub>N<sub>2</sub>O<sub>4</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.71, 4.58 (1H each, s, H-29), 3.64–3.51 (4H, m, 28-CON(C<i>H</i><sub>2</sub>CH<sub>2</sub>)<sub>2</sub>N-), 3.19 (1H, m, H-3), 2.99 (1H, m, H-19), 2.89–2.72 (4H, m, 28-CON(CH<sub>2</sub>C<i>H</i><sub>2</sub>)<sub>2</sub>N-), 2.46 (2H, m, -NC<i>H</i><sub>2</sub>-), 1.68 (3H, s, H-30), 0.98, 0.95, 0.92, 0.82, 0.81 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-Succinimide 3β-Hydroxylup-20(29)-en-28-oate (<b>9</b>)</h3><div class="NLM_p last">A mixture of <b>1</b> (260 mg, 1 equiv), <i>N</i>-hydroxysuccinimide (1.5 equiv), EDCI (1.5 equiv), and DMAP (0.1 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and stirred under N<sub>2</sub> at room temperature overnight. The solution was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and washed with brine. The organic layer was dried over anhydrous MgSO<sub>4</sub> and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield 167 mg of <b>9</b> (53% yield), a white amorphous powder. Mp 189–191 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 576.3656 (C<sub>34</sub>H<sub>51</sub>NO<sub>5</sub> + Na). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.72, 4.61 (2H, s, H-29), 3.18 (1H, dd, <i>J</i> = 11.2, 4.8 Hz, H-3), 2.95 (1H, m, H-19), 2.84, 2.82 (4H, d, <i>J</i> = 5.2 Hz, -COC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CO-), 2.47–2.42 (1H, m, H-13), 1.69 (3H, s, H-30), 0.98 (6H, s, 2 × CH<sub>3</sub>), 0.96, 0.82, 0.75 (3H each, s, 3 × CH<sub>3</sub>).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Syntheses of <b>26</b> and <b>27</b></h3><div class="NLM_p last">A mixture of tetraethylene glycol (<b>25</b>, 35 g, 5 equiv), TEA (1.5 equiv), and DMAP (0.1 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) at 0 °C. TBSCl (5 g, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added dropwise, and reaction continued overnight. The solution was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with mildly acidic water and brine. The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography to yield 50 g of TBS-protected tetraethylene glycol <b>26</b> (90%).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In the next step, a mixture of <b>26</b> (852 mg, 1 equiv) and CBr<sub>4</sub> (2 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) at 0 °C. Pyridine (2.5 mL, 10 equiv) was added, followed by PPh<sub>3</sub> (2 equiv). The mixture was stirred overnight with a gradual warming to room temperature. The suspension was filtered through Celite, and the organic layer was concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield 872 mg of bromo-substituted TBS-protected tetraethylene glycol <b>27</b> (85% yield).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Syntheses of <b>10</b>–<b>15</b> and <b>28</b></h3><div class="NLM_p last">Compound <b>1</b> (1 equiv) and CS<sub>2</sub>CO<sub>3</sub> (3 equiv) were dissolved in a 1:1 mixed solution of DMF and THF (4 mL), and the mixture was stirred for 30 min at room temperature. Bromo- or iodo-substituted compound (RX) or <b>27</b> (3 equiv) was then added, and the reaction was carried out overnight at room temperature. Water was added to stop the reaction, and the solution was extracted with EtOAc. The organic layer was washed further with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure. The residue was chromatographed using a silica gel column to yield the pure target compounds <b>10</b>–<b>15</b> and <b>28</b>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Propyl 3β-Hydroxylup-20(29)-en-28-oate (<b>10</b>)</h3><div class="NLM_p last">Yield, 56 mg (86% yield), starting from 60 mg of <b>1</b>; white amorphous powder. Mp 106–107 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 499.4155 (C<sub>33</sub>H<sub>54</sub>O<sub>3</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (2H, s, H-29), 4.09 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 3.18 (1H, dd, <i>J</i> = 11.2, 4.8 Hz, H-3), 3.01 (1H, m, H-19), 1.68 (3H, s, H-30), 1.01 (6H, s, 2 × CH<sub>3</sub>), 0.94 (3H, s, CH<sub>3</sub>), 0.91 (3H, m, CH<sub>3</sub>), 0.82, 0.76 (3H each, s, 2 × CH<sub>3</sub>).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Prop-2′-ynyl 3β-Hydroxylup-20(29)-en-28-oate (<b>11</b>)</h3><div class="NLM_p last">Yield, 47 mg (72% yield), starting from 60 mg of <b>1</b>; white amorphous powder. Mp 131–133 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 495.3826 (C<sub>33</sub>H<sub>50</sub>O<sub>3</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.61 (2H, s, H-29), 4.69, 4.65 (2H, d, <i>J</i> = 2.2 Hz, 28-COOC<i>H</i><sub>2</sub>-), 3.18 (1H, m, H-3), 3.01 (1H, m, H-19), 2.43 (1H, t, <i>J</i> = 2.2 Hz, -C≡C<i>H</i>), 1.69 (3H, s, H-30), 0.97 (6H, s, 2 × CH<sub>3</sub>), 0.93, 0.82, 0.75 (3H each, s, 3 × CH<sub>3</sub>).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3′-Phenylpropyl 3β-Hydroxylup-20(29)-en-28-oate (<b>12</b>)</h3><div class="NLM_p last">Yield, 72 mg (96% yield), starting from 60 mg of <b>1</b>; white amorphous powder. Mp 169–172 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 575.4465 (C<sub>39</sub>H<sub>58</sub>O<sub>3</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.31–7.26, 7.22–7.18 (5H, m, -C<sub>6</sub><i>H</i><sub>5</sub>), 4.73, 4.61 (2H, s, H-29), 4.09 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 3.18 (1H, m, H-3), 3.02 (1H, m, H-19), 2.72 (1H, t, <i>J</i> = 6.4 Hz, -C<i>H</i><sub>2</sub>C<sub>6</sub>H<sub>5</sub>), 1.69 (3H, s, H-30), 0.97, 0.96, 0.91, 0.81, 0.75 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Hexyl 3β-Hydroxylup-20(29)-en-28-oate (<b>13</b>)</h3><div class="NLM_p last">Yield, 48 mg (67% yield), starting from 60 mg of <b>1</b>; white amorphous powder. Mp 124–125 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 541.4629 (C<sub>36</sub>H<sub>60</sub>O<sub>3</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.59 (2H, s, H-29), 4.07 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 3.18 (1H, dd, <i>J</i> = 11.8, 4.4 Hz, H-3), 3.02 (1H, m, H-19), 1.68 (3H, s, H-30), 0.97 (6H, s, 2 × CH<sub>3</sub>), 0.92 (3H, s, CH<sub>3</sub>), 0.90 (3H, m, CH<sub>3</sub>), 0.82, 0.75 (3H each, s, 2 × CH<sub>3</sub>).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Ethyl <i>O</i>-[3β-Hydroxylup-20(29)-en-28-oyl]-6-hexanoate (<b>14</b>)</h3><div class="NLM_p last">Yield, 77 mg (98% yield), starting from 60 mg of <b>1</b>; white amorphous powder. Mp 191–194 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 599.4649 (C<sub>38</sub>H<sub>62</sub>O<sub>5</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.72, 4.59 (2H, s, H-29), 4.16–4.02 (4H, m, 28-COOC<i>H</i><sub>2</sub>-, -COOC<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.41 (1H, t, <i>J</i> = 6.8 Hz, -OH), 3.17 (1H, dd, <i>J</i> = 11.8, 4.4 Hz, H-3), 3.00 (1H, m, H-19), 2.31 (2H, m, -C<i>H</i><sub>2</sub>COO-), 1.68 (3H, s, H-30), 1.26 (3H, t, <i>J</i> = 7.2 Hz, -COOCH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.97 (6H, s, 2 × CH<sub>3</sub>), 0.91, 0.82, 0.75 (3H each, s, 3 × CH<sub>3</sub>).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Octyl 3β-Hydroxylup-20(29)-en-28-oate (<b>15</b>)</h3><div class="NLM_p last">Yield, 70 mg (94% yield), starting from 60 mg of <b>1</b>; white amorphous powder. Mp 146–147 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 569.4936 (C<sub>38</sub>H<sub>64</sub>O<sub>3</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (2H, s, H-29), 4.07 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 3.17 (1H, dd, <i>J</i> = 12.0, 4.0 Hz, H-3), 3.02 (1H, m, H-19), 1.68 (3H, s, H-30), 0.96 (6H, s, 2 × CH<sub>3</sub>), 0.92 (3H, s, CH<sub>3</sub>), 0.89 (3H, t, <i>J</i> = 6.4 Hz, CH<sub>3</sub>), 0.82, 0.75 (3H each, s, 2 × CH<sub>3</sub>).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-(2-(2-(2-<i>O</i>-<i>tert</i>-Butyldimethylsilylethoxy)ethoxy)ethoxy)ethyl 3β-hydroxylup-20(29)-en-28-oate (<b>28</b>)</h3><div class="NLM_p last">Yield, 142 mg (72% yield), starting from 120 mg of <b>1</b>; white amorphous powder. Mp 203–206 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 747.5603 (C<sub>44</sub>H<sub>78</sub>O<sub>7</sub>Si + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.62 (2H, s, H-29), 4.25 (2H, m, -COOC<i>H</i><sub>2</sub>CH<sub>2</sub>O-), 3.96–3.54 (2H each, m, -COOCH<sub>2</sub>C<i>H</i><sub>2</sub>O-, 3 × -OCH<sub>2</sub>CH<sub>2</sub>O-), 3.17 (1H, dd, <i>J</i> = 11.2, 4.8 Hz, H-3), 3.01 (1H, m, H-19), 1.68 (3H, s, H-30), 0.98 (12H, s, CH<sub>3</sub>, -Si(CH<sub>3</sub>)<sub>2</sub>C(C<i>H</i><sub>3</sub>)<sub>3</sub>), 0.91, 0.89, 0.82, 0.75 (3H each, s, 4 × CH<sub>3</sub>), 0.21 (6H, s, -Si(C<i>H</i><sub>3</sub>)<sub>2</sub>C(CH<sub>3</sub>)<sub>3</sub>).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl 3β-hydroxylup-20(29)-en-28-oate (<b>29</b>)</h3><div class="NLM_p last">To a solution of <b>28</b> (170 mg, 1 equiv) in THF (5 mL) was added TBAF (1.5 equiv). The mixture was stirred overnight at room temperature. The organic layer was concentrated to dryness under reduced pressure and the residue was chromatographed using a silica gel column to yield 166 mg of <b>29</b> (98% yield), a white amorphous powder. Mp 178–180 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 633.4743 (C<sub>38</sub>H<sub>64</sub>O<sub>7</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.61 (2H, s, H-29), 4.25 (2H, m, -COOC<i>H</i><sub>2</sub>CH<sub>2</sub>O-), 3.65–3.44 (2H each, m, -COOCH<sub>2</sub>C<i>H</i><sub>2</sub>O-, 3 × -OCH<sub>2</sub>CH<sub>2</sub>O-), 3.17 (1H, dd, <i>J</i> = 11.6, 4.8 Hz, H-3), 3.01 (1H, m, H-19), 1.68 (3H, s, H-30), 0.98, 0.97, 0.89, 0.82, 0.76 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Syntheses of <b>16</b>–<b>23</b>, <b>30</b>, <b>40</b>, and <b>41</b></h3><div class="NLM_p last">The appropriate BA derivative (1 equiv), 2,2-dimethylsuccinic anhydride (5 equiv), DMAP (1.6 equiv), and PTSA (catalytic amount) was dissolved in THF (1.5 mL), and the mixture was stirred at 130 °C for 2 h using a microwave synthesizer (Biotage). Water was added, and the mixture was then extracted with CH<sub>2</sub>Cl<sub>2</sub> (15 mL). The organic layer was dried over anhydrous MgSO<sub>4</sub> and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield pure target compounds <b>16</b>–<b>23</b>, <b>30</b>, <b>40</b>, and <b>41</b>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Methoxymethyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>16</b>)</h3><div class="NLM_p last">Yield, 25 mg (40% yield), starting from 52 mg of <b>7</b>; white amorphous powder. Mp 107–109 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 627.4247 (C<sub>38</sub>H<sub>60</sub>O<sub>7</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.11 (1H, br s, -COO<i>H</i>), 5.28–5.22 (2H, app d, <i>J</i> = 5.8 Hz, -COOC<i>H</i><sub>2</sub>O-), 4.72, 4.60 (1H each, s, H-29), 4.47 (1H, dd, <i>J</i> = 11.2, 5.6 Hz, H-3), 3.48 (3H, s, -OC<i>H</i><sub>3</sub>), 3.00 (1H, m, H-19), 2.64–2.42 (2H, m, H-2′), 1.68 (3H, s, H-30), 1.30, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 0.98, 0.97, 0.92, 0.81, 0.75 (3H each, s, 5 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.9, 16.2, 16.4, 16.7, 18.4, 19.6, 21.1, 23.8, 25.3, 25.7, 25.8, 28.1, 29.9, 30.8, 32.2, 34.5, 37.1, 37.3, 38.0, 38.4, 38.6, 40.7, 41.0, 42.6, 44.9, 47.1, 49.6, 50.7, 55.7, 57.0, 57.9, 81.8, 90.1, 109.9, 150.6, 171.2, 175.8, 182.6.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methoxyethoxymethyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>17</b>)</h3><div class="NLM_p last">Yield, 30.5 mg (41% yield), starting from 60 mg of <b>8</b>; white amorphous powder. Mp 115–118 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 671.4511 (C<sub>40</sub>H<sub>64</sub>O<sub>8</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.16 (1H, br s, -COO<i>H</i>), 5.37–5.30 (2H, app d, <i>J</i> = 6.0 Hz, -COOC<i>H</i><sub>2</sub>O-), 4.72, 4.59 (1H each, s, H-29), 4.47 (1H, t, <i>J</i> = 7.6 Hz, H-3), 3.80, 3.56 (2H each, t, <i>J</i> = 5.2 Hz, -OC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>O-), 3.42 (3H, s, -OC<i>H</i><sub>3</sub>), 3.01 (1H, m, H-19), 2.67–2.46 (2H, m, H-2′), 1.68 (3H, s, H-30), 1.29, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 1.00, 0.97, 0.92, 0.82, 0.76 (3H each, s, 5 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.9, 16.2, 16.4, 16.7, 18.4, 19.6, 21.1, 23.8, 25.3, 25.7, 25.8, 28.1, 29.9, 30.7, 32.2, 34.5, 37.1, 37.3, 37.9, 38.4, 38.6, 40.7, 41.0, 42.6, 45.0, 47.1, 49.6, 50.7, 55.7, 56.9, 59.3, 69.7, 71.7, 81.8, 89.1, 109.9, 150.6, 171.2, 175.8, 183.0. [α]<sub>D</sub><sup>25</sup> −13.8° (<i>c</i> 0.28, MeOH).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-Succinimide 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>18</b>)</h3><div class="NLM_p last">Yield, 17 mg (39% yield), starting from 35 mg of <b>9</b>; light yellow amorphous powder. Mp 164–166 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 680.4161 (C<sub>40</sub>H<sub>59</sub>NO<sub>8</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.72, 4.60 (2H, s, H-29), 4.47 (1H, dd, <i>J</i> = 11.2, 5.2 Hz, H-3), 2.99 (1H, m, H-19), 2.84, 2.82 (4H, d, <i>J</i> = 5.2 Hz, -COC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>CO-), 2.64–2.41 (2H, m, H-2′), 1.68 (3H, s, H-30), 1.28 (6H, s, 2 × CH<sub>3</sub>-3′), 0.98 (6H, s, 2 × CH<sub>3</sub>), 0.91, 0.82, 0.75 (3H each, s, 3 × CH<sub>3</sub>).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Propyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>19</b>)</h3><div class="NLM_p last">Yield, 23 mg (46% yield), starting from 40 mg of <b>10</b>; white amorphous powder. Mp 109–111 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 625.4465 (C<sub>39</sub>H<sub>62</sub>O<sub>6</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (2H, s, H-29), 4.48 (1H, dd, <i>J</i> = 11.0, 4.8 Hz, H-3), 4.09 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 3.00 (1H, m, H-19), 2.58–2.39 (2H, m, H-2′), 1.68 (3H, s, H-30), 1.28, 1.27 (3H each, s, 2 × CH<sub>3</sub>-3′), 1.00, 0.98, 0.93 (3H each, s, 3 × CH<sub>3</sub>), 0.89 (3H, t, <i>J</i> = 6.4 Hz, CH<sub>3</sub>), 0.82, 0.75 (3H each, s, 2 × CH<sub>3</sub>).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Prop-2′-ynyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>20</b>)</h3><div class="NLM_p last">Yield, 28 mg (55% yield), starting from 40 mg of <b>11</b>; light yellow amorphous powder. Mp 127–129 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 621.4175 (C<sub>39</sub>H<sub>58</sub>O<sub>6</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (2H, s, H-29), 4.69, 4.66 (2H, d, <i>J</i> = 2.4 Hz, 28-COOC<i>H</i><sub>2</sub>-), 4.47 (1H, dd, <i>J</i> = 11.8, 5.6 Hz, H-3), 3.00 (1H, m, H-19), 2.62–2.40 (3H, m, H-2′, -C≡C<i>H</i>), 1.69 (3H, s, H-30), 1.30, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 0.97 (6H, s, 2 × CH<sub>3</sub>), 0.93, 0.81, 0.75 (3H each, s, 3 × CH<sub>3</sub>).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Hexyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>21</b>)</h3><div class="NLM_p last">Yield, 26 mg (52% yield), starting from 40 mg of <b>13</b>; white amorphous powder. Mp 118–120 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 667.4931 (C<sub>42</sub>H<sub>68</sub>O<sub>6</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (2H, s, H-29), 4.47 (1H, dd, <i>J</i> = 11.2, 4.8 Hz, H-3), 4.07 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 3.01 (1H, m, H-19), 2.54–2.41 (2H, m, H-2′), 1.68 (3H, s, H-30), 1.31, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 0.97 (6H, s, 2 × CH<sub>3</sub>), 0.92 (3H, s, CH<sub>3</sub>), 0.89 (3H, m, CH<sub>3</sub>), 0.81, 0.75 (3H each, s, 2 × CH<sub>3</sub>).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Ethyl <i>O</i>-[3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oyl]-6-hexanoate (<b>22</b>)</h3><div class="NLM_p last">Yield, 28 mg (46% yield), starting from 50 mg of <b>14</b>; light yellow amorphous powder. Mp 179–181 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 725.4989 (C<sub>44</sub>H<sub>70</sub>O<sub>8</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.72, 4.59 (2H, s, H-29), 4.48 (1H, t, <i>J</i> = 7.8 Hz, H-3), 4.18–4.02 (4H, m, 28-COOC<i>H</i><sub>2</sub>-, -COOC<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.01 (1H, m, H-19), 2.62–2.43 (2H, m, H-2′), 2.31 (2H, m, -C<i>H</i><sub>2</sub>COO-), 1.68 (3H, s, H-30), 1.31, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 1.26 (3H, t, <i>J</i> = 7.2 Hz, -COOCH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.98 (6H, s, 2 × CH<sub>3</sub>), 0.91, 0.82, 0.75 (3H each, s, 3 × CH<sub>3</sub>). [α]<sub>D</sub><sup>25</sup> −16.6° (<i>c</i> 0.22, MeOH).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Octyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>23</b>)</h3><div class="NLM_p last">Yield, 31 mg (51% yield), starting from 50 mg of <b>15</b>; white amorphous powder. Mp 136–137 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 695.5248 (C<sub>44</sub>H<sub>72</sub>O<sub>6</sub> - H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (2H, s, H-29), 4.47 (1H, t, <i>J</i> = 7.6 Hz, H-3), 4.07 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 3.01 (1H, m, H-19), 2.61–2.40 (2H, m, H-2′), 1.68 (3H, s, H-30), 1.28 (6H, s, 2 × CH<sub>3</sub>-3′), 0.97 (6H, s, 2 × CH<sub>3</sub>), 0.92 (3H, s, CH<sub>3</sub>), 0.89 (3H, t, <i>J</i> = 6.4 Hz, CH<sub>3</sub>), 0.82, 0.75 (3H each, s, 2 × CH<sub>3</sub>).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-[2-[2-[2-<i>O</i>-(3′,3′-Dimethylsuccinyl)ethoxy]ethoxy]ethoxy]ethyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>30</b>)</h3><div class="NLM_p last">Yield, 50 mg (41% yield), starting from 100 mg of <b>29</b>; light yellow amorphous powder. Mp 165–167 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 759.5013 (C<sub>44</sub>H<sub>72</sub>O<sub>10</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (2H, s, H-29), 4.48 (1H, dd, <i>J</i> = 11.4, 4.8 Hz, H-3), 4.26 (2H, m, -COOC<i>H</i><sub>2</sub>CH<sub>2</sub>O-), 3.68–3.41 (2H each, m, -COOCH<sub>2</sub>C<i>H</i><sub>2</sub>O-, 3 × -OCH<sub>2</sub>CH<sub>2</sub>O-), 3.01 (1H, m, H-19), 2.64–2.42 (2H, m, H-2′), 1.68 (3H, s, H-30), 1.30, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 0.98, 0.97, 0.91, 0.82, 0.76 (3H each, s, 5 × CH<sub>3</sub>).</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-[3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oyl]-4-piperazinebutyric Acid (<b>40</b>)</h3><div class="NLM_p last">Yield, 45 mg (53% yield), starting from 70 mg of <b>38</b>; light yellow amorphous powder. Mp 127–129 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 737.5109 (C<sub>44</sub>H<sub>70</sub>N<sub>2</sub>O<sub>7</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.71, 4.60 (1H each, s, H-29), 4.47 (1H, dd, <i>J</i> = 11.6, 4.8 Hz, H-3), 3.65–3.49 (4H, m, 28-CON(C<i>H</i><sub>2</sub>CH<sub>2</sub>)<sub>2</sub>N-), 3.01 (1H, m, H-19), 2.82–2.68 (4H, m, 28-CON(CH<sub>2</sub>C<i>H</i><sub>2</sub>)<sub>2</sub>N-), 2.64–2.40 (3H, m, H-2′, -NC<i>H</i><sub>2</sub>-), 1.68 (3H, s, H-30), 1.31, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 1.01, 0.98, 0.91, 0.84, 0.76 (3H each, s, 5 × CH<sub>3</sub>). [α]<sub>D</sub><sup>25</sup> −17.5° (<i>c</i> 0.28, MeOH).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-[3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oyl]-5-piperazinepentanoic Acid (<b>41</b>)</h3><div class="NLM_p last">Yield, 199 mg (55% yield), starting from 300 mg of <b>39</b>; white amorphous powder. Mp 135–137 °C. HRMS (ESI−) <i>m</i>/<i>z</i>: 751.5251 (C<sub>45</sub>H<sub>72</sub>N<sub>2</sub>O<sub>7</sub> – H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.73, 4.60 (1H each, s, H-29), 4.47 (1H, dd, <i>J</i> = 11.2, 4.8 Hz, H-3), 3.64–3.51 (4H, m, 28-CON(C<i>H</i><sub>2</sub>CH<sub>2</sub>)<sub>2</sub>N-), 3.00 (1H, m, H-19), 2.89–2.72 (4H, m, 28-CON(CH<sub>2</sub>C<i>H</i><sub>2</sub>)<sub>2</sub>N-), 2.61–2.40 (3H, m, H-2′, -NC<i>H</i><sub>2</sub>-), 1.69 (3H, s, H-30), 1.30, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 0.98, 0.97, 0.92, 0.82, 0.75 (3H each, s, 5 × CH<sub>3</sub>). [α]<sub>D</sub><sup>25</sup> −18.4° (<i>c</i> 0.30, MeOH).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> [1-(3′-Deoxythymidine)-1<i>H</i>-1,2,3-triazol-4-yl]methyl 3β-<i>O</i>-(3′,3′-Dimethylsuccinyl)lup-20(29)-en-28-oate (<b>24</b>)</h3><div class="NLM_p last">Compound <b>20</b> (25 mg, 1.3 equiv), AZT (1 equiv), CuI (0.2 equiv), and <i>i</i>-Pr<sub>2</sub>EtN (2 equiv) were dissolved in DMF (1 mL), and the mixture was stirred at 120 °C for 30 min using a microwave synthesizer (Biotage). The solution was diluted with EtOAc and then washed with water, saturated NaHCO<sub>3</sub>, and brine. The organic layer was dried over anhydrous MgSO<sub>4</sub> and concentrated to dryness under reduced pressure. The residue was chromatographed using a silica gel column to yield 20 mg of <b>24</b> (75%), a white amorphous powder. Mp 186–189 °C. HRMS (ESI+) <i>m</i>/<i>z</i>: 890.5227 (C<sub>49</sub>H<sub>71</sub>N<sub>5</sub>O<sub>10</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.31 (1H, br, s, -NH), 7.79 (1H, s, triazol-H), 7.48, 7.44 (1H, d, <i>J</i> = 16 Hz, Thy-H), 6.21 (1H, t, <i>J</i> = 5.6 Hz, ribose-C<i>H</i>-2′), 5.42 (1H, m, ribose-C<i>H</i>-4′), 5.28–5.20 (2H, m, 28-COOC<i>H</i><sub>2</sub>-), 4.72, 4.60 (2H, s, H-29), 4.46 (1H, m, H-3), 4.04, 3.80–3.73 (4H, m, ribose-C<i>H</i>-5′-C<i>H</i><sub>2</sub>-O<i>H</i>), 3.06–2.96 (3H, m, H-19, ribose-C<i>H</i><sub>2</sub>-3′), 2.70–2.56 (2H, m, H-2′), 1.94 (3H, s, Thy-CH<sub>3</sub>), 1.67 (3H, s, H-30), 1.30, 1.28 (3H each, s, 2 × CH<sub>3</sub>-3′), 1.01 (6H, s, 2 × CH<sub>3</sub>), 0.93, 0.81, 0.75 (3H each, s, 3 × CH<sub>3</sub>).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> HIV-1<sub>NL4-3</sub> Replication Inhibition Assay in MT-4 Lymphocytes</h3><div class="NLM_p last">A previously described HIV-1 infectivity assay was used.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> A 96-well microtiter plate was used to set up the HIV-1<sub>NL4-3</sub> replication screening assay. NL4-3 variants at a multiplicity of infection (MOI) of 0.01 were used to infect MT4 cells. Culture supernatants were collected on day 4 PI for the p24 antigen capture using an ELISA kit from ZeptoMetrix Corporation (Buffalo, NY). The 50% inhibition concentration (IC<sub>50</sub>) was defined as the concentration that inhibits HIV-1<sub>NL4-3</sub> replication by 50%.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Cytotoxicity Assay</h3><div class="NLM_p last">A CytoTox-Glo cytotoxicity assay (Promega) was used to determine the cytotoxicity of the synthesized BA derivatives. Mock-infected MT-4 cells were cultured in the presence of various concentrations of the compounds for 2 days. Percent of viable cells was determined by following the protocol provided by the manufacturer. The 50% cytotoxic concentration (CC<sub>50</sub>) was defined as the concentration that caused a 50% reduction of cell viability.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> TZM-bl Assay</h3><div class="NLM_p last">Anti-HIV-1 activity was measured as reduction in Luc reporter gene expression after a single round of virus infection of TZM-bl cells. HIV-1 at 200 TCID<sub>50</sub> and test samples were mixed in a total volume of 100 mL of growth medium in 96-well black solid plates (Corning-Costar). After 48 h of incubation, culture medium was removed from each well and 100 mL of Bright Glo luciferase reagent was added to each culture well. The luciferase activity in the assay wells was measured using a Victor 2 luminometer. The 50% inhibitory dose (IC<sub>50</sub>) was defined as the sample concentration that caused a 50% reduction in relative luminescence units (RLU) compared to virus control wells after subtraction of background RLU.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Microsomal Stability Assay</h3><div class="NLM_p last">Stock solutions of <b>41</b>, as well as reference compounds propranolol and terfenadine (1 mg/mL), were prepared by dissolving the pure compound in DMSO and were stored at 4 °C. Before the assay, the stock solution was diluted with ACN to 0.1 mM. For measurement of metabolic stability, all compounds were brought to a final concentration of 1 μM with 0.1 M potassium phosphate buffer at pH 7.4, which contained 0.1 mg/mL human liver microsomes and 5 mM MgCl<sub>2</sub>. The incubation volumes were 300 μL, and reaction temperature was 37 °C. Reactions were started by adding 60 μL of NADPH (final concentration of 1.0 mM) and quenched by adding 600 μL of ice-cold ACN to stop the reaction at 5, 15, 30, and 60 min time points. Samples at 0 min time point were prepared by adding 600 μL of ice-cold ACN first, followed by 60 μL of NADPH. Incubations of all samples were conducted in duplicate. After quenching, all samples were centrifuged at 12 000 rpm for 5 min at 0 °C. The supernatant was collected, and 30 μL of the supernatant was injected directly onto a Shimadzu LC–MS 2010 system by autosampler. The HPLC–MS analysis was carried out with an electrospray ionization source (ESI). An Alltima C18 column (5 μm, 150 mm × 2.1 mm) was used for HPLC with a gradient elution at a flow rate of 0.3 mL/min. The elution conditions for <b>41</b> were ACN (B) in water (A) at 30% for 0–3 min, 95% for 3–9 min, and 30% for 9–12 min. The MS conditions were optimized to detector voltage of +1.7 kV, positive acquisition mode with selected ion monitoring (SIM) of the appropriate molecular weights of the testing compounds. The CDL temperature was 250 °C, and heat block temperature was 200 °C. The neutralizing gas flow was 1.5 L/min. The peak heights of test compounds at different time points were converted to the percentage remaining, and the peak height values at initial time (0 min) served as 100%. The slope of the linear regression from log of the percentage remaining versus incubation time relationships (−<i>k</i>) was used to calculate in vitro half-life (<i>t</i><sub>1/2</sub>) by the formula of in vitro <i>t</i><sub>1/2</sub> = 0.693/<i>k</i>, regarded as first-order kinetics. Conversion to in vitro clearance (CL<sub>int</sub> in units of (mL/min)/mg protein) was calculated by the formula:<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> CL<sub>int</sub> = (0.693/in vitro <i>t</i><sub>1/2</sub>)[(mL incubation)/(mg of microsomes)]. Fast and moderate metabolizing reference compounds terfenadine and propranolol, respectively, have <i>t</i><sub>1/2</sub> of 21.14 and 40.82 min, respectively, in these assay conditions.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52"><a href="/doi/suppl/10.1021/jm301040s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional information on compound purity, high-resolution mass spectroscopic data, and HPLC analysis results of the target compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301040s/suppl_file/jm301040s_si_001.pdf">jm301040s_si_001.pdf (59.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm301040s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keduo Qian</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research
Laboratories,
UNC Eshelman School of Pharmacy, University of North
Carolina, Chapel Hill, North Carolina 27599, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#731817021a121d33061d105d16170653181b1f161633061d105d161706"><span class="__cf_email__" data-cfemail="f8939c89919996b88d969bd69d9c8d">[email protected]</span> <span class="__cf_email__" data-cfemail="9df6f5f1f8f8dde8f3feb3f8f9e8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuo-Hsiung Lee</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research
Laboratories,
UNC Eshelman School of Pharmacy, University of North
Carolina, Chapel Hill, North Carolina 27599, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Chinese
Medicine Research and
Development Center, China Medical University and Hospital, Taichung 401, Taiwan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#48232c39212926083d262b662d2c3d682320242d2d083d262b662d2c3d"><span class="__cf_email__" data-cfemail="0f646b7e666e614f7a616c216a6b7a">[email protected]</span> <span class="__cf_email__" data-cfemail="c2a9aaaea7a782b7aca1eca7a6b7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ibrahim D. Bori</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research
Laboratories,
UNC Eshelman School of Pharmacy, University of North
Carolina, Chapel Hill, North Carolina 27599, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chin-Ho Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Surgery, Duke University Medical Center, Durham, North Carolina
27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Huang</span> - <span class="hlFld-Affiliation affiliation">Department of Surgery, Duke University Medical Center, Durham, North Carolina
27710, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1705e4135-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This investigation was supported by Grant AI-077417 from the National Institute of Allergy and Infectious Diseases (NIAID) awarded to K.-H.L. I.D.B. thanks the NIAID for a Minority Research Supplement grant. Thanks are also due to the support of Taiwan Department of Health Clinical Trial and Research Center of Excellence (Grant DOH100-TD-B-111-004).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> Abbreviations Used</h2><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immunodeficiency syndrome</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">BA</td><td class="NLM_def"><p class="first last">betulinic acid</p></td></tr><tr><td class="NLM_term">HAART</td><td class="NLM_def"><p class="first last">highly active antiretroviral therapy</p></td></tr><tr><td class="NLM_term">MI</td><td class="NLM_def"><p class="first last">maturation inhibitor</p></td></tr><tr><td class="NLM_term">P24 (CA)</td><td class="NLM_def"><p class="first last">capsid</p></td></tr><tr><td class="NLM_term">P25 (CA-SP1)</td><td class="NLM_def"><p class="first last">capsid precursor</p></td></tr><tr><td class="NLM_term">bevirimat</td><td class="NLM_def"><p class="first last">3-<i>O</i>-(3′,3′-dimethylsuccinyl)betulinic acid</p></td></tr><tr><td class="NLM_term">AZT</td><td class="NLM_def"><p class="first last">zidovudine</p></td></tr><tr><td class="NLM_term">MOMCl</td><td class="NLM_def"><p class="first last">methoxymethyl chloride</p></td></tr><tr><td class="NLM_term">MEMCl</td><td class="NLM_def"><p class="first last">methoxyethoxymethyl chloride</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylaluminum</p></td></tr><tr><td class="NLM_term">PTSA</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium fluoride</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">postinfection</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Barbaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrolorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1805</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.2174%2F1381612053764869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=15892677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Chur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1805-1843&author=G.+Barbaroauthor=A.+Scozzafavaauthor=A.+Mastrolorenzoauthor=C.+T.+Supuran&title=Highly+active+antiretroviral+therapy%3A+current+state+of+the+art%2C+new+agents+and+their+pharmacological+interactions+useful+for+improving+therapeutic+outcome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Highly active antiretroviral therapy: Current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome</span></div><div class="casAuthors">Barbaro, Giuseppe; Scozzafava, Andrea; Mastrolorenzo, Antonio; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1805-1843</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) dramatically changed the course of HIV infection.  Currently, this therapy involves the use of agents from at least two distinct classes of antivirals: a protease inhibitor (PI) in combination with two nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTIs), or a non-nucleoside reverse transcriptase inhibitor (NNRTI) in combination with NRTIs.  Recently, the third family of antivirals started to be used clin., with the advent of enfuvirtide, the first fusion inhibitor (FI).  Several pharmacol. agents are available form these classes of antivirals, NRTIs, NNRTIs, PIs and FIs, which will be briefly reviewed here.  Some more agents are in advanced clin. evaluation or have recently been approved (such as tenofovir, a NtRTI; atazanavir, a PI; tipranavir, another PI), mainly against drug-resistant viruses.  Compds. inhibiting HIV integrase, the third enzyme of HIV, are also available ultimately, with several such derivs. in clin. trials (L-731,988 and S-1360).  Another approach to inhibit the growth of retroviruses, including HIV, targets the ejection of zinc ions from crit. zinc finger viral proteins, which has as a consequence the inhibition of viral replication in the absence of mutations leading to drug resistance phenotypes.  All steps in the process of HIV entry into the cell may be targeted by specific compds. that might be developed as novel types of antiretrovirals.  Thus, inhibitors of the gp120 - CD4 interaction have been detected (zintevir, FP-21399 and BMS-378806 in clin. trials).  Small mol. chemokine antagonists acting as HIV entry inhibitors also were described in the last period, which interact both with the CXCR4 coreceptor (such as AMD3100; AMD3465; ALX40-4C; T22, T134 and T140), or which are antagonist of the CCR5 coreceptor (TAK-779, TAK-220, SCH-C, SCH-D, E913, AK-602 and NSC 651016 in clin. trials), together with new types of fusion inhibitors possessing the same mechanism of action as enfuvirtide (such as T1249).  Compds. interacting with Tat/Tar have also been detected which inhibit HIV replication in low micromolar range (EM2487, tamacrazine, CGP 64222 or CGA 137053 among others).  Unexploited viral and cellular targets (such as the maturation process - with a first potent compd. available, PA-457; the cellular proteins Tsg101, APOBEC3G, or the viral ones Vif, Rev or RNase H) are also presented, together with recently emerged approaches for eradication of HIV reservoirs.  A review on the pharmacol. and interactions of these agents with other drugs is presented here, with emphasis on how these pharmacol. interferences may improve the clin. use of antivirals, or how side effects due to these drugs may be managed better by taking them into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIUHwOtcVvSLVg90H21EOLACvtfcHk0lhVQFClcAp59A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Chur8%253D&md5=e5bff5d10a92b31e61423b0fafade5f2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1381612053764869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612053764869%26sid%3Dliteratum%253Aachs%26aulast%3DBarbaro%26aufirst%3DG.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMastrolorenzo%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DHighly%2520active%2520antiretroviral%2520therapy%253A%2520current%2520state%2520of%2520the%2520art%252C%2520new%2520agents%2520and%2520their%2520pharmacological%2520interactions%2520useful%2520for%2520improving%2520therapeutic%2520outcome%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D1805%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ho, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perelson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span> </span><span class="NLM_article-title">Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=1995&pages=123-126&author=D.+D.+Hoauthor=A.+U.+Neumannauthor=A.+S.+Perelsonauthor=W.+Chenauthor=J.+M.+Leonardauthor=M.+Markowitz&title=Rapid+turnover+of+plasma+virions+and+CD4+lymphocytes+in+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DD.%2BD.%26aulast%3DNeumann%26aufirst%3DA.%2BU.%26aulast%3DPerelson%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLeonard%26aufirst%3DJ.%2BM.%26aulast%3DMarkowitz%26aufirst%3DM.%26atitle%3DRapid%2520turnover%2520of%2520plasma%2520virions%2520and%2520CD4%2520lymphocytes%2520in%2520HIV-1%2520infection%26jtitle%3DNature%26date%3D1995%26volume%3D373%26spage%3D123%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hammer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenstein, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundacker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schooley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubrich, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lederman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phair, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merigan, T. C.</span><span> </span><span class="NLM_article-title">A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1056%2FNEJM199610103351501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=8813038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK28XmsValtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1996&pages=1081-1090&author=S.+M.+Hammerauthor=D.+A.+Katzensteinauthor=M.+D.+Hughesauthor=H.+Gundackerauthor=R.+T.+Schooleyauthor=R.+H.+Haubrichauthor=W.+K.+Henryauthor=M.+M.+Ledermanauthor=J.+P.+Phairauthor=M.+Niuauthor=M.+S.+Hirschauthor=T.+C.+Merigan&title=A+trial+comparing+nucleoside+monotherapy+with+combination+therapy+in+HIV-infected+adults+with+CD4+cell+counts+from+200+to+500+per+cubic+millimeter.+AIDS+Clinical+Trials+Group+Study+175+Study+Team"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter</span></div><div class="casAuthors">Hammer, Scott M.; Katzenstein, David A.; Hughes, Michael D.; Gundacker, Holly; Schooley, Robert T.; Haubrich, Richard H.; Henry, W. Keith; Lederman, Michael M.; Phair, John P.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1081-1090</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">This double-blind study evaluated treatment with either a single nucleoside or two nucleosides in adults infected with human immunodeficiency virus type 1 (HIV-1) whose CD4 cell counts were from 200 to 500 per cubic millimeter.  The authors randomly assigned 2467 HIV-1-infected patients (43 % without prior antiretroviral treatment) to one of four daily regimens: 600 mg of zidovudine; 600 mg of zidovudine plus 400 mg of didanosine; 600 mg of zidovudine plus 2.25 mg of zalcitabine; or 400 mg of didanosine.  The primary end point was a percent decline in the CD4 cell count, development of the acquired immunodeficiency syndrome (AIDS), or death.  Progression to the primary end point was more frequent with zidovudine alone (32 %) than with zidovudine plus didanosine (18 %; relative hazard ratio, 0.50), zidovudine plus zalcitabine (20 %; relative hazard ratio, 0.54), or didanosine alone (22 %; relative hazard ratio, 0.61).  The relative hazard ratios for progression to an AIDS-defining event or death were 0.64 for zidovudine plus didanosine, as compared with zidovudine alone, 0.77 for zidovudine plus zalcitabine, and 0.69 for didanosine alone.  The relative hazard ratios for death were 0.55, 0.71, and 0.51, resp.  For zidovudine plus zalcitabine, the benefits were limited to those without previous treatment.  Treatment with zidovudine plus didanosine, zidovudine plus zalcitabine, or didanosine alone slows the progression of HIV disease and is superior to treatment with zidovudine alone.  Antiretroviral therapy can improve survival in patients with 200 to 500 CD4 cells per cubic millimeter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGratg9tInWNpbVg90H21EOLACvtfcHk0lhVQFClcAp59A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsValtrY%253D&md5=e3f78d691ac4ab52a6b2eb86f5a6dc19</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM199610103351501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199610103351501%26sid%3Dliteratum%253Aachs%26aulast%3DHammer%26aufirst%3DS.%2BM.%26aulast%3DKatzenstein%26aufirst%3DD.%2BA.%26aulast%3DHughes%26aufirst%3DM.%2BD.%26aulast%3DGundacker%26aufirst%3DH.%26aulast%3DSchooley%26aufirst%3DR.%2BT.%26aulast%3DHaubrich%26aufirst%3DR.%2BH.%26aulast%3DHenry%26aufirst%3DW.%2BK.%26aulast%3DLederman%26aufirst%3DM.%2BM.%26aulast%3DPhair%26aufirst%3DJ.%2BP.%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26aulast%3DMerigan%26aufirst%3DT.%2BC.%26atitle%3DA%2520trial%2520comparing%2520nucleoside%2520monotherapy%2520with%2520combination%2520therapy%2520in%2520HIV-infected%2520adults%2520with%2520CD4%2520cell%2520counts%2520from%2520200%2520to%2520500%2520per%2520cubic%2520millimeter.%2520AIDS%2520Clinical%2520Trials%2520Group%2520Study%2520175%2520Study%2520Team%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1996%26volume%3D335%26spage%3D1081%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gulick, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meibohm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlir, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chodakewitz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellors, J. W.</span><span> </span><span class="NLM_article-title">Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2345-2349&author=R.+M.+Gulickauthor=A.+Meibohmauthor=D.+Havlirauthor=J.+J.+Eronauthor=A.+Mosleyauthor=J.+A.+Chodakewitzauthor=R.+Isaacsauthor=C.+Gonzalezauthor=D.+McMahonauthor=D.+D.+Richmanauthor=M.+Robertsonauthor=J.+W.+Mellors&title=Six-year+follow-up+of+HIV-1-infected+adults+in+a+clinical+trial+of+antiretroviral+therapy+with+indinavir%2C+zidovudine%2C+and+lamivudine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGulick%26aufirst%3DR.%2BM.%26aulast%3DMeibohm%26aufirst%3DA.%26aulast%3DHavlir%26aufirst%3DD.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26aulast%3DMosley%26aufirst%3DA.%26aulast%3DChodakewitz%26aufirst%3DJ.%2BA.%26aulast%3DIsaacs%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DMcMahon%26aufirst%3DD.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DRobertson%26aufirst%3DM.%26aulast%3DMellors%26aufirst%3DJ.%2BW.%26atitle%3DSix-year%2520follow-up%2520of%2520HIV-1-infected%2520adults%2520in%2520a%2520clinical%2520trial%2520of%2520antiretroviral%2520therapy%2520with%2520indinavir%252C%2520zidovudine%252C%2520and%2520lamivudine%26jtitle%3DAIDS%26date%3D2003%26volume%3D17%26spage%3D2345%26epage%3D2349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span>World Health Organization. Health Topics: HIV/AIDS. <a href="http://www.who.int/topics/hiv_aids/en/" class="extLink">http://www.who.int/topics/hiv_aids/en/</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization.+Health+Topics%3A+HIV%2FAIDS.+http%3A%2F%2Fwww.who.int%2Ftopics%2Fhiv_aids%2Fen%2F+%28accessed+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chun, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiGiuseppe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermankova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadwick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeiger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barditch-Crovo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1038%2F387183a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=9144289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK2sXjtF2gtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=1997&pages=183-188&author=T.+W.+Chunauthor=L.+Carruthauthor=D.+Finziauthor=X.+Shenauthor=J.+A.+DiGiuseppeauthor=H.+Taylorauthor=M.+Hermankovaauthor=K.+Chadwickauthor=J.+Margolickauthor=T.+C.+Quinnauthor=Y.+H.+Kuoauthor=R.+Brookmeyerauthor=M.+A.+Zeigerauthor=P.+Barditch-Crovoauthor=R.+F.+Siliciano&title=Quantification+of+latent+tissue+reservoirs+and+total+body+viral+load+in+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection</span></div><div class="casAuthors">Chun, Tae-Wook; Carruth, Lucy; Finzi, Diana; Shen, Xuefei; DiGiuseppe, Joseph A.; Taylor, Harry; Hermankova, Monika; Chadwick, Karen; Margolick, Joseph; Quinn, Thomas C.; Kuo, Yen-Hong; Brookmeyer, Ronald; Zeiger, Martha A.; Barditch-Crovo, Patricia; Siliciano, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">6629</span>),
    <span class="NLM_cas:pages">183-188</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy.  Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral mRNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection.  Uncertainty remains over what fraction of CD4+T cells are infected and whether there are latent reservoirs for the virus.  We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+T cells with replication-competent integrated provirus (<107 cells).  The most prevalent form of HIV-1 DNA in resting and activated CD4+T cells is a full-length, linear, unintegrated form that is not replication competent.  The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+T cells and macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHllJ5UFoRbVg90H21EOLACvtfcHk0liSKApXq_zvVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtF2gtr8%253D&md5=f5b12cfeaf7edde8fde49e9573a97c44</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F387183a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F387183a0%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DT.%2BW.%26aulast%3DCarruth%26aufirst%3DL.%26aulast%3DFinzi%26aufirst%3DD.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DDiGiuseppe%26aufirst%3DJ.%2BA.%26aulast%3DTaylor%26aufirst%3DH.%26aulast%3DHermankova%26aufirst%3DM.%26aulast%3DChadwick%26aufirst%3DK.%26aulast%3DMargolick%26aufirst%3DJ.%26aulast%3DQuinn%26aufirst%3DT.%2BC.%26aulast%3DKuo%26aufirst%3DY.%2BH.%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DZeiger%26aufirst%3DM.%2BA.%26aulast%3DBarditch-Crovo%26aufirst%3DP.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DQuantification%2520of%2520latent%2520tissue%2520reservoirs%2520and%2520total%2520body%2520viral%2520load%2520in%2520HIV-1%2520infection%26jtitle%3DNature%26date%3D1997%26volume%3D387%26spage%3D183%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Finzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermankova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruth, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaisson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadwick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1295-1300&author=D.+Finziauthor=M.+Hermankovaauthor=T.+Piersonauthor=L.+M.+Carruthauthor=C.+Buckauthor=R.+E.+Chaissonauthor=T.+C.+Quinnauthor=K.+Chadwickauthor=J.+Margolickauthor=R.+Brookmeyerauthor=J.+Gallantauthor=M.+Markowitzauthor=D.+D.+Hoauthor=D.+D.+Richmanauthor=R.+F.+Siliciano&title=Identification+of+a+reservoir+for+HIV-1+in+patients+on+highly+active+antiretroviral+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinzi%26aufirst%3DD.%26aulast%3DHermankova%26aufirst%3DM.%26aulast%3DPierson%26aufirst%3DT.%26aulast%3DCarruth%26aufirst%3DL.%2BM.%26aulast%3DBuck%26aufirst%3DC.%26aulast%3DChaisson%26aufirst%3DR.%2BE.%26aulast%3DQuinn%26aufirst%3DT.%2BC.%26aulast%3DChadwick%26aufirst%3DK.%26aulast%3DMargolick%26aufirst%3DJ.%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DGallant%26aufirst%3DJ.%26aulast%3DMarkowitz%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%2BD.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DIdentification%2520of%2520a%2520reservoir%2520for%2520HIV-1%2520in%2520patients%2520on%2520highly%2520active%2520antiretroviral%2520therapy%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D1295%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hezareh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunthard, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlir, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignacio, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spina, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span> </span><span class="NLM_article-title">Recovery of replication-competent HIV despite prolonged suppression of plasma viremia</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1291-1295&author=J.+K.+Wongauthor=M.+Hezarehauthor=H.+F.+Gunthardauthor=D.+V.+Havlirauthor=C.+C.+Ignacioauthor=C.+A.+Spinaauthor=D.+D.+Richman&title=Recovery+of+replication-competent+HIV+despite+prolonged+suppression+of+plasma+viremia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DJ.%2BK.%26aulast%3DHezareh%26aufirst%3DM.%26aulast%3DGunthard%26aufirst%3DH.%2BF.%26aulast%3DHavlir%26aufirst%3DD.%2BV.%26aulast%3DIgnacio%26aufirst%3DC.%2BC.%26aulast%3DSpina%26aufirst%3DC.%2BA.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26atitle%3DRecovery%2520of%2520replication-competent%2520HIV%2520despite%2520prolonged%2520suppression%2520of%2520plasma%2520viremia%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D1291%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flexner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masur, H.</span><span> </span><span class="NLM_article-title">Drug interactions in patients infected with human immunodeficiency virus</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1093%2Fclinids%2F23.4.685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=8909827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK28XmsFOmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=685-693&author=S.+C.+Piscitelliauthor=C.+Flexnerauthor=J.+R.+Minorauthor=M.+A.+Polisauthor=H.+Masur&title=Drug+interactions+in+patients+infected+with+human+immunodeficiency+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interactions in patients infected with human immunodeficiency virus</span></div><div class="casAuthors">Piscitelli, Stephen C.; Flexner, Charles; Minor, James R.; Polis, Michael A.; Masur, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-693</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review with 60 refs.  Patients with AIDS who are receiving optimal medical care, including combination therapy with antiretroviral agents and more effective prophylaxis and therapy for opportunistic infections and neoplasms, are surviving longer.  However, the potential for drug interactions in these patients is increased because many of the currently used antibiotics and antiviral agents have profound effects on the hepatic cytochrome P 450 enzyme system, on renal tubular function, and on bone marrow function.  In this AIDS Commentary, Dr. Piscitelli and colleagues have succinctly reviewed the current state of our knowledge regarding the potential for additive or synergistic drug interactions that can result in enhanced toxicity or, alternatively, augmented therapeutic benefit.  Information on these interactions will become more important as more intensive and effective therapy becomes available for persons with far-advanced infection due to human immunodeficiency virus type 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSA8rMebW2VrVg90H21EOLACvtfcHk0lhafrOf8LIYIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFOmsrg%253D&md5=493ca45123681d99bc0dd2efb9e4a86e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F23.4.685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F23.4.685%26sid%3Dliteratum%253Aachs%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26aulast%3DFlexner%26aufirst%3DC.%26aulast%3DMinor%26aufirst%3DJ.%2BR.%26aulast%3DPolis%26aufirst%3DM.%2BA.%26aulast%3DMasur%26aufirst%3DH.%26atitle%3DDrug%2520interactions%2520in%2520patients%2520infected%2520with%2520human%2520immunodeficiency%2520virus%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1996%26volume%3D23%26spage%3D685%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Louie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span> </span><span class="NLM_article-title">Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2002&pages=15-25&author=M.+Louieauthor=M.+Markowitz&title=Goals+and+milestones+during+treatment+of+HIV-1+infection+with+antiretroviral+therapy%3A+a+pathogenesis-based+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DM.%26aulast%3DMarkowitz%26aufirst%3DM.%26atitle%3DGoals%2520and%2520milestones%2520during%2520treatment%2520of%2520HIV-1%2520infection%2520with%2520antiretroviral%2520therapy%253A%2520a%2520pathogenesis-based%2520perspective%26jtitle%3DAntiviral%2520Res.%26date%3D2002%26volume%3D55%26spage%3D15%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Boden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farthing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span> </span><span class="NLM_article-title">HIV-1 drug resistance in newly infected individuals</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1999&pages=1135-1141&author=D.+Bodenauthor=A.+Hurleyauthor=L.+Zhangauthor=Y.+Caoauthor=Y.+Guoauthor=E.+Jonesauthor=J.+Tsayauthor=J.+Ipauthor=C.+Farthingauthor=K.+Limoliauthor=N.+Parkinauthor=M.+Markowitz&title=HIV-1+drug+resistance+in+newly+infected+individuals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoden%26aufirst%3DD.%26aulast%3DHurley%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DTsay%26aufirst%3DJ.%26aulast%3DIp%26aufirst%3DJ.%26aulast%3DFarthing%26aufirst%3DC.%26aulast%3DLimoli%26aufirst%3DK.%26aulast%3DParkin%26aufirst%3DN.%26aulast%3DMarkowitz%26aufirst%3DM.%26atitle%3DHIV-1%2520drug%2520resistance%2520in%2520newly%2520infected%2520individuals%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1999%26volume%3D282%26spage%3D1135%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Fujioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilkuskie, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosentino, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from <i>Syzigium claviflorum</i>, and the anti-HIV activity of structurally related triterpenoids</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/doi/10.1021/np50104a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1994&pages=243-247&author=T.+Fujiokaauthor=Y.+Kashiwadaauthor=R.+E.+Kilkuskieauthor=L.+M.+Cosentinoauthor=L.+M.+Ballasauthor=J.+B.+Jiangauthor=W.+P.+Janzenauthor=I.+S.+Chenauthor=K.+H.+Lee&title=Anti-AIDS+agents%2C+11.+Betulinic+acid+and+platanic+acid+as+anti-HIV+principles+from+Syzigium+claviflorum%2C+and+the+anti-HIV+activity+of+structurally+related+triterpenoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fnp50104a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50104a008%26sid%3Dliteratum%253Aachs%26aulast%3DFujioka%26aufirst%3DT.%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DKilkuskie%26aufirst%3DR.%2BE.%26aulast%3DCosentino%26aufirst%3DL.%2BM.%26aulast%3DBallas%26aufirst%3DL.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%2BB.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAnti-AIDS%2520agents%252C%252011.%2520Betulinic%2520acid%2520and%2520platanic%2520acid%2520as%2520anti-HIV%2520principles%2520from%2520Syzigium%2520claviflorum%252C%2520and%2520the%2520anti-HIV%2520activity%2520of%2520structurally%2520related%2520triterpenoids%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1994%26volume%3D57%26spage%3D243%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kashiwada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosentino, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1017</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950922q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK28XpsFKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1016-1017&author=Y.+Kashiwadaauthor=F.+Hashimotoauthor=L.+M.+Cosentinoauthor=C.+H.+Chenauthor=P.+E.+Garrettauthor=K.+H.+Lee&title=Betulinic+acid+and+dihydrobetulinic+acid+derivatives+as+potent+anti-HIV+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV Agents</span></div><div class="casAuthors">Kashiwada, Yoshiki; Hashimoto, Fumio; Cosentino, L. Mark; Chen, Chin-Ho; Garrett, Patricia E.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1016-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the prepn. of 12 betulinic acid and dihydrobetulinic acid derivs. and their anti-HIV activity.  Both 3-O-(3',3'-dimethylsuccinyl)betulinic acid and 3-O-(3',3'-dimethylsuccinyl)dihydrobetulinic acid demonstrated extremely potent anti-HIV activity in acutely infected H9 lymphocytes with EC50 values of <3.5 x 10-4 μM.  They exhibited remarkable TI values (IC50 value divided by EC50 value) of >20,000 and >14,000, resp.  Four of the other derivs. also exhibited potent anti-HIV activities with EC50 values ranging from 0.01 to 2.3 x 10-3 μM and TI values from 1017 to 2344.  Results from preliminary mechanism of action studies are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7QcghyIgNcLVg90H21EOLACvtfcHk0lhafrOf8LIYIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsFKgtg%253D%253D&md5=c04b2b671f0c434cb1815be9ded50fbd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm950922q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950922q%26sid%3Dliteratum%253Aachs%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DF.%26aulast%3DCosentino%26aufirst%3DL.%2BM.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DGarrett%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DBetulinic%2520acid%2520and%2520dihydrobetulinic%2520acid%2520derivatives%2520as%2520potent%2520anti-HIV%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1016%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kanamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanbara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span> </span><span class="NLM_article-title">Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=1225-1230&author=T.+Kanamotoauthor=Y.+Kashiwadaauthor=K.+Kanbaraauthor=K.+Gotohauthor=M.+Yoshimoriauthor=T.+Gotoauthor=K.+Sanoauthor=H.+Nakashima&title=Anti-human+immunodeficiency+virus+activity+of+YK-FH312+%28a+betulinic+acid+derivative%29%2C+a+novel+compound+blocking+viral+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanamoto%26aufirst%3DT.%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DKanbara%26aufirst%3DK.%26aulast%3DGotoh%26aufirst%3DK.%26aulast%3DYoshimori%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DK.%26aulast%3DNakashima%26aufirst%3DH.%26atitle%3DAnti-human%2520immunodeficiency%2520virus%2520activity%2520of%2520YK-FH312%2520%2528a%2520betulinic%2520acid%2520derivative%2529%252C%2520a%2520novel%2520compound%2520blocking%2520viral%2520maturation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D1225%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goila-Gaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgore, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matallana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoumplis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orenstein, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C. T.</span><span> </span><span class="NLM_article-title">PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">13555</span><span class="NLM_x">–</span> <span class="NLM_lpage">13560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13555-13560&author=F.+Liauthor=R.+Goila-Gaurauthor=K.+Salzwedelauthor=N.+R.+Kilgoreauthor=M.+Reddickauthor=C.+Matallanaauthor=A.+Castilloauthor=D.+Zoumplisauthor=D.+E.+Martinauthor=J.+M.+Orensteinauthor=G.+P.+Allawayauthor=E.+O.+Freedauthor=C.+T.+Wild&title=PA-457%3A+a+potent+HIV+inhibitor+that+disrupts+core+condensation+by+targeting+a+late+step+in+Gag+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGoila-Gaur%26aufirst%3DR.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DKilgore%26aufirst%3DN.%2BR.%26aulast%3DReddick%26aufirst%3DM.%26aulast%3DMatallana%26aufirst%3DC.%26aulast%3DCastillo%26aufirst%3DA.%26aulast%3DZoumplis%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%2BE.%26aulast%3DOrenstein%26aufirst%3DJ.%2BM.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DFreed%26aufirst%3DE.%2BO.%26aulast%3DWild%26aufirst%3DC.%2BT.%26atitle%3DPA-457%253A%2520a%2520potent%2520HIV%2520inhibitor%2520that%2520disrupts%2520core%2520condensation%2520by%2520targeting%2520a%2520late%2520step%2520in%2520Gag%2520processing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D13555%26epage%3D13560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Qian, K.; Nitz, T. J.; Yu, D.; Allaway, G. P.; Morris-Natschke, S. L.; Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS Agents 76. From Natural Product to Clinical Trials: Bevirimat, a Plant-Derived Anti-AIDS Drug</span>. In  <span class="citation_source-book">Natural Product Chemistry for Drug Discoverys</span>; <span class="NLM_contrib-group">Buss, T.; Butler, M.</span>, Eds.; Biomolecular Sciences Series; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1039%2F9781847559890-00374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=374-391&author=K.+Qian&author=T.+J.+Nitz&author=D.+Yu&author=G.+P.+Allaway&author=S.+L.+Morris-Natschke&author=K.+H.+Leeauthor=T.+Buss&author=M.+Butler&title=Natural+Product+Chemistry+for+Drug+Discoverys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2F9781847559890-00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781847559890-00374%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26atitle%3DAnti-AIDS%2520Agents%252076.%2520From%2520Natural%2520Product%2520to%2520Clinical%2520Trials%253A%2520Bevirimat%252C%2520a%2520Plant-Derived%2520Anti-AIDS%2520Drug%26btitle%3DNatural%2520Product%2520Chemistry%2520for%2520Drug%2520Discoverys%26aulast%3DBuss%26aufirst%3DT.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2009%26spage%3D374%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Smith, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogundele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. E.</span><span> </span><span class="NLM_article-title">Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-<i>O</i>-(3′,3′-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3574</span><span class="NLM_x">–</span> <span class="NLM_lpage">3581</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3574-3581&author=P.+F.+Smithauthor=A.+Ogundeleauthor=A.+Forrestauthor=J.+Wiltonauthor=K.+Salzwedelauthor=J.+Dotoauthor=G.+P.+Allawayauthor=D.+E.+Martin&title=Phase+I+and+II+study+of+the+safety%2C+virologic+effect%2C+and+pharmacokinetics%2Fpharmacodynamics+of+single-dose+3-O-%283%E2%80%B2%2C3%E2%80%B2-dimethylsuccinyl%29betulinic+acid+%28bevirimat%29+against+human+immunodeficiency+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BF.%26aulast%3DOgundele%26aufirst%3DA.%26aulast%3DForrest%26aufirst%3DA.%26aulast%3DWilton%26aufirst%3DJ.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DDoto%26aufirst%3DJ.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DMartin%26aufirst%3DD.%2BE.%26atitle%3DPhase%2520I%2520and%2520II%2520study%2520of%2520the%2520safety%252C%2520virologic%2520effect%252C%2520and%2520pharmacokinetics%252Fpharmacodynamics%2520of%2520single-dose%25203-O-%25283%25E2%2580%25B2%252C3%25E2%2580%25B2-dimethylsuccinyl%2529betulinic%2520acid%2520%2528bevirimat%2529%2520against%2520human%2520immunodeficiency%2520virus%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3574%26epage%3D3581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Martin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbraith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballow, C.</span><span> </span><span class="NLM_article-title">Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.2165%2F00003088-200746070-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=17596104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlGrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=589-598&author=D.+E.+Martinauthor=R.+Blumauthor=J.+Dotoauthor=H.+Galbraithauthor=C.+Ballow&title=Multiple-dose+pharmacokinetics+and+safety+of+bevirimat%2C+a+novel+inhibitor+of+HIV+maturation%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers</span></div><div class="casAuthors">Martin, David E.; Blum, Robert; Doto, Judy; Galbraith, Hal; Ballow, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">589-598</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">Bevirimat [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] is a novel inhibitor of HIV-1 maturation.  This study was performed to investigate the pharmacokinetics and safety of bevirimat during repeated dosing in healthy volunteers.  The study was a 10-day, randomised, double-blind, placebo-controlled, dose escalation study.  A total of 48 healthy male volunteers, aged 19-54 years, took part in the study.  Treatment was administered for 10 days in six escalating dose cohorts (n = 8 in each cohort; 6 bevirimat, 2 placebo).  The doses of bevirimat given in each successive cohort were 25 mg, 50 mg, 75 mg (with 150 mg loading dose), 100 mg, 150 mg, and 200 mg.  Safety follow-up was performed 28 days after the first dose.  Pharmacokinetic and statistical anal.: plasma bevirimat levels were measured from blood samples collected pre-dose on days 1-10 and then at approx. 48-h intervals until 21 days after dosing started.  On days 1 and 10, further blood samples were obtained at 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, and 12 h after dosing.  Urine samples were collected in the morning on days 1, 5, and 11 and at the end of the study for the measurement of cortisol and 6β-hydroxycortisol.  The pharmacokinetic parameters of bevirimat were estd. using non-compartmental methods.  Dose proportionality of exposure to bevirimat, assessed by the max. plasma concn. and the area under the plasma concn.-time curve.  The mean terminal elimination half-life of bevirimat ranged from 56.3-69.5 h, and the mean clearance ranged from 173.9-185.8 mL/h.  Bevirimat showed approx. 4-fold greater accumulation on day 10 compared with day 1, and the degree of accumulation was similar with all doses.  Maximum plasma concns. ranged from 8-58 μg/mL at day 10.  Testing for dose-proportionality showed that exposure to bevirimat was proportional to the dose, both after a single dose and after repeat dosing for 10 days.  Measurement of the urinary 6β-hydroxycortisol/cortisol ratio indicated that bevirimat did not affect cytochrome P 450 3A activity.  Repeated dosing with bevirimat for 10 days was well tolerated.  There was no increase in adverse events obsd. for bevirimat compared with placebo, and no serious adverse events occurred.  No clin. relevant changes in vital signs, phys. examn. or clin. lab. evaluations were obsd.  Bevirimat shows dose-proportional pharmacokinetics during repeated dosing for 10 days.  Its accumulation is approx. 4-fold greater on day 10 compared with day 1.  Repeated dosing with bevirimat is well tolerated.  These properties make bevirimat potentially suitable for inclusion in highly active antiretroviral therapy regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUcy3iQBaHRLVg90H21EOLACvtfcHk0ljRrUY4UhUXnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlGrurY%253D&md5=a64c8813a9521a4e96b9b4fa311947c5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2165%2F00003088-200746070-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200746070-00004%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DD.%2BE.%26aulast%3DBlum%26aufirst%3DR.%26aulast%3DDoto%26aufirst%3DJ.%26aulast%3DGalbraith%26aufirst%3DH.%26aulast%3DBallow%26aufirst%3DC.%26atitle%3DMultiple-dose%2520pharmacokinetics%2520and%2520safety%2520of%2520bevirimat%252C%2520a%2520novel%2520inhibitor%2520of%2520HIV%2520maturation%252C%2520in%2520healthy%2520volunteers%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2007%26volume%3D46%26spage%3D589%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Martin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbraith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballow, C.</span><span> </span><span class="NLM_article-title">Safety and pharmacokinetics of bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3063</span><span class="NLM_x">–</span> <span class="NLM_lpage">3066</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1128%2FAAC.01391-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=17576843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVais7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3063-3066&author=D.+E.+Martinauthor=R.+Blumauthor=J.+Wiltonauthor=J.+Dotoauthor=H.+Galbraithauthor=G.+L.+Burgessauthor=P.+C.+Smithauthor=C.+Ballow&title=Safety+and+pharmacokinetics+of+bevirimat+%28PA-457%29%2C+a+novel+inhibitor+of+human+immunodeficiency+virus+maturation%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and pharmacokinetics of bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers</span></div><div class="casAuthors">Martin, David E.; Blum, Robert; Wilton, John; Doto, Judy; Galbraith, Hal; Burgess, Gina L.; Smith, Philip C.; Ballow, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3063-3066</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Bevirimat (BVM; formerly known as PA-457) is a novel inhibitor of human immunodeficiency virus (HIV) maturation that is being developed for the treatment of HIV infection.  The pharmacokinetics of this agent in healthy male volunteers were studied in a randomized, double-blind study in which the participants received single oral doses of placebo (n = 8) or escalating doses of BVM at 25, 50, 100, or 250 mg (n = 6 per dose); escalation was performed only after the pharmacokinetics and safety of the preceding dose had been evaluated.  Plasma was collected over 480 h after dosing and urine was collected over 48 h after dosing for detn. of the values of pharmacokinetic parameters.  BVM was well absorbed after oral administration, with peak plasma concns. being achieved 1 to 3 h after dosing.  The half-life was 60 to 80 h.  The exposure assessed by detn. of the peak concn. and the area under the concn.-time curve was dose proportional.  Single oral doses of BVM were well tolerated: there were no dose-limiting toxicities, and no serious adverse events were reported.  These findings suggest that BVM offers a favorable pharmacokinetic profile, with predictable pharmacokinetics following the oral administration of single doses.  The long half-life of BVM may facilitate once-daily dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8T8o2VtH7OLVg90H21EOLACvtfcHk0ljW7Igf7LPBFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVais7zL&md5=091f6022f3cb5a9cd114c2f533835c74</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.01391-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01391-06%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DD.%2BE.%26aulast%3DBlum%26aufirst%3DR.%26aulast%3DWilton%26aufirst%3DJ.%26aulast%3DDoto%26aufirst%3DJ.%26aulast%3DGalbraith%26aufirst%3DH.%26aulast%3DBurgess%26aufirst%3DG.%2BL.%26aulast%3DSmith%26aufirst%3DP.%2BC.%26aulast%3DBallow%26aufirst%3DC.%26atitle%3DSafety%2520and%2520pharmacokinetics%2520of%2520bevirimat%2520%2528PA-457%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520maturation%252C%2520in%2520healthy%2520volunteers%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3063%26epage%3D3066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><a href="http://investor.myriad.com/releasedetail.cfm?ReleaseID=360258" class="extLink">http://investor.myriad.com/releasedetail.cfm?ReleaseID=360258</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Finvestor.myriad.com%2Freleasedetail.cfm%3FReleaseID%3D360258."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span> </span><span class="NLM_article-title">Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1016%2Fj.bmc.2005.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=16314103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFKqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2279-2289&author=L.+Huangauthor=P.+Hoauthor=K.+H.+Leeauthor=C.+H.+Chen&title=Synthesis+and+anti-HIV+activity+of+bi-functional+betulinic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives</span></div><div class="casAuthors">Huang, Li; Ho, Phong; Lee, Kuo-Hsiung; Chen, Chin-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2279-2289</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Betulinic acid (BA) derivs. with a side chain at C-3 can inhibit HIV-1 maturation.  On the other hand, BA derivs. with a side chain at C-28 can block HIV-1 entry.  In order to combine the anti-maturation and anti-entry activities in a single mol., new bi-functional BA derivs. contg. side chains at C-3 and C-28 have been synthesized.  The most potent compd. ([[N-[3β-O-(3',3'-dimethylsuccinyl)-lup-20(29)-en-28-oyl]-7-aminoheptyl]-carbamoyl]methane) inhibited HIV-1 at an EC50 of 0.0026 μM and was at least 20 times more potent than either the anti-maturation lead compd. DSB or the anti-entry lead compd. IC9564.  This bi-functional BA deriv. was active against both HIV entry and maturation.  These results suggest that bi-functional BA derivs. with dual mechanisms of action have the potential to become clin. useful for AIDS therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRS_sXlvXSE7Vg90H21EOLACvtfcHk0ljW7Igf7LPBFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFKqtr4%253D&md5=107c13965a50e62447973596f9f7fecd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DSynthesis%2520and%2520anti-HIV%2520activity%2520of%2520bi-functional%2520betulinic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2279%26epage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">HIV entry inhibitors and their potential in HIV therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1002%2Fmed.20138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=18720513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1KnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=369-393&author=K.+Qianauthor=S.+L.+Morris-Natschkeauthor=K.+H.+Lee&title=HIV+entry+inhibitors+and+their+potential+in+HIV+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">HIV entry inhibitors and their potential in HIV therapy</span></div><div class="casAuthors">Qian, Keduo; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-393</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">This review discusses recent progress in the development of anti-HIV agents targeting the viral entry process.  The three main classes (attachment inhibitors, co-receptor binding inhibitors, and fusion inhibitors) are further broken down by specific mechanism of action and structure.  Many of these inhibitors are in advanced clin. trials, including the HIV maturation inhibitor bevirimat, from the authors' labs.  In addn., the CCR5 inhibitor maraviroc has recently been FDA-approved.  Possible roles for these agents in anti-HIV therapy, including treatment of virus resistant to current drugs, are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKIQKEhZgdsrVg90H21EOLACvtfcHk0ljW7Igf7LPBFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1KnsbY%253D&md5=c540ead4fc60e9b0b7c21355ce98f0a6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fmed.20138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20138%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DHIV%2520entry%2520inhibitors%2520and%2520their%2520potential%2520in%2520HIV%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D369%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3248</span><span class="NLM_x">–</span> <span class="NLM_lpage">3258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900136j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvFers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3248-3258&author=K.+Qianauthor=D.+Yuauthor=C.+H.+Chenauthor=L.+Huangauthor=S.+L.+Morris-Natschkeauthor=T.+J.+Nitzauthor=K.+Salzwedelauthor=M.+Reddickauthor=G.+P.+Allawayauthor=K.+H.+Lee&title=Anti-AIDS+agents.+78.+Design%2C+synthesis%2C+metabolic+stability+assessment%2C+and+antiviral+evaluation+of+novel+betulinic+acid+derivatives+as+potent+anti-human+immunodeficiency+virus+%28HIV%29+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-AIDS Agents. 78. Design, Synthesis, Metabolic Stability Assessment, and Antiviral Evaluation of Novel Betulinic Acid Derivatives as Potent Anti-Human Immunodeficiency Virus (HIV) Agents</span></div><div class="casAuthors">Qian, Keduo; Yu, Donglei; Chen, Chin-Ho; Huang, Li; Morris-Natschke, Susan L.; Nitz, Theodore J.; Salzwedel, Karl; Reddick, Mary; Allaway, Graham P.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3248-3258</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a continuing study of potent anti-HIV agents, seventeen 28,30-disubstituted derivs. of betulinic acid (I) and seven novel 3,28-disubstituted analogs were designed, synthesized, and evaluated for in vitro antiviral activity.  Among them, compd. II [R1 = OCH2CH2-(morpholin-4-yl), X = (CH2)7, R2 = NHMe] showed an improved soly. and equal anti-HIV potency (EC50 = 0.09 μM) when compared to HIV entry inhibitors IC9564 {[(3R,4S)-N'-[N-[3β-hydroxy-lup-20(29)-en-28-oyl]-8-aminooctanoyl]-4-amino-3-hydroxy-6-methylheptanoic acid; [III; R3 = CONHCH(CH2CHMe2)CH(OH)CH2CO2H-(3R,4S)]} and A43-D {[N-[3β-O-(3',3'-dimethylsuccinyl)-lup-20(29)-en-28-oyl]-7-aminoheptyl]carbamoyl]methane; (III; R3 = NHAc)}.  Using a cyclic secondary amine to form the C-28 amide bond increased the metabolic stability of the derivs. significantly in pooled human liver microsomes.  The most potent compds. IV [R4 = NH(CH2)n-(morpholin-4-yl); n = 2, 3] displayed potent anti-HIV activity with EC50 values of 0.007 and 0.006 μM, resp.  These results are slightly better than that of bevirimat (3',3'-dimethylsuccinylbetulinic acid), which is currently in phase IIb clin. trials.  Compds. IV should serve as attractive promising leads to develop next generation, metabolically stable, 3,28-disubstituted bifunctional HIV-1 inhibitors as clin. trials candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnG8q47AfIZbVg90H21EOLACvtfcHk0li9UsSm7_ND-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvFers7k%253D&md5=2cb7709d314dc06552c7dc499f9b8a56</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm900136j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900136j%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DReddick%26aufirst%3DM.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAnti-AIDS%2520agents.%252078.%2520Design%252C%2520synthesis%252C%2520metabolic%2520stability%2520assessment%252C%2520and%2520antiviral%2520evaluation%2520of%2520novel%2520betulinic%2520acid%2520derivatives%2520as%2520potent%2520anti-human%2520immunodeficiency%2520virus%2520%2528HIV%2529%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3248%26epage%3D3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y. B.</span><span> </span><span class="NLM_article-title">The design and synthesis of highly branched and spherically symmetric fluorinated oils and amphiles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=3982-3988&author=Z.+X.+Jiangauthor=Y.+B.+Yu&title=The+design+and+synthesis+of+highly+branched+and+spherically+symmetric+fluorinated+oils+and+amphiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYu%26aufirst%3DY.%2BB.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520highly%2520branched%2520and%2520spherically%2520symmetric%2520fluorinated%2520oils%2520and%2520amphiles%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D3982%26epage%3D3988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1016%2Fj.nucmedbio.2005.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=16253804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=799-809&author=W.+Zhangauthor=S.+Oyaauthor=M.+P.+Kungauthor=C.+Houauthor=D.+L.+Maierauthor=H.+F.+Kung&title=F-18+polyethyleneglycol+stilbenes+as+PET+imaging+agents+targeting+A%CE%B2+aggregates+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span></div><div class="casAuthors">Zhang, Wei; Oya, Shunichi; Kung, Mei-Ping; Hou, Catherine; Maier, Donna L.; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">799-809</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This paper describes a novel series of 18F-labeled polyethyleneglycol (PEG)-stilbene derivs. as potential β-amyloid (Aβ) plaque-specific imaging agents for positron emission tomog. (PET).  In these series of compds., 18F is linked to the stilbene through a PEG chain, of which the no. of ethoxy groups ranges from 2 to 5.  The purpose of adding PEG groups is to lower the lipophilicity and improve bioavailability.  The syntheses of the "cold" compds. and the 18F-labeled PEG stilbene derivs. are successfully achieved.  All of the fluorinated stilbenes displayed high binding affinities in an assay using postmortem AD brain homogenates (Ki=2.9-6.7 nM).  Labeling was successfully performed by a substitution of the mesylate group of 10a-d by [18F]fluoride giving the target compds. [18F]12a-d (EOS, specific activity, 900-1500 Ci/mmol; radiochem. purity >99%).  In vivo biodistribution of these novel 18F ligands in normal mice exhibited excellent brain penetrations and rapid washouts after an i.v. injection (6.6-8.1 and 1.2-2.6 %dose/g at 2 and 60 min, resp.).  Autoradiog. of postmortem AD brain sections of [18F]12a-d confirmed the specific binding related to the presence of Aβ plaques.  In addn., in vivo plaque labeling can be clearly demonstrated with these 18F-labeled agents in transgenic mice (Tg2576), a useful animal model for Alzheimer's disease.  In conclusion, the preliminary results strongly suggest these fluorinated PEG stilbene derivs. are suitable candidates as Aβ plaque imaging agents for studying patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLVZvNjp7mrVg90H21EOLACvtfcHk0li9UsSm7_ND-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN&md5=059e56c983730296968273991e30f0b8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DOya%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DMaier%26aufirst%3DD.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DF-18%2520polyethyleneglycol%2520stilbenes%2520as%2520PET%2520imaging%2520agents%2520targeting%2520A%25CE%25B2%2520aggregates%2520in%2520the%2520brain%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D799%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holz-Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span> </span><span class="NLM_article-title">The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">15227</span><span class="NLM_x">–</span> <span class="NLM_lpage">15232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=15227-15232&author=C.+B.+Zhuauthor=L.+Zhuauthor=S.+Holz-Smithauthor=T.+J.+Matthewsauthor=C.+H.+Chen&title=The+role+of+the+third+beta+strand+in+gp120+conformation+and+neutralization+sensitivity+of+the+HIV-1+primary+isolate+DH012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DHolz-Smith%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DT.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520the%2520third%2520beta%2520strand%2520in%2520gp120%2520conformation%2520and%2520neutralization%2520sensitivity%2520of%2520the%2520HIV-1%2520primary%2520isolate%2520DH012%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D15227%26epage%3D15232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS agents 81. Design, synthesis, and structure–activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3133</span><span class="NLM_x">–</span> <span class="NLM_lpage">3141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901782m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3133-3141&author=K.+Qianauthor=R.+Y.+Kuoauthor=C.+H.+Chenauthor=L.+Huangauthor=S.+L.+Morris-Natschkeauthor=K.+H.+Lee&title=Anti-AIDS+agents+81.+Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+study+of+betulinic+acid+and+moronic+acid+derivatives+as+potent+HIV+maturation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm901782m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901782m%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DR.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAnti-AIDS%2520agents%252081.%2520Design%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520betulinic%2520acid%2520and%2520moronic%2520acid%2520derivatives%2520as%2520potent%2520HIV%2520maturation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3133%26epage%3D3141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lhc_44p6dHTXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yingying Chen, Xinchen Wang, Yinbiao Zhu, Longlong Si, Bo Zhang, Yongmin Zhang, Lihe Zhang, Demin Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Sulong Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Hexavalent Betulinic Acid Derivative as a Hemagglutinin-Targeted Influenza Virus Entry Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (7)
                                     , 2546-2554. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c00244" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c00244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c00244%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSynthesis%252Bof%252Ba%252BHexavalent%252BBetulinic%252BAcid%252BDerivative%252Bas%252Ba%252BHemagglutinin-Targeted%252BInfluenza%252BVirus%252BEntry%252BInhibitor%26aulast%3DChen%26aufirst%3DYingying%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05032020%26date%3D19052020%26date%3D16052020%26date%3D01062020%26date%3D19052020%26volume%3D17%26issue%3D7%26spage%3D2546%26epage%3D2554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">K. C. Nicolaou, Yogesh G. Shelke, Balu D. Dherange, Aaron Kempema, Baiwei Lin, Christine Gu, Joseph Sandoval, Mikhail Hammond, Monette Aujay, <span class="NLM_string-name hlFld-ContribAuthor">Julia Gavrilyuk</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Investigation of Epothilone B Analogues Featuring Lactone, Lactam, and Carbocyclic Macrocycles, Epoxide, Aziridine, and 1,1-Difluorocyclopropane and Other Fluorine Residues. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (5)
                                     , 2865-2917. <a href="https://doi.org/10.1021/acs.joc.0c00123" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00123%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BInvestigation%252Bof%252BEpothilone%252BB%252BAnalogues%252BFeaturing%252BLactone%25252C%252BLactam%25252C%252Band%252BCarbocyclic%252BMacrocycles%25252C%252BEpoxide%25252C%252BAziridine%25252C%252Band%252B1%25252C1-Difluorocyclopropane%252Band%252BOther%252BFluorine%252BResidues%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16012020%26date%3D17022020%26volume%3D85%26issue%3D5%26spage%3D2865%26epage%3D2917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qingbo Liu, Yung-Yi Cheng, Wei Li, Li Huang, Yoshihisa Asada, Min-Tsang Hsieh, Susan L. Morris-Natschke, Chin-Ho Chen, Kazuo Koike, <span class="NLM_string-name hlFld-ContribAuthor">Kuo-Hsiung Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationship Correlations of Gnidimacrin Derivatives as Potent HIV-1 Inhibitors and HIV Latency Reversing Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 6958-6971. <a href="https://doi.org/10.1021/acs.jmedchem.9b00339" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BCorrelations%252Bof%252BGnidimacrin%252BDerivatives%252Bas%252BPotent%252BHIV-1%252BInhibitors%252Band%252BHIV%252BLatency%252BReversing%252BAgents%26aulast%3DLiu%26aufirst%3DQingbo%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22022019%26date%3D25072019%26volume%3D62%26issue%3D15%26spage%3D6958%26epage%3D6971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, and <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 9262-9268. <a href="https://doi.org/10.1021/acs.jmedchem.6b00461" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00461%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIncorporation%252Bof%252BPrivileged%252BStructures%252Binto%252BBevirimat%252BCan%252BImprove%252BActivity%252Bagainst%252BWild-Type%252Band%252BBevirimat-Resistant%252BHIV-1%26aulast%3DZhao%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11042016%26date%3D22092016%26date%3D13102016%26volume%3D59%26issue%3D19%26spage%3D9262%26epage%3D9268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver  Callies</span>, <span class="hlFld-ContribAuthor ">Luis M.  Bedoya</span>, <span class="hlFld-ContribAuthor ">Manuela  Beltrán</span>, <span class="hlFld-ContribAuthor ">Alejandro  Muñoz</span>, <span class="hlFld-ContribAuthor ">Patricia Obregón  Calderón</span>, <span class="hlFld-ContribAuthor ">Alex A.  Osorio</span>, <span class="hlFld-ContribAuthor ">Ignacio A.  Jiménez</span>, <span class="hlFld-ContribAuthor ">José  Alcamí</span>, and <span class="hlFld-ContribAuthor ">Isabel L.  Bazzocchi</span>  . </span><span class="cited-content_cbyCitation_article-title">Isolation, Structural Modification, and HIV Inhibition of Pentacyclic Lupane-Type Triterpenoids from Cassine xylocarpa and Maytenus cuzcoina. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2015,</strong> <em>78 </em>
                                    (5)
                                     , 1045-1055. <a href="https://doi.org/10.1021/np501025r" title="DOI URL">https://doi.org/10.1021/np501025r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/np501025r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnp501025r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DIsolation%25252C%252BStructural%252BModification%25252C%252Band%252BHIV%252BInhibition%252Bof%252BPentacyclic%252BLupane-Type%252BTriterpenoids%252Bfrom%252BCassine%252Bxylocarpa%252Band%252BMaytenus%252Bcuzcoina%26aulast%3DCallies%26aufirst%3DOliver%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D18122014%26date%3D30042015%26date%3D22052015%26volume%3D78%26issue%3D5%26spage%3D1045%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Lu  Lu</span>, <span class="hlFld-ContribAuthor ">Heya  Na</span>, <span class="hlFld-ContribAuthor ">Xiangpeng  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Xifeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Tianhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinglai  Li</span>, <span class="hlFld-ContribAuthor ">Zhenqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Baohua  Zheng</span>, <span class="hlFld-ContribAuthor ">Guodong  Liang</span>, <span class="hlFld-ContribAuthor ">Lifeng  Cai</span>, <span class="hlFld-ContribAuthor ">Shibo  Jiang</span>, and <span class="hlFld-ContribAuthor ">Keliang  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Conjugation of a Nonspecific Antiviral Sapogenin with a Specific HIV Fusion Inhibitor: A Promising Strategy for Discovering New Antiviral Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (17)
                                     , 7342-7354. <a href="https://doi.org/10.1021/jm500763m" title="DOI URL">https://doi.org/10.1021/jm500763m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500763m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500763m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DConjugation%252Bof%252Ba%252BNonspecific%252BAntiviral%252BSapogenin%252Bwith%252Ba%252BSpecific%252BHIV%252BFusion%252BInhibitor%25253A%252BA%252BPromising%252BStrategy%252Bfor%252BDiscovering%252BNew%252BAntiviral%252BTherapeutics%26aulast%3DWang%26aufirst%3DChao%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D16052014%26date%3D26082014%26date%3D11092014%26volume%3D57%26issue%3D17%26spage%3D7342%26epage%3D7354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhao  Dang</span>, <span class="hlFld-ContribAuthor ">Phong  Ho</span>, <span class="hlFld-ContribAuthor ">Lei  Zhu</span>, <span class="hlFld-ContribAuthor ">Keduo  Qian</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Li  Huang</span>, and <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">New Betulinic Acid Derivatives for Bevirimat-Resistant Human Immunodeficiency Virus Type-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (5)
                                     , 2029-2037. <a href="https://doi.org/10.1021/jm3016969" title="DOI URL">https://doi.org/10.1021/jm3016969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3016969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3016969%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BBetulinic%252BAcid%252BDerivatives%252Bfor%252BBevirimat-Resistant%252BHuman%252BImmunodeficiency%252BVirus%252BType-1%26aulast%3DDang%26aufirst%3DZhao%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D17112012%26date%3D20022013%26date%3D14032013%26date%3D04022013%26volume%3D56%26issue%3D5%26spage%3D2029%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dibya  Ghimire</span>, <span class="hlFld-ContribAuthor ">Yuvraj  KC</span>, <span class="hlFld-ContribAuthor ">Uddhav  Timilsina</span>, <span class="hlFld-ContribAuthor ">Kriti  Goel</span>, <span class="hlFld-ContribAuthor ">T. J.  Nitz</span>, <span class="hlFld-ContribAuthor ">Carl T.  Wild</span>, <span class="hlFld-ContribAuthor ">Ritu  Gaur</span>. </span><span class="cited-content_cbyCitation_article-title">A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Retrovirology</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12977-021-00553-5" title="DOI URL">https://doi.org/10.1186/s12977-021-00553-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12977-021-00553-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12977-021-00553-5%26sid%3Dliteratum%253Aachs%26jtitle%3DRetrovirology%26atitle%3DA%252Bsingle%252BG10T%252Bpolymorphism%252Bin%252BHIV-1%252Bsubtype%252BC%252BGag-SP1%252Bregulates%252Bsensitivity%252Bto%252Bmaturation%252Binhibitors%26aulast%3DGhimire%26aufirst%3DDibya%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. V.  Giniyatullina</span>, <span class="hlFld-ContribAuthor ">O. B.  Kazakova</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxicity of Lupane Mono- and Bis-Piperazinylamides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Natural Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (4)
                                     , 698-705. <a href="https://doi.org/10.1007/s10600-021-03453-4" title="DOI URL">https://doi.org/10.1007/s10600-021-03453-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10600-021-03453-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10600-021-03453-4%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Natural%2520Compounds%26atitle%3DSynthesis%252Band%252BCytotoxicity%252Bof%252BLupane%252BMono-%252Band%252BBis-Piperazinylamides%26aulast%3DGiniyatullina%26aufirst%3DG.%2BV.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D4%26spage%3D698%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113287. <a href="https://doi.org/10.1016/j.ejmech.2021.113287" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113287%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure%252Bactivity%252Brelationship%252Banalysis%252Bof%252Bnew%252Bbetulinic%252Bacid%252Bderivatives%252Bas%252Bpotent%252BHIV%252Binhibitors%26aulast%3DZhao%26aufirst%3DYu%26date%3D2021%26volume%3D215%26spage%3D113287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai‐Feng  Wu</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris‐Natschke</span>, <span class="hlFld-ContribAuthor ">Xu‐Dong  Xu</span>, <span class="hlFld-ContribAuthor ">Mei‐Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Yung‐Yi  Cheng</span>, <span class="hlFld-ContribAuthor ">Shi‐Shan  Yu</span>, <span class="hlFld-ContribAuthor ">Kuo‐Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in natural anti‐HIV triterpenoids and analogs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2339-2385. <a href="https://doi.org/10.1002/med.21708" title="DOI URL">https://doi.org/10.1002/med.21708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21708%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bnatural%252Banti%2525E2%252580%252590HIV%252Btriterpenoids%252Band%252Banalogs%26aulast%3DWu%26aufirst%3DHai%25E2%2580%2590Feng%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2339%26epage%3D2385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex B.  Kleinpeter</span>, <span class="hlFld-ContribAuthor ">Eric O.  Freed</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 Maturation: Lessons Learned from Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2020,</strong> <em>12 </em>
                                    (9)
                                     , 940. <a href="https://doi.org/10.3390/v12090940" title="DOI URL">https://doi.org/10.3390/v12090940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v12090940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv12090940%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DHIV-1%252BMaturation%25253A%252BLessons%252BLearned%252Bfrom%252BInhibitors%26aulast%3DKleinpeter%26aufirst%3DAlex%2BB.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D9%26spage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaodong  Liu</span>, <span class="hlFld-ContribAuthor ">Yang  Da</span>, <span class="hlFld-ContribAuthor ">Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Renjie  Yan</span>, <span class="hlFld-ContribAuthor ">Yongzhi  Shu</span>, <span class="hlFld-ContribAuthor ">Pei  Lin</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted selective degradation of Bruton’s tyrosine kinase by PROTACs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (4)
                                     , 802-808. <a href="https://doi.org/10.1007/s00044-020-02526-3" title="DOI URL">https://doi.org/10.1007/s00044-020-02526-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02526-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02526-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DTargeted%252Bselective%252Bdegradation%252Bof%252BBruton%2525E2%252580%252599s%252Btyrosine%252Bkinase%252Bby%252BPROTACs%26aulast%3DLiu%26aufirst%3DShaodong%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D4%26spage%3D802%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexej  Dick</span>, <span class="hlFld-ContribAuthor ">Simon  Cocklin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in HIV-1 Gag Inhibitor Design and Development. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1687. <a href="https://doi.org/10.3390/molecules25071687" title="DOI URL">https://doi.org/10.3390/molecules25071687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071687%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252BHIV-1%252BGag%252BInhibitor%252BDesign%252Band%252BDevelopment%26aulast%3DDick%26aufirst%3DAlexej%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uladzimir  Bildziukevich</span>, <span class="hlFld-ContribAuthor ">Zülal  Özdemir</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Wimmer</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Achievements in Medicinal and Supramolecular Chemistry of Betulinic Acid and Its Derivatives ‡. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (19)
                                     , 3546. <a href="https://doi.org/10.3390/molecules24193546" title="DOI URL">https://doi.org/10.3390/molecules24193546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24193546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24193546%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAchievements%252Bin%252BMedicinal%252Band%252BSupramolecular%252BChemistry%252Bof%252BBetulinic%252BAcid%252Band%252BIts%252BDerivatives%252B%2525E2%252580%2525A1%26aulast%3DBildziukevich%26aufirst%3DUladzimir%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D19%26spage%3D3546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jizhen  Li</span>, <span class="hlFld-ContribAuthor ">Ling-Chu  Chang</span>, <span class="hlFld-ContribAuthor ">Kan-Yen  Hsieh</span>, <span class="hlFld-ContribAuthor ">Pei-Ling  Hsu</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Capuzzi</span>, <span class="hlFld-ContribAuthor ">Ying-Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Kang-Po  Li</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (13)
                                     , 2871-2882. <a href="https://doi.org/10.1016/j.bmc.2019.05.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bantiproliferative%252Bactivity%252Bof%252Bfluorinated%252Bbetulinic%252Bacid%26aulast%3DLi%26aufirst%3DJizhen%26date%3D2019%26volume%3D27%26issue%3D13%26spage%3D2871%26epage%3D2882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aymeric  Neyret</span>, <span class="hlFld-ContribAuthor ">Bernard  Gay</span>, <span class="hlFld-ContribAuthor ">Anaïs  Cransac</span>, <span class="hlFld-ContribAuthor ">Laurence  Briant</span>, <span class="hlFld-ContribAuthor ">Pascale  Coric</span>, <span class="hlFld-ContribAuthor ">Serge  Turcaud</span>, <span class="hlFld-ContribAuthor ">Philippe  Laugâa</span>, <span class="hlFld-ContribAuthor ">Serge  Bouaziz</span>, <span class="hlFld-ContribAuthor ">Nathalie  Chazal</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2019,</strong> <em>164 </em>, 162-175. <a href="https://doi.org/10.1016/j.antiviral.2019.02.014" title="DOI URL">https://doi.org/10.1016/j.antiviral.2019.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2019.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2019.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DInsight%252Binto%252Bthe%252Bmechanism%252Bof%252Baction%252Bof%252BEP-39%25252C%252Ba%252Bbevirimat%252Bderivative%252Bthat%252Binhibits%252BHIV-1%252Bmaturation%26aulast%3DNeyret%26aufirst%3DAymeric%26date%3D2019%26volume%3D164%26spage%3D162%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emiko  Urano</span>, <span class="hlFld-ContribAuthor ">Uddhav  Timilsina</span>, <span class="hlFld-ContribAuthor ">Justin A.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Sherimay  Ablan</span>, <span class="hlFld-ContribAuthor ">Dibya  Ghimire</span>, <span class="hlFld-ContribAuthor ">Phuong  Pham</span>, <span class="hlFld-ContribAuthor ">Nishani  Kuruppu</span>, <span class="hlFld-ContribAuthor ">Rebecca  Mandt</span>, <span class="hlFld-ContribAuthor ">Stewart R.  Durell</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Nitz</span>, <span class="hlFld-ContribAuthor ">David E.  Martin</span>, <span class="hlFld-ContribAuthor ">Carl T.  Wild</span>, <span class="hlFld-ContribAuthor ">Ritu  Gaur</span>, <span class="hlFld-ContribAuthor ">Eric O.  Freed</span>, . </span><span class="cited-content_cbyCitation_article-title">Resistance to Second-Generation HIV-1 Maturation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2019,</strong> <em>93 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/JVI.02017-18" title="DOI URL">https://doi.org/10.1128/JVI.02017-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.02017-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.02017-18%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DResistance%252Bto%252BSecond-Generation%252BHIV-1%252BMaturation%252BInhibitors%26aulast%3DUrano%26aufirst%3DEmiko%26date%3D2019%26volume%3D93%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Swidorski</span>, <span class="hlFld-ContribAuthor ">Zheng  Liu</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Dawn D.  Parker</span>, <span class="hlFld-ContribAuthor ">Beata  Nowicka-Sans</span>, <span class="hlFld-ContribAuthor ">Zeyu  Lin</span>, <span class="hlFld-ContribAuthor ">Zhufang  Li</span>, <span class="hlFld-ContribAuthor ">Brian J.  Terry</span>, <span class="hlFld-ContribAuthor ">Tricia  Protack</span>, <span class="hlFld-ContribAuthor ">Sandhya  Rahematpura</span>, <span class="hlFld-ContribAuthor ">Umesh  Hanumegowda</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Mark  Krystal</span>, <span class="hlFld-ContribAuthor ">Ira D.  Dicker</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Alicia  Regueiro-Ren</span>. </span><span class="cited-content_cbyCitation_article-title">The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (9)
                                     , 1550-1557. <a href="https://doi.org/10.1016/j.bmcl.2018.03.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.03.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.03.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationships%252Bassociated%252Bwith%252BC28%252Bamine-based%252Bbetulinic%252Bacid%252Bderivatives%252Bas%252Binhibitors%252Bof%252BHIV-1%252Bmaturation%26aulast%3DChen%26aufirst%3DYan%26date%3D2018%26volume%3D28%26issue%3D9%26spage%3D1550%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Zirak</span>, <span class="hlFld-ContribAuthor ">Elham  Jamali Garegeshlagi</span>. </span><span class="cited-content_cbyCitation_article-title">Picolinimidoamide-Cu(II) complex anchored on Fe
              3
              O
              4
              @SiO
              2
              core–shell magnetic nanoparticles: an efficient reusable catalyst for click reaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Coordination Chemistry</span><span> <strong>2018,</strong> <em>71 </em>
                                    (8)
                                     , 1168-1179. <a href="https://doi.org/10.1080/00958972.2018.1450975" title="DOI URL">https://doi.org/10.1080/00958972.2018.1450975</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00958972.2018.1450975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00958972.2018.1450975%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Coordination%2520Chemistry%26atitle%3DPicolinimidoamide-Cu%252528II%252529%252Bcomplex%252Banchored%252Bon%252BFe%252B3%252BO%252B4%252B%252540SiO%252B2%252Bcore%2525E2%252580%252593shell%252Bmagnetic%252Bnanoparticles%25253A%252Ban%252Befficient%252Breusable%252Bcatalyst%252Bfor%252Bclick%252Breaction%26aulast%3DZirak%26aufirst%3DMaryam%26date%3D2018%26date%3D2018%26volume%3D71%26issue%3D8%26spage%3D1168%26epage%3D1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Tang</span>, <span class="hlFld-ContribAuthor ">Stacey A.  Jones</span>, <span class="hlFld-ContribAuthor ">Jerry L.  Jeffrey</span>, <span class="hlFld-ContribAuthor ">Sonia R.  Miranda</span>, <span class="hlFld-ContribAuthor ">Cristin M.  Galardi</span>, <span class="hlFld-ContribAuthor ">David M.  Irlbeck</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Brown</span>, <span class="hlFld-ContribAuthor ">Charlene B.  McDanal</span>, <span class="hlFld-ContribAuthor ">Brian A.  Johns</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (12)
                                     , 2689-2694. <a href="https://doi.org/10.1016/j.bmcl.2017.04.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Band%252Bpotent%252Bclass%252Bof%252Banti-HIV-1%252Bmaturation%252Binhibitors%252Bwith%252Bimproved%252Bvirology%252Bprofile%252Bagainst%252Bgag%252Bpolymorphisms%26aulast%3DTang%26aufirst%3DJun%26date%3D2017%26volume%3D27%26issue%3D12%26spage%3D2689%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dibya  Ghimire</span>, <span class="hlFld-ContribAuthor ">Uddhav  Timilsina</span>, <span class="hlFld-ContribAuthor ">Tryambak Pratap  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ritu  Gaur</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep43711" title="DOI URL">https://doi.org/10.1038/srep43711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep43711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep43711%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DInsights%252Binto%252Bthe%252Bactivity%252Bof%252Bmaturation%252Binhibitor%252BPF-46396%252Bon%252BHIV-1%252Bclade%252BC%26aulast%3DGhimire%26aufirst%3DDibya%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankit  Saneja</span>, <span class="hlFld-ContribAuthor ">Love  Sharma</span>, <span class="hlFld-ContribAuthor ">Ravindra Dhar  Dubey</span>, <span class="hlFld-ContribAuthor ">Mubashir Javed  Mintoo</span>, <span class="hlFld-ContribAuthor ">Amrinder  Singh</span>, <span class="hlFld-ContribAuthor ">Amit  Kumar</span>, <span class="hlFld-ContribAuthor ">Payare Lal  Sangwan</span>, <span class="hlFld-ContribAuthor ">Sheikh Abdullah  Tasaduq</span>, <span class="hlFld-ContribAuthor ">Gurdarshan  Singh</span>, <span class="hlFld-ContribAuthor ">Dilip M.  Mondhe</span>, <span class="hlFld-ContribAuthor ">Prem N.  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate. </span><span class="cited-content_cbyCitation_journal-name">Materials Science and Engineering: C</span><span> <strong>2017,</strong> <em>73 </em>, 616-626. <a href="https://doi.org/10.1016/j.msec.2016.12.109" title="DOI URL">https://doi.org/10.1016/j.msec.2016.12.109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.msec.2016.12.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.msec.2016.12.109%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Science%2520and%2520Engineering%253A%2520C%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Baugmented%252Banticancer%252Bpotential%252Bof%252BPEG-betulinic%252Bacid%252Bconjugate%26aulast%3DSaneja%26aufirst%3DAnkit%26date%3D2017%26volume%3D73%26spage%3D616%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seungil  Kim</span>, <span class="hlFld-ContribAuthor ">Yufei  Chen</span>, <span class="hlFld-ContribAuthor ">Emmanuel A.  Ho</span>, <span class="hlFld-ContribAuthor ">Song  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Acta Biomaterialia</span><span> <strong>2017,</strong> <em>47 </em>, 100-112. <a href="https://doi.org/10.1016/j.actbio.2016.10.006" title="DOI URL">https://doi.org/10.1016/j.actbio.2016.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.actbio.2016.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.actbio.2016.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Biomaterialia%26atitle%3DReversibly%252BpH-responsive%252Bpolyurethane%252Bmembranes%252Bfor%252Bon-demand%252Bintravaginal%252Bdrug%252Bdelivery%26aulast%3DKim%26aufirst%3DSeungil%26date%3D2017%26volume%3D47%26spage%3D100%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Murgatroyd</span>, <span class="hlFld-ContribAuthor ">Lisa  Pirrie</span>, <span class="hlFld-ContribAuthor ">Fanny  Tran</span>, <span class="hlFld-ContribAuthor ">Terry K.  Smith</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Westwood</span>, <span class="hlFld-ContribAuthor ">Catherine S.  Adamson</span>, . </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2016,</strong> <em>90 </em>
                                    (18)
                                     , 8181-8197. <a href="https://doi.org/10.1128/JVI.01075-16" title="DOI URL">https://doi.org/10.1128/JVI.01075-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.01075-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.01075-16%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DStructure-Activity%252BRelationships%252Bof%252Bthe%252BHuman%252BImmunodeficiency%252BVirus%252BType%252B1%252BMaturation%252BInhibitor%252BPF-46396%26aulast%3DMurgatroyd%26aufirst%3DChristopher%26date%3D2016%26volume%3D90%26issue%3D18%26spage%3D8181%26epage%3D8197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uddhav  Timilsina</span>, <span class="hlFld-ContribAuthor ">Dibya  Ghimire</span>, <span class="hlFld-ContribAuthor ">Bivek  Timalsina</span>, <span class="hlFld-ContribAuthor ">Theodore J.  Nitz</span>, <span class="hlFld-ContribAuthor ">Carl T.  Wild</span>, <span class="hlFld-ContribAuthor ">Eric O.  Freed</span>, <span class="hlFld-ContribAuthor ">Ritu  Gaur</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potent maturation inhibitors against HIV-1 clade C. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep27403" title="DOI URL">https://doi.org/10.1038/srep27403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep27403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep27403%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIdentification%252Bof%252Bpotent%252Bmaturation%252Binhibitors%252Bagainst%252BHIV-1%252Bclade%252BC%26aulast%3DTimilsina%26aufirst%3DUddhav%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Liu</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Swidorski</span>, <span class="hlFld-ContribAuthor ">Beata  Nowicka-Sans</span>, <span class="hlFld-ContribAuthor ">Brian  Terry</span>, <span class="hlFld-ContribAuthor ">Tricia  Protack</span>, <span class="hlFld-ContribAuthor ">Zeyu  Lin</span>, <span class="hlFld-ContribAuthor ">Himadri  Samanta</span>, <span class="hlFld-ContribAuthor ">Sharon  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhufang  Li</span>, <span class="hlFld-ContribAuthor ">Dawn D.  Parker</span>, <span class="hlFld-ContribAuthor ">Sandhya  Rahematpura</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Brett R.  Beno</span>, <span class="hlFld-ContribAuthor ">Mark  Krystal</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Ira B.  Dicker</span>, <span class="hlFld-ContribAuthor ">Alicia  Regueiro-Ren</span>. </span><span class="cited-content_cbyCitation_article-title">C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (8)
                                     , 1757-1770. <a href="https://doi.org/10.1016/j.bmc.2016.03.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DC-3%252Bbenzoic%252Bacid%252Bderivatives%252Bof%252BC-3%252Bdeoxybetulinic%252Bacid%252Band%252Bdeoxybetulin%252Bas%252BHIV-1%252Bmaturation%252Binhibitors%26aulast%3DLiu%26aufirst%3DZheng%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1757%26epage%3D1770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob J.  Swidorski</span>, <span class="hlFld-ContribAuthor ">Zheng  Liu</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Dawn D.  Parker</span>, <span class="hlFld-ContribAuthor ">Beata  Nowicka-Sans</span>, <span class="hlFld-ContribAuthor ">Brian J.  Terry</span>, <span class="hlFld-ContribAuthor ">Tricia  Protack</span>, <span class="hlFld-ContribAuthor ">Sandhya  Rahematpura</span>, <span class="hlFld-ContribAuthor ">Umesh  Hanumegowda</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Mark  Krystal</span>, <span class="hlFld-ContribAuthor ">Ira B.  Dicker</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Alicia  Regueiro-Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of HIV-1 maturation: Development of structure–activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (8)
                                     , 1925-1930. <a href="https://doi.org/10.1016/j.bmcl.2016.03.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhibitors%252Bof%252BHIV-1%252Bmaturation%25253A%252BDevelopment%252Bof%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bfor%252BC-28%252Bamides%252Bbased%252Bon%252BC-3%252Bbenzoic%252Bacid-modified%252Btriterpenoids%26aulast%3DSwidorski%26aufirst%3DJacob%2BJ.%26date%3D2016%26volume%3D26%26issue%3D8%26spage%3D1925%26epage%3D1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jizhen  Li</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Yang</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Li  Huang</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (1)
                                     , 68-71. <a href="https://doi.org/10.1016/j.bmcl.2015.11.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFluorinated%252Bbetulinic%252Bacid%252Bderivatives%252Band%252Bevaluation%252Bof%252Btheir%252Banti-HIV%252Bactivity%26aulast%3DLi%26aufirst%3DJizhen%26date%3D2016%26volume%3D26%26issue%3D1%26spage%3D68%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debabrata  Bhunia</span>, <span class="hlFld-ContribAuthor ">Preethi M. C.  Pallavi</span>, <span class="hlFld-ContribAuthor ">Srinivasa Reddy  Bonam</span>, <span class="hlFld-ContribAuthor ">Sandeep A.  Reddy</span>, <span class="hlFld-ContribAuthor ">Yogesh  Verma</span>, <span class="hlFld-ContribAuthor ">M. Sampath Kumar  Halmuthur</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Novel 1,2,3-Triazole-Tethered Glycolipids as Vaccine Adjuvants. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (10)
                                     , 689-703. <a href="https://doi.org/10.1002/ardp.201500143" title="DOI URL">https://doi.org/10.1002/ardp.201500143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201500143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201500143%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BNovel%252B1%25252C2%25252C3-Triazole-Tethered%252BGlycolipids%252Bas%252BVaccine%252BAdjuvants%26aulast%3DBhunia%26aufirst%3DDebabrata%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D10%26spage%3D689%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. N.  Dubovitskii</span>, <span class="hlFld-ContribAuthor ">N. G.  Komissarova</span>, <span class="hlFld-ContribAuthor ">O. V.  Shitikova</span>, <span class="hlFld-ContribAuthor ">L. V.  Spirikhin</span>, <span class="hlFld-ContribAuthor ">M. F.  Abdullin</span>, <span class="hlFld-ContribAuthor ">M. S.  Yunusov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Betulin 28-(2-Bromoacetate) Conjugates with Uracil and its Methyl-Substituted Homologs. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Natural Compounds</span><span> <strong>2015,</strong> <em>51 </em>
                                    (3)
                                     , 505-511. <a href="https://doi.org/10.1007/s10600-015-1325-5" title="DOI URL">https://doi.org/10.1007/s10600-015-1325-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10600-015-1325-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10600-015-1325-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Natural%2520Compounds%26atitle%3DSynthesis%252Bof%252BBetulin%252B28-%2525282-Bromoacetate%252529%252BConjugates%252Bwith%252BUracil%252Band%252Bits%252BMethyl-Substituted%252BHomologs%26aulast%3DDubovitskii%26aufirst%3DS.%2BN.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D3%26spage%3D505%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip R.  Tedbury</span>, <span class="hlFld-ContribAuthor ">Eric O.  Freed</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 Gag: An Emerging Target for Antiretroviral Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 171-201. <a href="https://doi.org/10.1007/82_2015_436" title="DOI URL">https://doi.org/10.1007/82_2015_436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/82_2015_436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F82_2015_436%26sid%3Dliteratum%253Aachs%26atitle%3DHIV-1%252BGag%25253A%252BAn%252BEmerging%252BTarget%252Bfor%252BAntiretroviral%252BTherapy%26aulast%3DTedbury%26aufirst%3DPhilip%2BR.%26date%3D2015%26date%3D2015%26spage%3D171%26epage%3D201%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BFuture%252Bof%252BHIV-1%252BTherapeutics%26aulast%3DTorbett%26aufirst%3DBruce%2BE.%26date%3D2015%26volume%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johan  Gising</span>, <span class="hlFld-ContribAuthor ">Mats  Larhed</span>, <span class="hlFld-ContribAuthor ">Luke R  Odell</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of anti-tuberculosis, HIV and hepatitis C agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 34-54. <a href="https://doi.org/10.4155/fseb2013.13.19" title="DOI URL">https://doi.org/10.4155/fseb2013.13.19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fseb2013.13.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffseb2013.13.19%26sid%3Dliteratum%253Aachs%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252Banti-tuberculosis%25252C%252BHIV%252Band%252Bhepatitis%252BC%252Bagents%26aulast%3DGising%26aufirst%3DJohan%26date%3D2014%26date%3D2014%26spage%3D34%26epage%3D54%26pub%3DFuture%2520Science%2520Ltd%26atitle%3DMicrowaves%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BAdvances%26aulast%3DSpencer%26aufirst%3DJohn%26date%3D2014%26date%3D2014%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I. Yu.  Strobykina</span>, <span class="hlFld-ContribAuthor ">M. G.  Belenok</span>, <span class="hlFld-ContribAuthor ">B. F.  Garifullin</span>, <span class="hlFld-ContribAuthor ">V. M.  Babaev</span>, <span class="hlFld-ContribAuthor ">V. E.  Kataev</span>. </span><span class="cited-content_cbyCitation_article-title">Open-Chain and Macrocyclic Polyethyleneglycol Esters of the Diterpenoid Isosteviol. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Natural Compounds</span><span> <strong>2014,</strong> <em>50 </em>
                                    (3)
                                     , 462-464. <a href="https://doi.org/10.1007/s10600-014-0987-8" title="DOI URL">https://doi.org/10.1007/s10600-014-0987-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10600-014-0987-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10600-014-0987-8%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Natural%2520Compounds%26atitle%3DOpen-Chain%252Band%252BMacrocyclic%252BPolyethyleneglycol%252BEsters%252Bof%252Bthe%252BDiterpenoid%252BIsosteviol%26aulast%3DStrobykina%26aufirst%3DI.%2BYu.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D3%26spage%3D462%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. M.  Islam</span>, <span class="hlFld-ContribAuthor ">Sumantra  Paul</span>, <span class="hlFld-ContribAuthor ">Anupam Singha  Roy</span>, <span class="hlFld-ContribAuthor ">Satabdi  Banerjee</span>, <span class="hlFld-ContribAuthor ">Manir  Mobarok</span>, <span class="hlFld-ContribAuthor ">S. C.  Santra</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, catalytic activity and phytotoxicity of a supported nickel(II) Schiff base complex. </span><span class="cited-content_cbyCitation_journal-name">Transition Metal Chemistry</span><span> <strong>2013,</strong> <em>38 </em>
                                    (8)
                                     , 855-864. <a href="https://doi.org/10.1007/s11243-013-9759-8" title="DOI URL">https://doi.org/10.1007/s11243-013-9759-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11243-013-9759-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11243-013-9759-8%26sid%3Dliteratum%253Aachs%26jtitle%3DTransition%2520Metal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcatalytic%252Bactivity%252Band%252Bphytotoxicity%252Bof%252Ba%252Bsupported%252Bnickel%252528II%252529%252BSchiff%252Bbase%252Bcomplex%26aulast%3DIslam%26aufirst%3DS.%2BM.%26date%3D2013%26date%3D2013%26volume%3D38%26issue%3D8%26spage%3D855%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai Yan  Quan</span>, <span class="hlFld-ContribAuthor ">Do Yeon  Kim</span>, <span class="hlFld-ContribAuthor ">Soo Jung  Kim</span>, <span class="hlFld-ContribAuthor ">Hee Kyung  Jo</span>, <span class="hlFld-ContribAuthor ">Go Woon  Kim</span>, <span class="hlFld-ContribAuthor ">Sung Hyun  Chung</span>. </span><span class="cited-content_cbyCitation_article-title">Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK–mTOR–SREBP signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2013,</strong> <em>85 </em>
                                    (9)
                                     , 1330-1340. <a href="https://doi.org/10.1016/j.bcp.2013.02.007" title="DOI URL">https://doi.org/10.1016/j.bcp.2013.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2013.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DBetulinic%252Bacid%252Balleviates%252Bnon-alcoholic%252Bfatty%252Bliver%252Bby%252Binhibiting%252BSREBP1%252Bactivity%252Bvia%252Bthe%252BAMPK%2525E2%252580%252593mTOR%2525E2%252580%252593SREBP%252Bsignaling%252Bpathway%26aulast%3DQuan%26aufirst%3DHai%2BYan%26date%3D2013%26volume%3D85%26issue%3D9%26spage%3D1330%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pascale  Coric</span>, <span class="hlFld-ContribAuthor ">Serge  Turcaud</span>, <span class="hlFld-ContribAuthor ">Florence  Souquet</span>, <span class="hlFld-ContribAuthor ">Laurence  Briant</span>, <span class="hlFld-ContribAuthor ">Bernard  Gay</span>, <span class="hlFld-ContribAuthor ">Jacques  Royer</span>, <span class="hlFld-ContribAuthor ">Nathalie  Chazal</span>, <span class="hlFld-ContribAuthor ">Serge  Bouaziz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>62 </em>, 453-465. <a href="https://doi.org/10.1016/j.ejmech.2013.01.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnew%252Bderivative%252Bof%252Bbevirimat%252Bthat%252Btargets%252Bthe%252BGag%252BCA-SP1%252Bcleavage%252Bsite%26aulast%3DCoric%26aufirst%3DPascale%26date%3D2013%26volume%3D62%26spage%3D453%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Han</span>, <span class="hlFld-ContribAuthor ">Wenjie  Ouyang</span>, <span class="hlFld-ContribAuthor ">Bin  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Po  Tien</span>, <span class="hlFld-ContribAuthor ">Shuwen  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective inhibition of reverse transcriptase (RT) of HIV-1 by non-racemic indole-based trifluoropropanoates developed by asymmetric catalysis using recyclable organocatalysts. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (48)
                                     , 8463. <a href="https://doi.org/10.1039/c3ob41667d" title="DOI URL">https://doi.org/10.1039/c3ob41667d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob41667d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob41667d%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DEnantioselective%252Binhibition%252Bof%252Breverse%252Btranscriptase%252B%252528RT%252529%252Bof%252BHIV-1%252Bby%252Bnon-racemic%252Bindole-based%252Btrifluoropropanoates%252Bdeveloped%252Bby%252Basymmetric%252Bcatalysis%252Busing%252Brecyclable%252Borganocatalysts%26aulast%3DHan%26aufirst%3DXin%26date%3D2013%26volume%3D11%26issue%3D48%26spage%3D8463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noor  Salam</span>, <span class="hlFld-ContribAuthor ">Arjyabaran  Sinha</span>, <span class="hlFld-ContribAuthor ">Paramita  Mondal</span>, <span class="hlFld-ContribAuthor ">Anupam Singha  Roy</span>, <span class="hlFld-ContribAuthor ">Nikhil R.  Jana</span>, <span class="hlFld-ContribAuthor ">Sk. Manirul  Islam</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient and reusable graphene-γ-Fe2O3 magnetic nano-composite for selective oxidation and one-pot synthesis of 1,2,3-triazole using a green solvent. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (39)
                                     , 18087. <a href="https://doi.org/10.1039/c3ra43184c" title="DOI URL">https://doi.org/10.1039/c3ra43184c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra43184c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra43184c%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DEfficient%252Band%252Breusable%252Bgraphene-%2525CE%2525B3-Fe2O3%252Bmagnetic%252Bnano-composite%252Bfor%252Bselective%252Boxidation%252Band%252Bone-pot%252Bsynthesis%252Bof%252B1%25252C2%25252C3-triazole%252Busing%252Ba%252Bgreen%252Bsolvent%26aulast%3DSalam%26aufirst%3DNoor%26date%3D2013%26volume%3D3%26issue%3D39%26spage%3D18087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/medium/jm-2012-01040s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-18/jm301040s/production/images/large/jm-2012-01040s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301040s&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Barbaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrolorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1805</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.2174%2F1381612053764869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=15892677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Chur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1805-1843&author=G.+Barbaroauthor=A.+Scozzafavaauthor=A.+Mastrolorenzoauthor=C.+T.+Supuran&title=Highly+active+antiretroviral+therapy%3A+current+state+of+the+art%2C+new+agents+and+their+pharmacological+interactions+useful+for+improving+therapeutic+outcome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Highly active antiretroviral therapy: Current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome</span></div><div class="casAuthors">Barbaro, Giuseppe; Scozzafava, Andrea; Mastrolorenzo, Antonio; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1805-1843</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) dramatically changed the course of HIV infection.  Currently, this therapy involves the use of agents from at least two distinct classes of antivirals: a protease inhibitor (PI) in combination with two nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTIs), or a non-nucleoside reverse transcriptase inhibitor (NNRTI) in combination with NRTIs.  Recently, the third family of antivirals started to be used clin., with the advent of enfuvirtide, the first fusion inhibitor (FI).  Several pharmacol. agents are available form these classes of antivirals, NRTIs, NNRTIs, PIs and FIs, which will be briefly reviewed here.  Some more agents are in advanced clin. evaluation or have recently been approved (such as tenofovir, a NtRTI; atazanavir, a PI; tipranavir, another PI), mainly against drug-resistant viruses.  Compds. inhibiting HIV integrase, the third enzyme of HIV, are also available ultimately, with several such derivs. in clin. trials (L-731,988 and S-1360).  Another approach to inhibit the growth of retroviruses, including HIV, targets the ejection of zinc ions from crit. zinc finger viral proteins, which has as a consequence the inhibition of viral replication in the absence of mutations leading to drug resistance phenotypes.  All steps in the process of HIV entry into the cell may be targeted by specific compds. that might be developed as novel types of antiretrovirals.  Thus, inhibitors of the gp120 - CD4 interaction have been detected (zintevir, FP-21399 and BMS-378806 in clin. trials).  Small mol. chemokine antagonists acting as HIV entry inhibitors also were described in the last period, which interact both with the CXCR4 coreceptor (such as AMD3100; AMD3465; ALX40-4C; T22, T134 and T140), or which are antagonist of the CCR5 coreceptor (TAK-779, TAK-220, SCH-C, SCH-D, E913, AK-602 and NSC 651016 in clin. trials), together with new types of fusion inhibitors possessing the same mechanism of action as enfuvirtide (such as T1249).  Compds. interacting with Tat/Tar have also been detected which inhibit HIV replication in low micromolar range (EM2487, tamacrazine, CGP 64222 or CGA 137053 among others).  Unexploited viral and cellular targets (such as the maturation process - with a first potent compd. available, PA-457; the cellular proteins Tsg101, APOBEC3G, or the viral ones Vif, Rev or RNase H) are also presented, together with recently emerged approaches for eradication of HIV reservoirs.  A review on the pharmacol. and interactions of these agents with other drugs is presented here, with emphasis on how these pharmacol. interferences may improve the clin. use of antivirals, or how side effects due to these drugs may be managed better by taking them into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIUHwOtcVvSLVg90H21EOLACvtfcHk0lgUT0eiq-oHvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Chur8%253D&md5=e5bff5d10a92b31e61423b0fafade5f2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1381612053764869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612053764869%26sid%3Dliteratum%253Aachs%26aulast%3DBarbaro%26aufirst%3DG.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMastrolorenzo%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DHighly%2520active%2520antiretroviral%2520therapy%253A%2520current%2520state%2520of%2520the%2520art%252C%2520new%2520agents%2520and%2520their%2520pharmacological%2520interactions%2520useful%2520for%2520improving%2520therapeutic%2520outcome%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D1805%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ho, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perelson, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span> </span><span class="NLM_article-title">Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=1995&pages=123-126&author=D.+D.+Hoauthor=A.+U.+Neumannauthor=A.+S.+Perelsonauthor=W.+Chenauthor=J.+M.+Leonardauthor=M.+Markowitz&title=Rapid+turnover+of+plasma+virions+and+CD4+lymphocytes+in+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DD.%2BD.%26aulast%3DNeumann%26aufirst%3DA.%2BU.%26aulast%3DPerelson%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLeonard%26aufirst%3DJ.%2BM.%26aulast%3DMarkowitz%26aufirst%3DM.%26atitle%3DRapid%2520turnover%2520of%2520plasma%2520virions%2520and%2520CD4%2520lymphocytes%2520in%2520HIV-1%2520infection%26jtitle%3DNature%26date%3D1995%26volume%3D373%26spage%3D123%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hammer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenstein, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundacker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schooley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubrich, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lederman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phair, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merigan, T. C.</span><span> </span><span class="NLM_article-title">A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1056%2FNEJM199610103351501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=8813038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK28XmsValtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1996&pages=1081-1090&author=S.+M.+Hammerauthor=D.+A.+Katzensteinauthor=M.+D.+Hughesauthor=H.+Gundackerauthor=R.+T.+Schooleyauthor=R.+H.+Haubrichauthor=W.+K.+Henryauthor=M.+M.+Ledermanauthor=J.+P.+Phairauthor=M.+Niuauthor=M.+S.+Hirschauthor=T.+C.+Merigan&title=A+trial+comparing+nucleoside+monotherapy+with+combination+therapy+in+HIV-infected+adults+with+CD4+cell+counts+from+200+to+500+per+cubic+millimeter.+AIDS+Clinical+Trials+Group+Study+175+Study+Team"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter</span></div><div class="casAuthors">Hammer, Scott M.; Katzenstein, David A.; Hughes, Michael D.; Gundacker, Holly; Schooley, Robert T.; Haubrich, Richard H.; Henry, W. Keith; Lederman, Michael M.; Phair, John P.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1081-1090</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">This double-blind study evaluated treatment with either a single nucleoside or two nucleosides in adults infected with human immunodeficiency virus type 1 (HIV-1) whose CD4 cell counts were from 200 to 500 per cubic millimeter.  The authors randomly assigned 2467 HIV-1-infected patients (43 % without prior antiretroviral treatment) to one of four daily regimens: 600 mg of zidovudine; 600 mg of zidovudine plus 400 mg of didanosine; 600 mg of zidovudine plus 2.25 mg of zalcitabine; or 400 mg of didanosine.  The primary end point was a percent decline in the CD4 cell count, development of the acquired immunodeficiency syndrome (AIDS), or death.  Progression to the primary end point was more frequent with zidovudine alone (32 %) than with zidovudine plus didanosine (18 %; relative hazard ratio, 0.50), zidovudine plus zalcitabine (20 %; relative hazard ratio, 0.54), or didanosine alone (22 %; relative hazard ratio, 0.61).  The relative hazard ratios for progression to an AIDS-defining event or death were 0.64 for zidovudine plus didanosine, as compared with zidovudine alone, 0.77 for zidovudine plus zalcitabine, and 0.69 for didanosine alone.  The relative hazard ratios for death were 0.55, 0.71, and 0.51, resp.  For zidovudine plus zalcitabine, the benefits were limited to those without previous treatment.  Treatment with zidovudine plus didanosine, zidovudine plus zalcitabine, or didanosine alone slows the progression of HIV disease and is superior to treatment with zidovudine alone.  Antiretroviral therapy can improve survival in patients with 200 to 500 CD4 cells per cubic millimeter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGratg9tInWNpbVg90H21EOLACvtfcHk0lgUT0eiq-oHvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsValtrY%253D&md5=e3f78d691ac4ab52a6b2eb86f5a6dc19</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM199610103351501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199610103351501%26sid%3Dliteratum%253Aachs%26aulast%3DHammer%26aufirst%3DS.%2BM.%26aulast%3DKatzenstein%26aufirst%3DD.%2BA.%26aulast%3DHughes%26aufirst%3DM.%2BD.%26aulast%3DGundacker%26aufirst%3DH.%26aulast%3DSchooley%26aufirst%3DR.%2BT.%26aulast%3DHaubrich%26aufirst%3DR.%2BH.%26aulast%3DHenry%26aufirst%3DW.%2BK.%26aulast%3DLederman%26aufirst%3DM.%2BM.%26aulast%3DPhair%26aufirst%3DJ.%2BP.%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26aulast%3DMerigan%26aufirst%3DT.%2BC.%26atitle%3DA%2520trial%2520comparing%2520nucleoside%2520monotherapy%2520with%2520combination%2520therapy%2520in%2520HIV-infected%2520adults%2520with%2520CD4%2520cell%2520counts%2520from%2520200%2520to%2520500%2520per%2520cubic%2520millimeter.%2520AIDS%2520Clinical%2520Trials%2520Group%2520Study%2520175%2520Study%2520Team%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1996%26volume%3D335%26spage%3D1081%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gulick, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meibohm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlir, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chodakewitz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellors, J. W.</span><span> </span><span class="NLM_article-title">Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2345-2349&author=R.+M.+Gulickauthor=A.+Meibohmauthor=D.+Havlirauthor=J.+J.+Eronauthor=A.+Mosleyauthor=J.+A.+Chodakewitzauthor=R.+Isaacsauthor=C.+Gonzalezauthor=D.+McMahonauthor=D.+D.+Richmanauthor=M.+Robertsonauthor=J.+W.+Mellors&title=Six-year+follow-up+of+HIV-1-infected+adults+in+a+clinical+trial+of+antiretroviral+therapy+with+indinavir%2C+zidovudine%2C+and+lamivudine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGulick%26aufirst%3DR.%2BM.%26aulast%3DMeibohm%26aufirst%3DA.%26aulast%3DHavlir%26aufirst%3DD.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26aulast%3DMosley%26aufirst%3DA.%26aulast%3DChodakewitz%26aufirst%3DJ.%2BA.%26aulast%3DIsaacs%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DMcMahon%26aufirst%3DD.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DRobertson%26aufirst%3DM.%26aulast%3DMellors%26aufirst%3DJ.%2BW.%26atitle%3DSix-year%2520follow-up%2520of%2520HIV-1-infected%2520adults%2520in%2520a%2520clinical%2520trial%2520of%2520antiretroviral%2520therapy%2520with%2520indinavir%252C%2520zidovudine%252C%2520and%2520lamivudine%26jtitle%3DAIDS%26date%3D2003%26volume%3D17%26spage%3D2345%26epage%3D2349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span>World Health Organization. Health Topics: HIV/AIDS. <a href="http://www.who.int/topics/hiv_aids/en/" class="extLink">http://www.who.int/topics/hiv_aids/en/</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization.+Health+Topics%3A+HIV%2FAIDS.+http%3A%2F%2Fwww.who.int%2Ftopics%2Fhiv_aids%2Fen%2F+%28accessed+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chun, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiGiuseppe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermankova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadwick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeiger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barditch-Crovo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1038%2F387183a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=9144289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK2sXjtF2gtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=1997&pages=183-188&author=T.+W.+Chunauthor=L.+Carruthauthor=D.+Finziauthor=X.+Shenauthor=J.+A.+DiGiuseppeauthor=H.+Taylorauthor=M.+Hermankovaauthor=K.+Chadwickauthor=J.+Margolickauthor=T.+C.+Quinnauthor=Y.+H.+Kuoauthor=R.+Brookmeyerauthor=M.+A.+Zeigerauthor=P.+Barditch-Crovoauthor=R.+F.+Siliciano&title=Quantification+of+latent+tissue+reservoirs+and+total+body+viral+load+in+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection</span></div><div class="casAuthors">Chun, Tae-Wook; Carruth, Lucy; Finzi, Diana; Shen, Xuefei; DiGiuseppe, Joseph A.; Taylor, Harry; Hermankova, Monika; Chadwick, Karen; Margolick, Joseph; Quinn, Thomas C.; Kuo, Yen-Hong; Brookmeyer, Ronald; Zeiger, Martha A.; Barditch-Crovo, Patricia; Siliciano, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">6629</span>),
    <span class="NLM_cas:pages">183-188</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy.  Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral mRNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection.  Uncertainty remains over what fraction of CD4+T cells are infected and whether there are latent reservoirs for the virus.  We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+T cells with replication-competent integrated provirus (<107 cells).  The most prevalent form of HIV-1 DNA in resting and activated CD4+T cells is a full-length, linear, unintegrated form that is not replication competent.  The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+T cells and macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHllJ5UFoRbVg90H21EOLACvtfcHk0liNFyy0gWJvxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtF2gtr8%253D&md5=f5b12cfeaf7edde8fde49e9573a97c44</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F387183a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F387183a0%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DT.%2BW.%26aulast%3DCarruth%26aufirst%3DL.%26aulast%3DFinzi%26aufirst%3DD.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DDiGiuseppe%26aufirst%3DJ.%2BA.%26aulast%3DTaylor%26aufirst%3DH.%26aulast%3DHermankova%26aufirst%3DM.%26aulast%3DChadwick%26aufirst%3DK.%26aulast%3DMargolick%26aufirst%3DJ.%26aulast%3DQuinn%26aufirst%3DT.%2BC.%26aulast%3DKuo%26aufirst%3DY.%2BH.%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DZeiger%26aufirst%3DM.%2BA.%26aulast%3DBarditch-Crovo%26aufirst%3DP.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DQuantification%2520of%2520latent%2520tissue%2520reservoirs%2520and%2520total%2520body%2520viral%2520load%2520in%2520HIV-1%2520infection%26jtitle%3DNature%26date%3D1997%26volume%3D387%26spage%3D183%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Finzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermankova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruth, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaisson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadwick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1295-1300&author=D.+Finziauthor=M.+Hermankovaauthor=T.+Piersonauthor=L.+M.+Carruthauthor=C.+Buckauthor=R.+E.+Chaissonauthor=T.+C.+Quinnauthor=K.+Chadwickauthor=J.+Margolickauthor=R.+Brookmeyerauthor=J.+Gallantauthor=M.+Markowitzauthor=D.+D.+Hoauthor=D.+D.+Richmanauthor=R.+F.+Siliciano&title=Identification+of+a+reservoir+for+HIV-1+in+patients+on+highly+active+antiretroviral+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinzi%26aufirst%3DD.%26aulast%3DHermankova%26aufirst%3DM.%26aulast%3DPierson%26aufirst%3DT.%26aulast%3DCarruth%26aufirst%3DL.%2BM.%26aulast%3DBuck%26aufirst%3DC.%26aulast%3DChaisson%26aufirst%3DR.%2BE.%26aulast%3DQuinn%26aufirst%3DT.%2BC.%26aulast%3DChadwick%26aufirst%3DK.%26aulast%3DMargolick%26aufirst%3DJ.%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DGallant%26aufirst%3DJ.%26aulast%3DMarkowitz%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%2BD.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DIdentification%2520of%2520a%2520reservoir%2520for%2520HIV-1%2520in%2520patients%2520on%2520highly%2520active%2520antiretroviral%2520therapy%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D1295%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hezareh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunthard, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havlir, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignacio, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spina, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span> </span><span class="NLM_article-title">Recovery of replication-competent HIV despite prolonged suppression of plasma viremia</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=1291-1295&author=J.+K.+Wongauthor=M.+Hezarehauthor=H.+F.+Gunthardauthor=D.+V.+Havlirauthor=C.+C.+Ignacioauthor=C.+A.+Spinaauthor=D.+D.+Richman&title=Recovery+of+replication-competent+HIV+despite+prolonged+suppression+of+plasma+viremia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DJ.%2BK.%26aulast%3DHezareh%26aufirst%3DM.%26aulast%3DGunthard%26aufirst%3DH.%2BF.%26aulast%3DHavlir%26aufirst%3DD.%2BV.%26aulast%3DIgnacio%26aufirst%3DC.%2BC.%26aulast%3DSpina%26aufirst%3DC.%2BA.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26atitle%3DRecovery%2520of%2520replication-competent%2520HIV%2520despite%2520prolonged%2520suppression%2520of%2520plasma%2520viremia%26jtitle%3DScience%26date%3D1997%26volume%3D278%26spage%3D1291%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flexner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polis, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masur, H.</span><span> </span><span class="NLM_article-title">Drug interactions in patients infected with human immunodeficiency virus</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1093%2Fclinids%2F23.4.685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=8909827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK28XmsFOmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=685-693&author=S.+C.+Piscitelliauthor=C.+Flexnerauthor=J.+R.+Minorauthor=M.+A.+Polisauthor=H.+Masur&title=Drug+interactions+in+patients+infected+with+human+immunodeficiency+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Drug interactions in patients infected with human immunodeficiency virus</span></div><div class="casAuthors">Piscitelli, Stephen C.; Flexner, Charles; Minor, James R.; Polis, Michael A.; Masur, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-693</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review with 60 refs.  Patients with AIDS who are receiving optimal medical care, including combination therapy with antiretroviral agents and more effective prophylaxis and therapy for opportunistic infections and neoplasms, are surviving longer.  However, the potential for drug interactions in these patients is increased because many of the currently used antibiotics and antiviral agents have profound effects on the hepatic cytochrome P 450 enzyme system, on renal tubular function, and on bone marrow function.  In this AIDS Commentary, Dr. Piscitelli and colleagues have succinctly reviewed the current state of our knowledge regarding the potential for additive or synergistic drug interactions that can result in enhanced toxicity or, alternatively, augmented therapeutic benefit.  Information on these interactions will become more important as more intensive and effective therapy becomes available for persons with far-advanced infection due to human immunodeficiency virus type 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSA8rMebW2VrVg90H21EOLACvtfcHk0liNFyy0gWJvxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFOmsrg%253D&md5=493ca45123681d99bc0dd2efb9e4a86e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F23.4.685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F23.4.685%26sid%3Dliteratum%253Aachs%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26aulast%3DFlexner%26aufirst%3DC.%26aulast%3DMinor%26aufirst%3DJ.%2BR.%26aulast%3DPolis%26aufirst%3DM.%2BA.%26aulast%3DMasur%26aufirst%3DH.%26atitle%3DDrug%2520interactions%2520in%2520patients%2520infected%2520with%2520human%2520immunodeficiency%2520virus%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1996%26volume%3D23%26spage%3D685%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Louie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span> </span><span class="NLM_article-title">Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2002&pages=15-25&author=M.+Louieauthor=M.+Markowitz&title=Goals+and+milestones+during+treatment+of+HIV-1+infection+with+antiretroviral+therapy%3A+a+pathogenesis-based+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DM.%26aulast%3DMarkowitz%26aufirst%3DM.%26atitle%3DGoals%2520and%2520milestones%2520during%2520treatment%2520of%2520HIV-1%2520infection%2520with%2520antiretroviral%2520therapy%253A%2520a%2520pathogenesis-based%2520perspective%26jtitle%3DAntiviral%2520Res.%26date%3D2002%26volume%3D55%26spage%3D15%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Boden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farthing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, M.</span><span> </span><span class="NLM_article-title">HIV-1 drug resistance in newly infected individuals</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1999&pages=1135-1141&author=D.+Bodenauthor=A.+Hurleyauthor=L.+Zhangauthor=Y.+Caoauthor=Y.+Guoauthor=E.+Jonesauthor=J.+Tsayauthor=J.+Ipauthor=C.+Farthingauthor=K.+Limoliauthor=N.+Parkinauthor=M.+Markowitz&title=HIV-1+drug+resistance+in+newly+infected+individuals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoden%26aufirst%3DD.%26aulast%3DHurley%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DTsay%26aufirst%3DJ.%26aulast%3DIp%26aufirst%3DJ.%26aulast%3DFarthing%26aufirst%3DC.%26aulast%3DLimoli%26aufirst%3DK.%26aulast%3DParkin%26aufirst%3DN.%26aulast%3DMarkowitz%26aufirst%3DM.%26atitle%3DHIV-1%2520drug%2520resistance%2520in%2520newly%2520infected%2520individuals%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1999%26volume%3D282%26spage%3D1135%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Fujioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilkuskie, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosentino, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from <i>Syzigium claviflorum</i>, and the anti-HIV activity of structurally related triterpenoids</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/doi/10.1021/np50104a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1994&pages=243-247&author=T.+Fujiokaauthor=Y.+Kashiwadaauthor=R.+E.+Kilkuskieauthor=L.+M.+Cosentinoauthor=L.+M.+Ballasauthor=J.+B.+Jiangauthor=W.+P.+Janzenauthor=I.+S.+Chenauthor=K.+H.+Lee&title=Anti-AIDS+agents%2C+11.+Betulinic+acid+and+platanic+acid+as+anti-HIV+principles+from+Syzigium+claviflorum%2C+and+the+anti-HIV+activity+of+structurally+related+triterpenoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fnp50104a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50104a008%26sid%3Dliteratum%253Aachs%26aulast%3DFujioka%26aufirst%3DT.%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DKilkuskie%26aufirst%3DR.%2BE.%26aulast%3DCosentino%26aufirst%3DL.%2BM.%26aulast%3DBallas%26aufirst%3DL.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%2BB.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DChen%26aufirst%3DI.%2BS.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAnti-AIDS%2520agents%252C%252011.%2520Betulinic%2520acid%2520and%2520platanic%2520acid%2520as%2520anti-HIV%2520principles%2520from%2520Syzigium%2520claviflorum%252C%2520and%2520the%2520anti-HIV%2520activity%2520of%2520structurally%2520related%2520triterpenoids%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1994%26volume%3D57%26spage%3D243%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kashiwada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosentino, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1017</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950922q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK28XpsFKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1016-1017&author=Y.+Kashiwadaauthor=F.+Hashimotoauthor=L.+M.+Cosentinoauthor=C.+H.+Chenauthor=P.+E.+Garrettauthor=K.+H.+Lee&title=Betulinic+acid+and+dihydrobetulinic+acid+derivatives+as+potent+anti-HIV+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV Agents</span></div><div class="casAuthors">Kashiwada, Yoshiki; Hashimoto, Fumio; Cosentino, L. Mark; Chen, Chin-Ho; Garrett, Patricia E.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1016-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the prepn. of 12 betulinic acid and dihydrobetulinic acid derivs. and their anti-HIV activity.  Both 3-O-(3',3'-dimethylsuccinyl)betulinic acid and 3-O-(3',3'-dimethylsuccinyl)dihydrobetulinic acid demonstrated extremely potent anti-HIV activity in acutely infected H9 lymphocytes with EC50 values of <3.5 x 10-4 μM.  They exhibited remarkable TI values (IC50 value divided by EC50 value) of >20,000 and >14,000, resp.  Four of the other derivs. also exhibited potent anti-HIV activities with EC50 values ranging from 0.01 to 2.3 x 10-3 μM and TI values from 1017 to 2344.  Results from preliminary mechanism of action studies are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7QcghyIgNcLVg90H21EOLACvtfcHk0ljvRpSdpK2meA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsFKgtg%253D%253D&md5=c04b2b671f0c434cb1815be9ded50fbd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm950922q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950922q%26sid%3Dliteratum%253Aachs%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DF.%26aulast%3DCosentino%26aufirst%3DL.%2BM.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DGarrett%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DBetulinic%2520acid%2520and%2520dihydrobetulinic%2520acid%2520derivatives%2520as%2520potent%2520anti-HIV%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1016%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kanamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanbara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span> </span><span class="NLM_article-title">Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=1225-1230&author=T.+Kanamotoauthor=Y.+Kashiwadaauthor=K.+Kanbaraauthor=K.+Gotohauthor=M.+Yoshimoriauthor=T.+Gotoauthor=K.+Sanoauthor=H.+Nakashima&title=Anti-human+immunodeficiency+virus+activity+of+YK-FH312+%28a+betulinic+acid+derivative%29%2C+a+novel+compound+blocking+viral+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanamoto%26aufirst%3DT.%26aulast%3DKashiwada%26aufirst%3DY.%26aulast%3DKanbara%26aufirst%3DK.%26aulast%3DGotoh%26aufirst%3DK.%26aulast%3DYoshimori%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DK.%26aulast%3DNakashima%26aufirst%3DH.%26atitle%3DAnti-human%2520immunodeficiency%2520virus%2520activity%2520of%2520YK-FH312%2520%2528a%2520betulinic%2520acid%2520derivative%2529%252C%2520a%2520novel%2520compound%2520blocking%2520viral%2520maturation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D1225%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goila-Gaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgore, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matallana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoumplis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orenstein, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C. T.</span><span> </span><span class="NLM_article-title">PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">13555</span><span class="NLM_x">–</span> <span class="NLM_lpage">13560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13555-13560&author=F.+Liauthor=R.+Goila-Gaurauthor=K.+Salzwedelauthor=N.+R.+Kilgoreauthor=M.+Reddickauthor=C.+Matallanaauthor=A.+Castilloauthor=D.+Zoumplisauthor=D.+E.+Martinauthor=J.+M.+Orensteinauthor=G.+P.+Allawayauthor=E.+O.+Freedauthor=C.+T.+Wild&title=PA-457%3A+a+potent+HIV+inhibitor+that+disrupts+core+condensation+by+targeting+a+late+step+in+Gag+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGoila-Gaur%26aufirst%3DR.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DKilgore%26aufirst%3DN.%2BR.%26aulast%3DReddick%26aufirst%3DM.%26aulast%3DMatallana%26aufirst%3DC.%26aulast%3DCastillo%26aufirst%3DA.%26aulast%3DZoumplis%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DD.%2BE.%26aulast%3DOrenstein%26aufirst%3DJ.%2BM.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DFreed%26aufirst%3DE.%2BO.%26aulast%3DWild%26aufirst%3DC.%2BT.%26atitle%3DPA-457%253A%2520a%2520potent%2520HIV%2520inhibitor%2520that%2520disrupts%2520core%2520condensation%2520by%2520targeting%2520a%2520late%2520step%2520in%2520Gag%2520processing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D13555%26epage%3D13560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Qian, K.; Nitz, T. J.; Yu, D.; Allaway, G. P.; Morris-Natschke, S. L.; Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS Agents 76. From Natural Product to Clinical Trials: Bevirimat, a Plant-Derived Anti-AIDS Drug</span>. In  <span class="citation_source-book">Natural Product Chemistry for Drug Discoverys</span>; <span class="NLM_contrib-group">Buss, T.; Butler, M.</span>, Eds.; Biomolecular Sciences Series; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1039%2F9781847559890-00374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=374-391&author=K.+Qian&author=T.+J.+Nitz&author=D.+Yu&author=G.+P.+Allaway&author=S.+L.+Morris-Natschke&author=K.+H.+Leeauthor=T.+Buss&author=M.+Butler&title=Natural+Product+Chemistry+for+Drug+Discoverys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2F9781847559890-00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781847559890-00374%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26atitle%3DAnti-AIDS%2520Agents%252076.%2520From%2520Natural%2520Product%2520to%2520Clinical%2520Trials%253A%2520Bevirimat%252C%2520a%2520Plant-Derived%2520Anti-AIDS%2520Drug%26btitle%3DNatural%2520Product%2520Chemistry%2520for%2520Drug%2520Discoverys%26aulast%3DBuss%26aufirst%3DT.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2009%26spage%3D374%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Smith, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogundele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. E.</span><span> </span><span class="NLM_article-title">Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-<i>O</i>-(3′,3′-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3574</span><span class="NLM_x">–</span> <span class="NLM_lpage">3581</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3574-3581&author=P.+F.+Smithauthor=A.+Ogundeleauthor=A.+Forrestauthor=J.+Wiltonauthor=K.+Salzwedelauthor=J.+Dotoauthor=G.+P.+Allawayauthor=D.+E.+Martin&title=Phase+I+and+II+study+of+the+safety%2C+virologic+effect%2C+and+pharmacokinetics%2Fpharmacodynamics+of+single-dose+3-O-%283%E2%80%B2%2C3%E2%80%B2-dimethylsuccinyl%29betulinic+acid+%28bevirimat%29+against+human+immunodeficiency+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DP.%2BF.%26aulast%3DOgundele%26aufirst%3DA.%26aulast%3DForrest%26aufirst%3DA.%26aulast%3DWilton%26aufirst%3DJ.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DDoto%26aufirst%3DJ.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DMartin%26aufirst%3DD.%2BE.%26atitle%3DPhase%2520I%2520and%2520II%2520study%2520of%2520the%2520safety%252C%2520virologic%2520effect%252C%2520and%2520pharmacokinetics%252Fpharmacodynamics%2520of%2520single-dose%25203-O-%25283%25E2%2580%25B2%252C3%25E2%2580%25B2-dimethylsuccinyl%2529betulinic%2520acid%2520%2528bevirimat%2529%2520against%2520human%2520immunodeficiency%2520virus%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3574%26epage%3D3581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Martin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbraith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballow, C.</span><span> </span><span class="NLM_article-title">Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.2165%2F00003088-200746070-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=17596104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlGrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=589-598&author=D.+E.+Martinauthor=R.+Blumauthor=J.+Dotoauthor=H.+Galbraithauthor=C.+Ballow&title=Multiple-dose+pharmacokinetics+and+safety+of+bevirimat%2C+a+novel+inhibitor+of+HIV+maturation%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers</span></div><div class="casAuthors">Martin, David E.; Blum, Robert; Doto, Judy; Galbraith, Hal; Ballow, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">589-598</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">Bevirimat [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] is a novel inhibitor of HIV-1 maturation.  This study was performed to investigate the pharmacokinetics and safety of bevirimat during repeated dosing in healthy volunteers.  The study was a 10-day, randomised, double-blind, placebo-controlled, dose escalation study.  A total of 48 healthy male volunteers, aged 19-54 years, took part in the study.  Treatment was administered for 10 days in six escalating dose cohorts (n = 8 in each cohort; 6 bevirimat, 2 placebo).  The doses of bevirimat given in each successive cohort were 25 mg, 50 mg, 75 mg (with 150 mg loading dose), 100 mg, 150 mg, and 200 mg.  Safety follow-up was performed 28 days after the first dose.  Pharmacokinetic and statistical anal.: plasma bevirimat levels were measured from blood samples collected pre-dose on days 1-10 and then at approx. 48-h intervals until 21 days after dosing started.  On days 1 and 10, further blood samples were obtained at 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, and 12 h after dosing.  Urine samples were collected in the morning on days 1, 5, and 11 and at the end of the study for the measurement of cortisol and 6β-hydroxycortisol.  The pharmacokinetic parameters of bevirimat were estd. using non-compartmental methods.  Dose proportionality of exposure to bevirimat, assessed by the max. plasma concn. and the area under the plasma concn.-time curve.  The mean terminal elimination half-life of bevirimat ranged from 56.3-69.5 h, and the mean clearance ranged from 173.9-185.8 mL/h.  Bevirimat showed approx. 4-fold greater accumulation on day 10 compared with day 1, and the degree of accumulation was similar with all doses.  Maximum plasma concns. ranged from 8-58 μg/mL at day 10.  Testing for dose-proportionality showed that exposure to bevirimat was proportional to the dose, both after a single dose and after repeat dosing for 10 days.  Measurement of the urinary 6β-hydroxycortisol/cortisol ratio indicated that bevirimat did not affect cytochrome P 450 3A activity.  Repeated dosing with bevirimat for 10 days was well tolerated.  There was no increase in adverse events obsd. for bevirimat compared with placebo, and no serious adverse events occurred.  No clin. relevant changes in vital signs, phys. examn. or clin. lab. evaluations were obsd.  Bevirimat shows dose-proportional pharmacokinetics during repeated dosing for 10 days.  Its accumulation is approx. 4-fold greater on day 10 compared with day 1.  Repeated dosing with bevirimat is well tolerated.  These properties make bevirimat potentially suitable for inclusion in highly active antiretroviral therapy regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUcy3iQBaHRLVg90H21EOLACvtfcHk0linIrjWfB2aRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlGrurY%253D&md5=a64c8813a9521a4e96b9b4fa311947c5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2165%2F00003088-200746070-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200746070-00004%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DD.%2BE.%26aulast%3DBlum%26aufirst%3DR.%26aulast%3DDoto%26aufirst%3DJ.%26aulast%3DGalbraith%26aufirst%3DH.%26aulast%3DBallow%26aufirst%3DC.%26atitle%3DMultiple-dose%2520pharmacokinetics%2520and%2520safety%2520of%2520bevirimat%252C%2520a%2520novel%2520inhibitor%2520of%2520HIV%2520maturation%252C%2520in%2520healthy%2520volunteers%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2007%26volume%3D46%26spage%3D589%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Martin, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galbraith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballow, C.</span><span> </span><span class="NLM_article-title">Safety and pharmacokinetics of bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3063</span><span class="NLM_x">–</span> <span class="NLM_lpage">3066</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1128%2FAAC.01391-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=17576843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVais7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3063-3066&author=D.+E.+Martinauthor=R.+Blumauthor=J.+Wiltonauthor=J.+Dotoauthor=H.+Galbraithauthor=G.+L.+Burgessauthor=P.+C.+Smithauthor=C.+Ballow&title=Safety+and+pharmacokinetics+of+bevirimat+%28PA-457%29%2C+a+novel+inhibitor+of+human+immunodeficiency+virus+maturation%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and pharmacokinetics of bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers</span></div><div class="casAuthors">Martin, David E.; Blum, Robert; Wilton, John; Doto, Judy; Galbraith, Hal; Burgess, Gina L.; Smith, Philip C.; Ballow, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3063-3066</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Bevirimat (BVM; formerly known as PA-457) is a novel inhibitor of human immunodeficiency virus (HIV) maturation that is being developed for the treatment of HIV infection.  The pharmacokinetics of this agent in healthy male volunteers were studied in a randomized, double-blind study in which the participants received single oral doses of placebo (n = 8) or escalating doses of BVM at 25, 50, 100, or 250 mg (n = 6 per dose); escalation was performed only after the pharmacokinetics and safety of the preceding dose had been evaluated.  Plasma was collected over 480 h after dosing and urine was collected over 48 h after dosing for detn. of the values of pharmacokinetic parameters.  BVM was well absorbed after oral administration, with peak plasma concns. being achieved 1 to 3 h after dosing.  The half-life was 60 to 80 h.  The exposure assessed by detn. of the peak concn. and the area under the concn.-time curve was dose proportional.  Single oral doses of BVM were well tolerated: there were no dose-limiting toxicities, and no serious adverse events were reported.  These findings suggest that BVM offers a favorable pharmacokinetic profile, with predictable pharmacokinetics following the oral administration of single doses.  The long half-life of BVM may facilitate once-daily dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8T8o2VtH7OLVg90H21EOLACvtfcHk0linIrjWfB2aRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVais7zL&md5=091f6022f3cb5a9cd114c2f533835c74</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.01391-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01391-06%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DD.%2BE.%26aulast%3DBlum%26aufirst%3DR.%26aulast%3DWilton%26aufirst%3DJ.%26aulast%3DDoto%26aufirst%3DJ.%26aulast%3DGalbraith%26aufirst%3DH.%26aulast%3DBurgess%26aufirst%3DG.%2BL.%26aulast%3DSmith%26aufirst%3DP.%2BC.%26aulast%3DBallow%26aufirst%3DC.%26atitle%3DSafety%2520and%2520pharmacokinetics%2520of%2520bevirimat%2520%2528PA-457%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520maturation%252C%2520in%2520healthy%2520volunteers%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3063%26epage%3D3066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><a href="http://investor.myriad.com/releasedetail.cfm?ReleaseID=360258" class="extLink">http://investor.myriad.com/releasedetail.cfm?ReleaseID=360258</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Finvestor.myriad.com%2Freleasedetail.cfm%3FReleaseID%3D360258."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span> </span><span class="NLM_article-title">Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1016%2Fj.bmc.2005.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=16314103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFKqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2279-2289&author=L.+Huangauthor=P.+Hoauthor=K.+H.+Leeauthor=C.+H.+Chen&title=Synthesis+and+anti-HIV+activity+of+bi-functional+betulinic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives</span></div><div class="casAuthors">Huang, Li; Ho, Phong; Lee, Kuo-Hsiung; Chen, Chin-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2279-2289</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Betulinic acid (BA) derivs. with a side chain at C-3 can inhibit HIV-1 maturation.  On the other hand, BA derivs. with a side chain at C-28 can block HIV-1 entry.  In order to combine the anti-maturation and anti-entry activities in a single mol., new bi-functional BA derivs. contg. side chains at C-3 and C-28 have been synthesized.  The most potent compd. ([[N-[3β-O-(3',3'-dimethylsuccinyl)-lup-20(29)-en-28-oyl]-7-aminoheptyl]-carbamoyl]methane) inhibited HIV-1 at an EC50 of 0.0026 μM and was at least 20 times more potent than either the anti-maturation lead compd. DSB or the anti-entry lead compd. IC9564.  This bi-functional BA deriv. was active against both HIV entry and maturation.  These results suggest that bi-functional BA derivs. with dual mechanisms of action have the potential to become clin. useful for AIDS therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRS_sXlvXSE7Vg90H21EOLACvtfcHk0lifh64YRbkgYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFKqtr4%253D&md5=107c13965a50e62447973596f9f7fecd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DSynthesis%2520and%2520anti-HIV%2520activity%2520of%2520bi-functional%2520betulinic%2520acid%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2279%26epage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">HIV entry inhibitors and their potential in HIV therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1002%2Fmed.20138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=18720513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1KnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=369-393&author=K.+Qianauthor=S.+L.+Morris-Natschkeauthor=K.+H.+Lee&title=HIV+entry+inhibitors+and+their+potential+in+HIV+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">HIV entry inhibitors and their potential in HIV therapy</span></div><div class="casAuthors">Qian, Keduo; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-393</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">This review discusses recent progress in the development of anti-HIV agents targeting the viral entry process.  The three main classes (attachment inhibitors, co-receptor binding inhibitors, and fusion inhibitors) are further broken down by specific mechanism of action and structure.  Many of these inhibitors are in advanced clin. trials, including the HIV maturation inhibitor bevirimat, from the authors' labs.  In addn., the CCR5 inhibitor maraviroc has recently been FDA-approved.  Possible roles for these agents in anti-HIV therapy, including treatment of virus resistant to current drugs, are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKIQKEhZgdsrVg90H21EOLACvtfcHk0lifh64YRbkgYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1KnsbY%253D&md5=c540ead4fc60e9b0b7c21355ce98f0a6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fmed.20138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20138%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DHIV%2520entry%2520inhibitors%2520and%2520their%2520potential%2520in%2520HIV%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D369%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaway, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3248</span><span class="NLM_x">–</span> <span class="NLM_lpage">3258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900136j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvFers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3248-3258&author=K.+Qianauthor=D.+Yuauthor=C.+H.+Chenauthor=L.+Huangauthor=S.+L.+Morris-Natschkeauthor=T.+J.+Nitzauthor=K.+Salzwedelauthor=M.+Reddickauthor=G.+P.+Allawayauthor=K.+H.+Lee&title=Anti-AIDS+agents.+78.+Design%2C+synthesis%2C+metabolic+stability+assessment%2C+and+antiviral+evaluation+of+novel+betulinic+acid+derivatives+as+potent+anti-human+immunodeficiency+virus+%28HIV%29+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-AIDS Agents. 78. Design, Synthesis, Metabolic Stability Assessment, and Antiviral Evaluation of Novel Betulinic Acid Derivatives as Potent Anti-Human Immunodeficiency Virus (HIV) Agents</span></div><div class="casAuthors">Qian, Keduo; Yu, Donglei; Chen, Chin-Ho; Huang, Li; Morris-Natschke, Susan L.; Nitz, Theodore J.; Salzwedel, Karl; Reddick, Mary; Allaway, Graham P.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3248-3258</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a continuing study of potent anti-HIV agents, seventeen 28,30-disubstituted derivs. of betulinic acid (I) and seven novel 3,28-disubstituted analogs were designed, synthesized, and evaluated for in vitro antiviral activity.  Among them, compd. II [R1 = OCH2CH2-(morpholin-4-yl), X = (CH2)7, R2 = NHMe] showed an improved soly. and equal anti-HIV potency (EC50 = 0.09 μM) when compared to HIV entry inhibitors IC9564 {[(3R,4S)-N'-[N-[3β-hydroxy-lup-20(29)-en-28-oyl]-8-aminooctanoyl]-4-amino-3-hydroxy-6-methylheptanoic acid; [III; R3 = CONHCH(CH2CHMe2)CH(OH)CH2CO2H-(3R,4S)]} and A43-D {[N-[3β-O-(3',3'-dimethylsuccinyl)-lup-20(29)-en-28-oyl]-7-aminoheptyl]carbamoyl]methane; (III; R3 = NHAc)}.  Using a cyclic secondary amine to form the C-28 amide bond increased the metabolic stability of the derivs. significantly in pooled human liver microsomes.  The most potent compds. IV [R4 = NH(CH2)n-(morpholin-4-yl); n = 2, 3] displayed potent anti-HIV activity with EC50 values of 0.007 and 0.006 μM, resp.  These results are slightly better than that of bevirimat (3',3'-dimethylsuccinylbetulinic acid), which is currently in phase IIb clin. trials.  Compds. IV should serve as attractive promising leads to develop next generation, metabolically stable, 3,28-disubstituted bifunctional HIV-1 inhibitors as clin. trials candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnG8q47AfIZbVg90H21EOLACvtfcHk0lifh64YRbkgYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvFers7k%253D&md5=2cb7709d314dc06552c7dc499f9b8a56</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm900136j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900136j%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DReddick%26aufirst%3DM.%26aulast%3DAllaway%26aufirst%3DG.%2BP.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAnti-AIDS%2520agents.%252078.%2520Design%252C%2520synthesis%252C%2520metabolic%2520stability%2520assessment%252C%2520and%2520antiviral%2520evaluation%2520of%2520novel%2520betulinic%2520acid%2520derivatives%2520as%2520potent%2520anti-human%2520immunodeficiency%2520virus%2520%2528HIV%2529%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3248%26epage%3D3258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y. B.</span><span> </span><span class="NLM_article-title">The design and synthesis of highly branched and spherically symmetric fluorinated oils and amphiles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=3982-3988&author=Z.+X.+Jiangauthor=Y.+B.+Yu&title=The+design+and+synthesis+of+highly+branched+and+spherically+symmetric+fluorinated+oils+and+amphiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYu%26aufirst%3DY.%2BB.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520highly%2520branched%2520and%2520spherically%2520symmetric%2520fluorinated%2520oils%2520and%2520amphiles%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D3982%26epage%3D3988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301040s&amp;key=10.1016%2Fj.nucmedbio.2005.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=16253804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=799-809&author=W.+Zhangauthor=S.+Oyaauthor=M.+P.+Kungauthor=C.+Houauthor=D.+L.+Maierauthor=H.+F.+Kung&title=F-18+polyethyleneglycol+stilbenes+as+PET+imaging+agents+targeting+A%CE%B2+aggregates+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span></div><div class="casAuthors">Zhang, Wei; Oya, Shunichi; Kung, Mei-Ping; Hou, Catherine; Maier, Donna L.; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">799-809</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This paper describes a novel series of 18F-labeled polyethyleneglycol (PEG)-stilbene derivs. as potential β-amyloid (Aβ) plaque-specific imaging agents for positron emission tomog. (PET).  In these series of compds., 18F is linked to the stilbene through a PEG chain, of which the no. of ethoxy groups ranges from 2 to 5.  The purpose of adding PEG groups is to lower the lipophilicity and improve bioavailability.  The syntheses of the "cold" compds. and the 18F-labeled PEG stilbene derivs. are successfully achieved.  All of the fluorinated stilbenes displayed high binding affinities in an assay using postmortem AD brain homogenates (Ki=2.9-6.7 nM).  Labeling was successfully performed by a substitution of the mesylate group of 10a-d by [18F]fluoride giving the target compds. [18F]12a-d (EOS, specific activity, 900-1500 Ci/mmol; radiochem. purity >99%).  In vivo biodistribution of these novel 18F ligands in normal mice exhibited excellent brain penetrations and rapid washouts after an i.v. injection (6.6-8.1 and 1.2-2.6 %dose/g at 2 and 60 min, resp.).  Autoradiog. of postmortem AD brain sections of [18F]12a-d confirmed the specific binding related to the presence of Aβ plaques.  In addn., in vivo plaque labeling can be clearly demonstrated with these 18F-labeled agents in transgenic mice (Tg2576), a useful animal model for Alzheimer's disease.  In conclusion, the preliminary results strongly suggest these fluorinated PEG stilbene derivs. are suitable candidates as Aβ plaque imaging agents for studying patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLVZvNjp7mrVg90H21EOLACvtfcHk0lg811WJbKvEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN&md5=059e56c983730296968273991e30f0b8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DOya%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DMaier%26aufirst%3DD.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DF-18%2520polyethyleneglycol%2520stilbenes%2520as%2520PET%2520imaging%2520agents%2520targeting%2520A%25CE%25B2%2520aggregates%2520in%2520the%2520brain%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D799%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holz-Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span> </span><span class="NLM_article-title">The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">15227</span><span class="NLM_x">–</span> <span class="NLM_lpage">15232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=15227-15232&author=C.+B.+Zhuauthor=L.+Zhuauthor=S.+Holz-Smithauthor=T.+J.+Matthewsauthor=C.+H.+Chen&title=The+role+of+the+third+beta+strand+in+gp120+conformation+and+neutralization+sensitivity+of+the+HIV-1+primary+isolate+DH012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DHolz-Smith%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DT.%2BJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520the%2520third%2520beta%2520strand%2520in%2520gp120%2520conformation%2520and%2520neutralization%2520sensitivity%2520of%2520the%2520HIV-1%2520primary%2520isolate%2520DH012%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D15227%26epage%3D15232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris-Natschke, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Anti-AIDS agents 81. Design, synthesis, and structure–activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3133</span><span class="NLM_x">–</span> <span class="NLM_lpage">3141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901782m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3133-3141&author=K.+Qianauthor=R.+Y.+Kuoauthor=C.+H.+Chenauthor=L.+Huangauthor=S.+L.+Morris-Natschkeauthor=K.+H.+Lee&title=Anti-AIDS+agents+81.+Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+study+of+betulinic+acid+and+moronic+acid+derivatives+as+potent+HIV+maturation+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm901782m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901782m%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%26aulast%3DKuo%26aufirst%3DR.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAnti-AIDS%2520agents%252081.%2520Design%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520betulinic%2520acid%2520and%2520moronic%2520acid%2520derivatives%2520as%2520potent%2520HIV%2520maturation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3133%26epage%3D3141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm301040s&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm301040s&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lg811WJbKvEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i52"><a href="/doi/suppl/10.1021/jm301040s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18833"></div></div></div></div></div><hr /></hr><p class="last">Additional information on compound purity, high-resolution mass spectroscopic data, and HPLC analysis results of the target compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301040s/suppl_file/jm301040s_si_001.pdf">jm301040s_si_001.pdf (59.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301040s&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-18%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm301040s%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301040s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                483KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992c96ed6f3d12","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
